Submitted URL: http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019102201ashp&r=9372293-e4bb&l=00c-87c&t=c
Effective URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idU...
Submission: On October 22 via api from US

Summary

This website contacted 80 IPs in 8 countries across 53 domains to perform 267 HTTP transactions. The main IP is 54.230.95.132, located in Seattle, United States and belongs to AMAZON-02 - Amazon.com, Inc., US. The main domain is www.reuters.com.
TLS certificate: Issued by Amazon on April 2nd 2019. Valid for: a year.
This is the only time www.reuters.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 1 69.174.55.131 3257 (GTT-BACKB...)
3 54.230.95.132 16509 (AMAZON-02)
10 143.204.101.92 16509 (AMAZON-02)
2 2600:9000:215... 16509 (AMAZON-02)
1 2600:9000:200... 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
5 13.225.78.70 16509 (AMAZON-02)
6 2a00:1450:400... 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
1 2a04:4e42:3::714 54113 (FASTLY)
1 54.228.221.127 16509 (AMAZON-02)
7 23.45.108.200 20940 (AKAMAI-ASN1)
1 143.204.99.83 16509 (AMAZON-02)
4 13.225.78.103 16509 (AMAZON-02)
10 104.18.135.13 13335 (CLOUDFLAR...)
1 147.75.85.25 54825 (PACKET)
3 2606:4700:20:... 13335 (CLOUDFLAR...)
3 2606:4700::68... 13335 (CLOUDFLAR...)
1 2600:9000:20e... 16509 (AMAZON-02)
3 52.72.30.216 14618 (AMAZON-AES)
2 2a03:2880:f01... 32934 (FACEBOOK)
1 147.75.85.103 54825 (PACKET)
1 2600:1f18:624... 14618 (AMAZON-AES)
1 143.204.101.12 16509 (AMAZON-02)
1 2600:9000:200... 16509 (AMAZON-02)
1 147.75.33.59 54825 (PACKET)
1 2606:4700::68... 13335 (CLOUDFLAR...)
1 34.199.180.208 14618 (AMAZON-AES)
1 3 2.19.43.224 20940 (AKAMAI-ASN1)
1 35.201.93.216 15169 (GOOGLE)
2 52.26.147.254 16509 (AMAZON-02)
2 2a03:2880:f11... 32934 (FACEBOOK)
1 1 2a00:1450:400... 15169 (GOOGLE)
1 1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
3 34.253.43.81 16509 (AMAZON-02)
1 2600:9000:21f... 16509 (AMAZON-02)
1 52.20.123.7 14618 (AMAZON-AES)
1 2600:9000:21f... 16509 (AMAZON-02)
1 136.243.25.83 24940 (HETZNER-AS)
7 2.18.235.93 16625 (AKAMAI-AS)
1 13.224.196.35 16509 (AMAZON-02)
1 66.81.204.228 40034 (CONFLUENC...)
2 23.62.140.165 16625 (AKAMAI-AS)
4 2a00:1450:400... 15169 (GOOGLE)
9 2a00:1450:400... 15169 (GOOGLE)
9 172.217.23.98 15169 (GOOGLE)
8 199.166.0.26 7415 (ADSAFE-1)
3 2a00:1450:400... 15169 (GOOGLE)
3 52.85.183.199 16509 (AMAZON-02)
5 2.18.235.40 16625 (AKAMAI-AS)
1 1 35.177.169.46 16509 (AMAZON-02)
11 152.195.39.46 15133 (EDGECAST)
1 1 54.235.136.175 14618 (AMAZON-AES)
1 52.216.113.117 16509 (AMAZON-02)
4 2600:9000:21f... 16509 (AMAZON-02)
2 3.9.140.177 16509 (AMAZON-02)
4 199.166.0.32 7415 (ADSAFE-1)
1 143.204.101.90 16509 (AMAZON-02)
4 13.224.196.105 16509 (AMAZON-02)
1 172.217.18.102 15169 (GOOGLE)
12 104.244.36.20 7415 (ADSAFE-1)
1 1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
2 172.217.23.162 15169 (GOOGLE)
5 216.58.208.34 15169 (GOOGLE)
1 3.224.94.188 14618 (AMAZON-AES)
7 35.173.24.113 14618 (AMAZON-AES)
4 2a00:1450:400... 15169 (GOOGLE)
1 34.239.9.60 14618 (AMAZON-AES)
2 2a00:1450:400... 15169 (GOOGLE)
4 54.230.95.152 16509 (AMAZON-02)
4 2.18.233.180 16625 (AKAMAI-AS)
4 104.16.87.26 13335 (CLOUDFLAR...)
1 185.64.190.78 62713 (AS-PUBMATIC)
4 104.16.39.14 13335 (CLOUDFLAR...)
1 185.64.189.111 62713 (AS-PUBMATIC)
2 208.100.17.180 32748 (STEADFAST)
3 208.100.17.185 32748 (STEADFAST)
6 185.33.223.202 29990 (ASN-APPNEXUS)
2 16 34.95.120.147 15169 (GOOGLE)
1 208.100.17.177 32748 (STEADFAST)
6 208.100.17.183 32748 (STEADFAST)
6 72.251.249.13 29791 (VOXEL-DOT...)
1 2600:9000:20e... 16509 (AMAZON-02)
267 80
Apex Domain
Subdomains
Transfer
25 adsafeprotected.com
cdn.adsafeprotected.com
pixel.adsafeprotected.com
static.adsafeprotected.com
dt.adsafeprotected.com
180 KB
21 carambo.la
route.carambo.la
cdata.carambo.la
logging.carambo.la
inimage.carambo.la
analytics.carambo.la
xtr.carambo.la
media.carambo.la
265 KB
17 reuters.com
www.reuters.com
static.reuters.com
wireapi.reuters.com
601 KB
16 openx.net
33across-d.openx.net
eu-u.openx.net
341 KB
16 doubleclick.net
stats.g.doubleclick.net
securepubads.g.doubleclick.net
ad.doubleclick.net
googleads4.g.doubleclick.net
290 KB
13 tynt.com
cdn.tynt.com
sc.tynt.com
ic.tynt.com Failed
de.tynt.com
15 KB
10 dianomi.com
www.dianomi.com
17 KB
9 media.net
contextual.media.net
cdneast2-xch.media.net
139 KB
8 brid.tv
services.brid.tv
p.brid.tv
stats-dev.brid.tv
92 KB
8 googlesyndication.com
pagead2.googlesyndication.com
tpc.googlesyndication.com
ade.googlesyndication.com
71 KB
8 evidon.com
c.evidon.com
iabmap.evidon.com
36 KB
7 33across.com
cdn-sic.33across.com
sic.33across.com
ssc.33across.com
258 KB
7 s-onetag.com
get.s-onetag.com
beacon.s-onetag.com
dfp-gateway.s-onetag.com
onetag-geo.s-onetag.com
22 KB
6 lijit.com
ap.lijit.com
40 KB
6 adnxs.com
ib.adnxs.com
4 KB
6 pubmatic.com
ads.pubmatic.com
image6.pubmatic.com
sshowads.pubmatic.com
aktrack.pubmatic.com
19 KB
6 google-analytics.com
www.google-analytics.com
63 KB
5 reutersmedia.net
s2.reutersmedia.net
static.reutersmedia.net
185 KB
4 adlightning.com
tagan.adlightning.com
79 KB
4 googleapis.com
fonts.googleapis.com
4 KB
4 moatads.com
z.moatads.com
geo.moatads.com
199 KB
4 googletagservices.com
www.googletagservices.com
101 KB
4 google.de
www.google.de
adservice.google.de
622 B
4 google.com
www.google.com
adservice.google.com
694 B
3 moatpixel.com
reutersdfpcw319687550988.s.moatpixel.com
1 KB
3 demdex.net
dpm.demdex.net
reuters.demdex.net
5 KB
3 scorecardresearch.com
sb.scorecardresearch.com
2 KB
3 betrad.com
l.betrad.com
360 B
3 tinypass.com
experience.tinypass.com
cdn.tinypass.com
118 KB
3 tru.am
tru.am
beacon.tru.am
13 KB
3 hotjar.com
static.hotjar.com
script.hotjar.com
vars.hotjar.com
77 KB
3 chartbeat.com
static.chartbeat.com
mab.chartbeat.com
31 KB
2 gstatic.com
fonts.gstatic.com
20 KB
2 2mdn.net
gcdn.2mdn.net
r4---sn-4g5ednee.c.2mdn.net
2 MB
2 facebook.com
www.facebook.com
320 B
2 segment.io
api.segment.io
282 B
2 consensu.org
vendorlist.consensu.org
evidon.mgr.consensu.org
17 KB
2 facebook.net
connect.facebook.net
88 KB
2 reuters.tv
queso-cdn.prod.reuters.tv
sope.prod.reuters.tv
26 KB
1 amazonaws.com
s3.amazonaws.com
2 KB
1 pixel.watch
pixel.watch
322 B
1 mnet-ad.net
s.mnet-ad.net
356 B
1 utoumine.net
utoumine.net
422 B
1 chartbeat.net
ping.chartbeat.net
168 B
1 globalwebindex.net
gwiqcdn.globalwebindex.net
15 KB
1 cloudflare.com
cdnjs.cloudflare.com
2 KB
1 native.ai
cdn.native.ai
43 KB
1 segment.com
cdn.segment.com
71 KB
1 admantx.com
async01.admantx.com
363 B
1 ytimg.com
s.ytimg.com
9 KB
1 youtube.com
www.youtube.com
1 KB
1 googletagmanager.com
www.googletagmanager.com
74 KB
1 bulletinhealthcare.com
mailview.bulletinhealthcare.com
439 B
267 53
Domain Requested by
13 securepubads.g.doubleclick.net www.googletagservices.com
securepubads.g.doubleclick.net
www.reuters.com
tagan.adlightning.com
12 33across-d.openx.net 2 redirects tagan.adlightning.com
33across-d.openx.net
www.reuters.com
12 dt.adsafeprotected.com
10 www.dianomi.com static.reuters.com
www.dianomi.com
www.reuters.com
10 static.reuters.com www.reuters.com
8 pixel.adsafeprotected.com cdn.adsafeprotected.com
www.reuters.com
7 analytics.carambo.la cdata.carambo.la
7 contextual.media.net static.reuters.com
contextual.media.net
7 c.evidon.com static.reuters.com
c.evidon.com
6 ap.lijit.com www.reuters.com
ap.lijit.com
6 ib.adnxs.com tagan.adlightning.com
6 ic.tynt.com
6 media.carambo.la cdata.carambo.la
6 www.google-analytics.com www.googletagmanager.com
www.google-analytics.com
www.reuters.com
4 eu-u.openx.net tagan.adlightning.com
4 cdn-sic.33across.com tagan.adlightning.com
4 tagan.adlightning.com cdata.carambo.la
4 fonts.googleapis.com cdata.carambo.la
4 stats-dev.brid.tv
4 static.adsafeprotected.com pixel.adsafeprotected.com
www.reuters.com
4 dfp-gateway.s-onetag.com get.s-onetag.com
4 cdata.carambo.la www.reuters.com
cdata.carambo.la
4 www.googletagservices.com contextual.media.net
securepubads.g.doubleclick.net
4 wireapi.reuters.com static.reuters.com
3 de.tynt.com cdn.tynt.com
3 ads.pubmatic.com cdata.carambo.la
tagan.adlightning.com
3 reutersdfpcw319687550988.s.moatpixel.com
3 services.brid.tv securepubads.g.doubleclick.net
services.brid.tv
3 tpc.googlesyndication.com securepubads.g.doubleclick.net
tagan.adlightning.com
3 pagead2.googlesyndication.com securepubads.g.doubleclick.net
3 adservice.google.com www.googletagservices.com
tagan.adlightning.com
3 adservice.google.de www.googletagservices.com
tagan.adlightning.com
3 sb.scorecardresearch.com 1 redirects www.reuters.com
3 l.betrad.com www.reuters.com
3 s2.reutersmedia.net www.reuters.com
3 www.reuters.com static.reuters.com
www.googletagmanager.com
2 sic.33across.com tagan.adlightning.com
2 sc.tynt.com tagan.adlightning.com
2 cdn.tynt.com tagan.adlightning.com
2 fonts.gstatic.com cdata.carambo.la
2 static.reutersmedia.net cdata.carambo.la
2 ade.googlesyndication.com
2 geo.moatads.com z.moatads.com
2 z.moatads.com securepubads.g.doubleclick.net
2 cdneast2-xch.media.net
2 reuters.demdex.net www.reuters.com
2 www.facebook.com www.reuters.com
www.googletagmanager.com
2 api.segment.io cdn.segment.com
2 connect.facebook.net cdn.segment.com
connect.facebook.net
2 experience.tinypass.com www.reuters.com
cdn.tinypass.com
2 tru.am www.googletagmanager.com
tru.am
2 static.chartbeat.com www.reuters.com
1 onetag-geo.s-onetag.com beacon.s-onetag.com
1 ssc.33across.com cdn-sic.33across.com
1 aktrack.pubmatic.com tagan.adlightning.com
1 sshowads.pubmatic.com tagan.adlightning.com
1 image6.pubmatic.com tagan.adlightning.com
1 xtr.carambo.la cdata.carambo.la
1 inimage.carambo.la cdata.carambo.la
1 logging.carambo.la cdata.carambo.la
1 googleads4.g.doubleclick.net
1 r4---sn-4g5ednee.c.2mdn.net
1 gcdn.2mdn.net 1 redirects
1 ad.doubleclick.net services.brid.tv
1 p.brid.tv services.brid.tv
1 s3.amazonaws.com www.reuters.com
1 pixel.watch 1 redirects
1 route.carambo.la 1 redirects
1 s.mnet-ad.net
1 cdn.adsafeprotected.com contextual.media.net
1 utoumine.net
1 beacon.s-onetag.com get.s-onetag.com
1 ping.chartbeat.net
1 get.s-onetag.com www.googletagmanager.com
1 dpm.demdex.net www.reuters.com
1 www.google.de www.reuters.com
1 www.google.com 1 redirects
1 stats.g.doubleclick.net 1 redirects
1 gwiqcdn.globalwebindex.net www.reuters.com
1 evidon.mgr.consensu.org c.evidon.com
1 cdnjs.cloudflare.com www.dianomi.com
1 beacon.tru.am tru.am
1 vars.hotjar.com static.hotjar.com
1 vendorlist.consensu.org c.evidon.com
1 cdn.native.ai www.reuters.com
1 sope.prod.reuters.tv static.reuters.com
1 script.hotjar.com static.hotjar.com
1 cdn.tinypass.com experience.tinypass.com
1 iabmap.evidon.com c.evidon.com
1 static.hotjar.com www.googletagmanager.com
1 cdn.segment.com www.reuters.com
1 async01.admantx.com static.reuters.com
1 s.ytimg.com www.youtube.com
1 mab.chartbeat.com static.chartbeat.com
1 www.youtube.com www.reuters.com
1 www.googletagmanager.com www.reuters.com
1 queso-cdn.prod.reuters.tv www.reuters.com
1 mailview.bulletinhealthcare.com 1 redirects
267 98
Subject Issuer Validity Valid
www.reuters.com
Amazon
2019-04-02 -
2020-05-02
a year crt.sh
static.reuters.com
Amazon
2018-11-28 -
2019-12-28
a year crt.sh
*.chartbeat.com
Gandi Standard SSL CA 2
2019-04-10 -
2020-04-10
a year crt.sh
*.prod.reuters.tv
Amazon
2019-01-28 -
2020-02-28
a year crt.sh
*.google-analytics.com
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
*.google.com
GTS CA 1O1
2019-10-10 -
2020-01-02
3 months crt.sh
f6.shared.global.fastly.net
GlobalSign CloudSSL CA - SHA256 - G3
2019-10-17 -
2020-08-07
10 months crt.sh
*.admantx.com
SSL.com RSA SSL subCA
2019-03-29 -
2021-06-25
2 years crt.sh
*.evidon.com
DigiCert ECC Secure Server CA
2019-02-01 -
2020-05-02
a year crt.sh
*.segment.com
DigiCert SHA2 Secure Server CA
2019-06-24 -
2020-07-01
a year crt.sh
wireapi.reuters.com
Amazon
2019-01-01 -
2020-02-01
a year crt.sh
ssl424245.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-08-30 -
2020-03-07
6 months crt.sh
static.hotjar.com
Let's Encrypt Authority X3
2019-10-06 -
2020-01-04
3 months crt.sh
ssl389962.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-09-11 -
2020-03-19
6 months crt.sh
*.tinypass.com
DigiCert SHA2 Secure Server CA
2019-01-31 -
2020-03-20
a year crt.sh
l.betrad.com
Go Daddy Secure Certificate Authority - G2
2019-04-25 -
2021-06-24
2 years crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2019-09-22 -
2019-12-20
3 months crt.sh
script.hotjar.com
Let's Encrypt Authority X3
2019-10-06 -
2020-01-04
3 months crt.sh
cdn.native.ai
Amazon
2019-08-26 -
2020-09-26
a year crt.sh
vendorlist.consensu.org
Amazon
2019-03-06 -
2020-04-06
a year crt.sh
vars.hotjar.com
Let's Encrypt Authority X3
2019-10-06 -
2020-01-04
3 months crt.sh
ssl412106.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-08-10 -
2020-02-16
6 months crt.sh
evidon.mgr.consensu.org
Amazon
2019-08-22 -
2020-09-22
a year crt.sh
*.scorecardresearch.com
COMODO RSA Organization Validation Secure Server CA
2018-11-28 -
2019-12-26
a year crt.sh
*.globalwebindex.net
RapidSSL RSA CA 2018
2017-12-13 -
2020-12-19
3 years crt.sh
www.google.de
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
*.demdex.net
DigiCert SHA2 High Assurance Server CA
2018-01-09 -
2021-02-12
3 years crt.sh
*.s-onetag.com
Amazon
2019-06-25 -
2020-07-25
a year crt.sh
*.chartbeat.net
Thawte RSA CA 2018
2018-12-20 -
2020-01-01
a year crt.sh
utoumine.net
Let's Encrypt Authority X3
2019-09-05 -
2019-12-04
3 months crt.sh
*.media.net
DigiCert SHA2 Secure Server CA
2018-12-30 -
2020-03-30
a year crt.sh
*.adsafeprotected.com
COMODO RSA Domain Validation Secure Server CA
2018-08-20 -
2020-09-17
2 years crt.sh
*.mnet-ad.net
Sectigo RSA Domain Validation Secure Server CA
2019-04-04 -
2020-04-15
a year crt.sh
*.g.doubleclick.net
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
tpc.googlesyndication.com
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
*.brid.tv
Go Daddy Secure Certificate Authority - G2
2019-01-02 -
2020-03-03
a year crt.sh
moatads.com
DigiCert ECC Secure Server CA
2018-11-10 -
2020-02-09
a year crt.sh
*.carambo.la
DigiCert SHA2 Secure Server CA
2019-02-21 -
2021-02-25
2 years crt.sh
s3.amazonaws.com
DigiCert Baltimore CA-2 G2
2019-09-06 -
2020-12-02
a year crt.sh
*.moatads.com
DigiCert SHA2 Secure Server CA
2019-03-12 -
2021-06-10
2 years crt.sh
*.doubleclick.net
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
*.c.docs.google.com
GTS CA 1O1
2019-10-10 -
2019-12-19
2 months crt.sh
*.googleapis.com
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
*.adlightning.com
Amazon
2019-08-19 -
2020-09-19
a year crt.sh
*.pubmatic.com
DigiCert SHA2 Secure Server CA
2018-12-13 -
2020-03-13
a year crt.sh
*.tynt.com
Sectigo RSA Domain Validation Secure Server CA
2019-10-01 -
2021-09-30
2 years crt.sh
*.33across.com
Sectigo RSA Domain Validation Secure Server CA
2019-10-01 -
2021-09-30
2 years crt.sh
*.adnxs.com
DigiCert ECC Secure Server CA
2019-01-23 -
2021-03-08
2 years crt.sh
*.openx.net
GeoTrust RSA CA 2018
2018-01-04 -
2020-07-09
3 years crt.sh
*.lijit.com
Go Daddy Secure Certificate Authority - G2
2019-03-11 -
2020-05-10
a year crt.sh

This page contains 32 frames:

Primary Page: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Frame ID: 59B5CFBA7355C5AFF6D129E922275EEC
Requests: 148 HTTP requests in this frame

Frame: https://vars.hotjar.com/box-74dcf4e32eff343c96838bf3a780ac1d.html
Frame ID: 5FE64F71C1D4DD23E0C57486AB1E7BC0
Requests: 1 HTTP requests in this frame

Frame: https://www.dianomi.com/smartads.epl?id=4728&num_ads=5&shuffle=0&cf=545.4.Reuters%20v3.1
Frame ID: ABBABD5FD42D06F0EFC3CABC60356D87
Requests: 1 HTTP requests in this frame

Frame: https://www.dianomi.com/recirculation.epl?id=98&cf=545.4.Reuters%20v3.1
Frame ID: 2E74CC8ECB05291B816ABD7D9A649C57
Requests: 1 HTTP requests in this frame

Frame: https://www.dianomi.com/recirculation.epl?id=99&start=6&cf=545.4.Reuters%20v3.1
Frame ID: 3E8953A3F1014CD4A54A304A2D0E7922
Requests: 1 HTTP requests in this frame

Frame: https://reuters.demdex.net/dest5.html?d_nsid=0
Frame ID: 6B4ADC28234FC18CF7B096863E84F44E
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: B902B2D2E53D919B778E4A9061C23EBB
Requests: 1 HTTP requests in this frame

Frame: https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=25&https=1&gdpr=1&gdprconsent=0
Frame ID: 8478972322D88652C659E32EEC61C701
Requests: 1 HTTP requests in this frame

Frame: https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=101&https=1&gdpr=1&gdprconsent=0
Frame ID: 04062B9C3DF4E085AA4ABD479FC75E6D
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsu17QDoyUyAytxLjXycPXC00EL1q69zHZaMfGyZcp4zBgD3lJzwwff3EVh-GhRfQt-NcUJkdBTVQaP-1yc5Dj5TTr2Gl73VZYF9DYWmSr2fpv05v1IpEoYUfFFO1NSS5eOStWnGhXEoY166-u8rU21GBjTehXBxpFFdwgdbQB-ymOcadWiRSLDkIBr4s13jUrOddFmgBN16oYupxUibu0M5oN7I6xY-aMDf_9s7UtUpJVStvhhytA3-MjI3WuUmJlpPSoseJf6y5lrnWqWASdlV3KozmMHI-aoffg&sai=AMfl-YRjnBMHsDD_jgFnc9zjWIvdpLxJIaOTLlbaxhVGtJLtkt1JP5iDWb34_6He_hAh84nt9Sd_0UWvKNZnMWKurvpfyCXfu5Z9OC4saFDk6A&sig=Cg0ArKJSzE9RspHzoNrBEAE&urlfix=1&adurl=
Frame ID: E6D524E54559E49AFF8F42676B2AA5DA
Requests: 17 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsudqolrdEBeZr-XPYtj2Ws2Wf_hUkrZpwLeQDsReC2r_E4t1i397DFPr_DnwGuUE4Yy0_o5MFpHYfehm3AG1mPRPCp7ocDzPyGsGVclLuEG_omQ4DJdD9C-90kLzRkCdCN73hDkhdxx9IdD_fqQwCcZSJWSTdHh-YFqHHMqcAAVUSc2sUIMd1nGLPEYP_B-cZcGrP5kyEcPlgcEgzHIHXF4fs9FkA716ZYFaE1PfvfgzLFlvJs-YuhcFjpqfNxRqv-l809xAzguqIJy8mdfY3hkWb2xZ5A&sai=AMfl-YSEf_b0dph5vnIuRwDGPYoiKlvY_2U6acdpDx3xEJNzfcbFs9-uF86zW54XDYOgrSdLVLzXiweLjcEiWjBj6hjW7lzRctegEcMMvbUZYg&sig=Cg0ArKJSzKGEOohhSo3MEAE&urlfix=1&adurl=
Frame ID: 37966FEF7E1153AC0724E139D38BDE37
Requests: 31 HTTP requests in this frame

Frame: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x280&pubId=20159232&chanId=37592232&placementId=139199112&pubCreative=138204787707&pubOrder=277213512&cb=20506831&custom=bizdev_article_rr2&custom2=20000&custom3=0&adsafe_par&impId=e42e934b-f4e0-11e9-b31e-382c4ac6318d
Frame ID: 7F7F210B9AE37CF32143797ECCEEDFEA
Requests: 2 HTTP requests in this frame

Frame: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x250&pubId=4789302609&chanId=37592232&placementId=5189420777&pubCreative=138289622787&pubOrder=2599246982&cb=875247425&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=e42fa4dd-f4e0-11e9-9948-00259086cbca
Frame ID: 7476B734A4786435801CD1D7D5BF7104
Requests: 2 HTTP requests in this frame

Frame: https://static.adsafeprotected.com/sca.17.4.95.js
Frame ID: D3D9CF32993DB5E22D3E0994C5E1349A
Requests: 1 HTTP requests in this frame

Frame: https://static.adsafeprotected.com/sca.17.4.95.js
Frame ID: CC9F9907D0595914434CFC02BF1B51CE
Requests: 1 HTTP requests in this frame

Frame: https://tagan.adlightning.com/carambola/blacklist_script.js
Frame ID: DE1E3DB0962579D353140D352DBE976F
Requests: 17 HTTP requests in this frame

Frame: https://tagan.adlightning.com/carambola/blacklist_script.js
Frame ID: 6FF71A5ECF3D5BA0FA08CD665F9F2EF4
Requests: 14 HTTP requests in this frame

Frame: https://ads.pubmatic.com/AdServer/js/showad.js
Frame ID: 79B9355885411725511FFAC5902C3193
Requests: 1 HTTP requests in this frame

Frame: https://ads.pubmatic.com/AdServer/js/showad.js
Frame ID: 6734D916D9A1E3691626CCB223486767
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Frame ID: CAB220136E3AFA58EEE6FF20E86D6F4F
Requests: 7 HTTP requests in this frame

Frame: https://aktrack.pubmatic.com/AdServer/AdDisplayTrackerServlet?operId=1&pubId=156612&siteId=251236&adId=2075066&adType=3&adServerId=165&kefact=0.000000&kaxefact=0.000000&kadNetFrequecy=0&kadwidth=300&kadheight=250&kadsizeid=0&kltstamp=1571758239&indirectAdId=1840519&adServerOptimizerId=1&ranreq=0.9155429433756597&kpbmtpfact=0.000000&dcId=3&tldId=0&passback=30&svr=ADS22411U&ekefact=nyCvXaPEAgBR3Q0HZLSWcyGv5ChnqB8gxs3y0mHeyt_t8Pr1&ekaxefact=nyCvXbnEAgAQnMioScn6EQEppR7gINrKd42-PjRbzz9zB_0k&ekpbmtpfact=nyCvXcrEAgBSIimC6i9rcWwOeWzqcT-7xDELQ7bHMPQf7_W-&crID=0&campaignId=0&isRTB=0&imprId=4E335D94-813E-446D-B480-3296B597B393&oid=4E335D94-813E-446D-B480-3296B597B393&cntryId=58&domain=reuters.com&pageURL=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&sec=1&pmc=0
Frame ID: C0D4E457C1800A2FEA712D8F51785F52
Requests: 1 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: D5CB98D5A0FB281360D21B92BDB59D56
Requests: 2 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: 52104F2F61580B76AAA95ADCAFB71A49
Requests: 2 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: 6D14F4894580AE4E5FE859543FD66105
Requests: 2 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: CE485742CAB4A060AD70F64EFE242EC3
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: B312C9153E6BB24327FAEE975E1D665F
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Frame ID: 06ED13B5ECD6AEE77FE13A52FA03ADAF
Requests: 7 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: 0719F0087BDFAB05F66135CE8A367C21
Requests: 1 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: A6DA307295E9CFBCDF77E0E0C2A3DB48
Requests: 2 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: 4F4348167DE575AAFD854E4FE0DD7E2F
Requests: 2 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: 20A7840B973F163D4633ADEA5B1ED2CD
Requests: 2 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: 10F155BC8027BD67D6A01C55D6954CCB
Requests: 1 HTTP requests in this frame

Screenshot


Page URL History Show full URLs

  1. http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019102201ashp&r=9372293-e4bb&l=00c-87c&t=c HTTP 302
    https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for... Page URL

Detected technologies

Overall confidence: 50%
Detected patterns
  • url /\.aspx?(?:$|\?)/i

Overall confidence: 100%
Detected patterns
  • url /\.aspx?(?:$|\?)/i

Overall confidence: 100%
Detected patterns
  • headers server /nginx(?:\/([\d.]+))?/i

Overall confidence: 100%
Detected patterns
  • headers via /\(CloudFront\)$/i

Overall confidence: 50%
Detected patterns
  • url /\.aspx?(?:$|\?)/i

Overall confidence: 100%
Detected patterns
  • headers via /\(CloudFront\)$/i

Overall confidence: 100%
Detected patterns
  • script /googletagservices\.com\/tag\/js\/gpt(?:_mobile)?\.js/i

Overall confidence: 100%
Detected patterns
  • script /\/\/connect\.facebook\.net\/[^\/]*\/[a-z]*\.js/i

Overall confidence: 100%
Detected patterns
  • script /googlesyndication\.com\//i

Overall confidence: 100%
Detected patterns
  • script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i

Overall confidence: 100%
Detected patterns
  • html /<!-- (?:End )?Google Tag Manager -->/i

Overall confidence: 100%
Detected patterns
  • script /^\/\/static\.hotjar\.com\/c\/hotjar-/i

Overall confidence: 100%
Detected patterns
  • script /cdn\.segment\.com\/analytics\.js/i

Overall confidence: 100%
Detected patterns
  • html /<iframe[^>]* (?:id="comscore"|scr=[^>]+comscore)|\.scorecardresearch\.com\/beacon\.js|COMSCORE\.beacon/i
  • script /\.scorecardresearch\.com\/beacon\.js|COMSCORE\.beacon/i

Page Statistics

267
Requests

98 %
HTTPS

33 %
IPv6

53
Domains

98
Subdomains

80
IPs

8
Countries

6072 kB
Transfer

13753 kB
Size

15
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019102201ashp&r=9372293-e4bb&l=00c-87c&t=c HTTP 302
    https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 69
  • https://sb.scorecardresearch.com/b?c1=2&c2=6035630&ns__t=1571758232923&ns_c=UTF-8&cv=3.1&c8=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year%20-%20Reuters&c7=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&c9= HTTP 302
  • https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1571758232923&ns_c=UTF-8&cv=3.1&c8=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year%20-%20Reuters&c7=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&c9=
Request Chain 73
  • https://stats.g.doubleclick.net/r/collect?t=dc&aip=1&_r=3&v=1&_v=j79&tid=UA-24152976-22&cid=2132169831.1571758232&jid=1248493107&gjid=391411436&_gid=1362649515.1571758232&_u=aGDAiEAjR~&z=1602535941 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=2132169831.1571758232&jid=1248493107&_v=j79&z=1602535941 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=2132169831.1571758232&jid=1248493107&_v=j79&z=1602535941&slf_rd=1&random=1900890762
Request Chain 120
  • https://route.carambo.la/inimage/getlayer?pid=thms97&did=112441&wid=3&rdn=[RANDOM_NUMBER] HTTP 302
  • https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Request Chain 123
  • https://pixel.watch/q4m9 HTTP 302
  • https://s3.amazonaws.com/scripts-clickmeter-com/js/pixelNew.js
Request Chain 152
  • https://gcdn.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/id,itag,source,ctier,acao,ip,ipbits,expire/signature/8B7A8A1C69C9F732DE398CB9822694E23BF26F51.313C9ACCFFAABC44E1BDD3BEDA9B426C2A2904DD/key/ck2/file/file.mp4 HTTP 302
  • https://r4---sn-4g5ednee.c.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/acao,ctier,expire,id,ip,ipbits,itag,mip,mm,mn,ms,mv,mvi,pl,source/signature/813AEF3C4A7EFC89895FEEDA4ED836099D2806BE.45FD87517AAA1E28CF3BE59DB738A7EF70754A93/key/cms1/cms_redirect/yes/mip/2a01:4f8:192:5414::2/mm/42/mn/sn-4g5ednee/ms/onc/mt/1571758061/mv/m/mvi/3/pl/41/file/file.mp4
Request Chain 228
  • https://33across-d.openx.net/w/1.0/acj?ai=e091fa8f-d75b-4d1b-8b9a-409793db6794&o=229d2b3fac25ea&ju=https%3A//www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&jr=&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier3&c.pf=30&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250 HTTP 302
  • https://33across-d.openx.net/w/1.0/acj?cc=1&ai=e091fa8f-d75b-4d1b-8b9a-409793db6794&o=229d2b3fac25ea&ju=https%3A//www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&jr=&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier3&c.pf=30&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Request Chain 249
  • https://33across-d.openx.net/w/1.0/acj?o=275db9797c2a71&ju=https%3A//www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&jr=&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier3&c.pf=30&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250 HTTP 302
  • https://33across-d.openx.net/w/1.0/acj?cc=1&o=275db9797c2a71&ju=https%3A//www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&jr=&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier3&c.pf=30&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250

267 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
www.reuters.com/article/us-vertex-pharms-fda/
Redirect Chain
  • http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019102201ashp&r=9372293-e4bb&l=00c-87c&t=c
  • https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
200 KB
54 KB
Document
General
Full URL
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.132 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-132.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
a5f34cfd51f64210dfe832ab7125f041efc6beed19f7804a3c508e4940dfc5ff

Request headers

:method
GET
:authority
www.reuters.com
:scheme
https
:path
/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
none
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
content-type
text/html;charset=UTF-8
access-control-allow-headers
Access-Control-Allow-Origin,charset
access-control-allow-origin
http://admin.reuters.com
channel-name
healthNews
content-encoding
gzip
date
Tue, 22 Oct 2019 15:30:32 GMT
expires
Tue, 22 Oct 2019 15:17:35 GMT
last-updateda
Mon, 21 Oct 2019 22:31:59 GMT
server
nginx
vary
Accept-Encoding
x-cache
Miss from cloudfront
via
1.1 7b88ef0d81161ffd0111d52a2de2bd25.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2
x-amz-cf-id
yRV6rA617uyqrYzqtJdDK_w7MRdGhjikJuMOKpkNwCLkBZ7icutUdg==

Redirect headers

Cache-Control
private
Content-Type
text/html; charset=utf-8
Location
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Server
Microsoft-IIS/10.0
Set-Cookie
ASP.NET_SessionId=ou4wgwwfz5xhefn2npxpk5eu; path=/; HttpOnly
X-AspNet-Version
4.0.30319
X-BNN-Server
biapp1
Date
Tue, 22 Oct 2019 15:30:31 GMT
Content-Length
247
article.bundle.css
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
149 KB
16 KB
Stylesheet
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/article.bundle.css
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
27f08df1567ca0787d0e9bdfd6dc30cb6d250efdb932e0ac752abbb10cb87f19

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:10:11 GMT
content-encoding
gzip
age
1221
x-cache
Hit from cloudfront
status
200
content-length
16097
last-modified
Fri, 18 Oct 2019 18:58:47 GMT
server
nginx
vary
Accept-Encoding
content-type
text/css
via
1.1 a1098f0eeab192209962e3a9d76d0339.cloudfront.net (CloudFront)
cache-control
max-age=7200
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
i5-sUwPz3c_-N6Z5QChlIIdn6cdCam75baEjW_jFh4JbAJO_BfbBSw==
expires
Tue, 22 Oct 2019 17:04:14 GMT
common.bundle.css
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
480 KB
279 KB
Stylesheet
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.css
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
f789c9224c81ba9c39f3dd523c7d53b289574ecb6e3554bcc63f575ab45652c0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:10:11 GMT
content-encoding
gzip
last-modified
Fri, 18 Oct 2019 18:58:51 GMT
server
nginx
age
1221
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=7200
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
egY9oSgreW_POkbIlD2hdjsdAO5avxJXYfUcadlzWRVieeHProjN9Q==
via
1.1 a1098f0eeab192209962e3a9d76d0339.cloudfront.net (CloudFront)
expires
Tue, 22 Oct 2019 17:03:02 GMT
chartbeat_mab.js
static.chartbeat.com/js/
19 KB
8 KB
Script
General
Full URL
https://static.chartbeat.com/js/chartbeat_mab.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:3800:18:1fcd:349:ca21 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx /
Resource Hash
c1acfa727754dab58bedc79995a642e235c6fde6449824c4fba4318fc060c91c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:08:06 GMT
content-encoding
gzip
last-modified
Wed, 14 Aug 2019 01:44:12 GMT
server
nginx
age
1346
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/x-javascript
status
200
cache-control
max-age=7200
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
fKeL9D1gpwjqSeRjjOlM7oRkUnFvf1-Gm1Hl1SNLcOcmbekflgfuhA==
via
1.1 f7b7cf90592cf6a380fd34cc45e9c4b5.cloudfront.net (CloudFront)
expires
Tue, 22 Oct 2019 17:08:06 GMT
embedder.bundle.js
queso-cdn.prod.reuters.tv/new/assets/
50 KB
13 KB
Script
General
Full URL
https://queso-cdn.prod.reuters.tv/new/assets/embedder.bundle.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200c:a600:1e:ef1b:aa40:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx/1.14.0 (Ubuntu) /
Resource Hash
3ad6849c327eac0d747d48c9e8d0430e5599933b668c944154f8228ec48b19ac

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:29:57 GMT
content-encoding
gzip
x-origin
i-001de507f23474502.queso.prod.us.reuters.tv
age
35
x-cache
Hit from cloudfront
status
200
access-control-allow-origin
*
last-modified
Thu, 21 Mar 2019 19:00:31 GMT
server
nginx/1.14.0 (Ubuntu)
vary
Accept-Encoding
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/javascript
via
1.1 7c2d73d3cd46e357090188fa2946f746.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2
access-control-allow-headers
connection, range, accept-encoding, user-agent, referer, content-type
x-amz-cf-id
DYt4D8i9dOjrasOvq4_fUESr1c2oeRnfiJraqj6OTS4GJxWxlt4dlQ==
gtm.js
www.googletagmanager.com/
286 KB
74 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
e5b5d63adc886c996f55c3cd74fab30fbd7769f9a2023b4ae83709ea44d75ab1
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
br
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
75404
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:32 GMT
3aae9fd5da3557fba61d6444cb943643.png
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
1 KB
2 KB
Image
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/3aae9fd5da3557fba61d6444cb943643.png
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
6346ee09058d555984eb04aac881775c926b5d9d4f73ca91493f7cb708ed90df

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 19:05:41 GMT
content-encoding
gzip
age
73491
x-cache
Hit from cloudfront
status
200
content-length
1539
last-modified
Fri, 18 Oct 2019 18:58:44 GMT
server
nginx
vary
Accept-Encoding
content-type
image/png
via
1.1 a1098f0eeab192209962e3a9d76d0339.cloudfront.net (CloudFront)
cache-control
max-age=86400
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
PXm2hlQ3_Kfe_tsTDnxeEAdvw0y_k6yCmcYwb2OFcuRFM1rW_4887g==
expires
Sat, 19 Oct 2019 19:05:11 GMT
/
s2.reutersmedia.net/resources/r/
741 B
1 KB
Image
General
Full URL
https://s2.reutersmedia.net/resources/r/?m=02&d=20191021&t=2&i=1443461056&r=LYNXMPEF9K1MF&w=20
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.70 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-70.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
3178348ceb9b22e193f3c01a54d3d109977b5bb3016e6abcc29bd30d4a1ae405

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 19:23:22 GMT
via
1.1 590590f04f79f692591f9db0e720a31d.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Thu, 21 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Mon, 21 Oct 2019 19:22:04 GMT
server
nginx
age
56436
etag
"29c2723bf9929dede273da21c993f526"
x-cache
Hit from cloudfront
x-amz-version-id
ayfMelckEv2_ObwV1aae.nY0Gr6T6OSI
status
200
x-amz-cf-pop
FRA2-C2
content-type
image/jpeg
content-length
741
x-amz-cf-id
rLSLJcQGnFpOD5GSOJQbjb4SlrDRIfLc7s_TRi6GoLGN1tjD2k9IAg==
common.bundle.js
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
731 KB
175 KB
Script
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
d62e1ce4a06c3bc837907935917e23462591f87162a171c0cdf5be61c7dcd04e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:10:08 GMT
content-encoding
gzip
last-modified
Fri, 18 Oct 2019 18:58:51 GMT
server
nginx
age
1224
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=7200
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
aPpzIvj0a5WW1KtaHCanURlGlmQ6ZINZG0dqUqmBzIt9g0svhmsSfg==
via
1.1 a1098f0eeab192209962e3a9d76d0339.cloudfront.net (CloudFront)
expires
Tue, 22 Oct 2019 17:06:07 GMT
article.bundle.js
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
360 KB
52 KB
Script
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/article.bundle.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
c35c41a7ff7df6d6d0d3e1ba8382602098f32fe9018ee20c827d8b82f7d390e7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:10:08 GMT
content-encoding
gzip
age
1224
x-cache
Hit from cloudfront
status
200
content-length
52458
last-modified
Fri, 18 Oct 2019 18:58:47 GMT
server
nginx
vary
Accept-Encoding
content-type
application/javascript
via
1.1 a1098f0eeab192209962e3a9d76d0339.cloudfront.net (CloudFront)
cache-control
max-age=7200
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
pwFCFHPQxCGuVakvi8Fsxf-ksAt_9CyxhZLcuDGQZ45pis9INPbsBg==
expires
Tue, 22 Oct 2019 17:07:43 GMT
analytics.js
www.google-analytics.com/
43 KB
17 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
dbb67c620eaabf6679a314db18d3ae43037aef71ab27422e6feec08ee987cc0a
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 19 Aug 2019 17:22:41 GMT
server
Golfe2
age
5783
date
Tue, 22 Oct 2019 13:54:09 GMT
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=7200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
17803
expires
Tue, 22 Oct 2019 15:54:09 GMT
js
www.google-analytics.com/gtm/
60 KB
22 KB
Script
General
Full URL
https://www.google-analytics.com/gtm/js?id=GTM-TBBXQQ&t=gtm1&cid=2132169831.1571758232
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
9e223d43450fc3a047c5eb120c7b38d5ae9b3cf337ffb18352820727dff5dc33
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
br
last-modified
Tue, 22 Oct 2019 15:00:00 GMT
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
22753
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:32 GMT
iframe_api
www.youtube.com/
859 B
1 KB
Script
General
Full URL
https://www.youtube.com/iframe_api
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
YouTube Frontend Proxy /
Resource Hash
16dd54686a3ed4ca169cba44af157ea072d91930a6b5ad3690b4651820e5e0b2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
x-content-type-options
nosniff
server
YouTube Frontend Proxy
content-type
application/javascript
status
200
cache-control
no-cache
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
859
x-xss-protection
0
expires
Tue, 27 Apr 1971 19:44:06 EST
/
mab.chartbeat.com/mab_strategy/headline_testing/get_strategy/
196 B
485 B
XHR
General
Full URL
https://mab.chartbeat.com/mab_strategy/headline_testing/get_strategy/?host=reuters.com&domain=reuters.com&path=%2Farticle%2Fus-vertex-pharms-fda-idUSKBN1X024U
Requested by
Host: static.chartbeat.com
URL: https://static.chartbeat.com/js/chartbeat_mab.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a04:4e42:3::714 , Ascension Island, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software
/
Resource Hash
27386ee8c40112e07aa75a555e1b14ece3923dfaa433eeb0a79727ad6b5e6ced

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
gzip
age
0
x-cache
MISS
status
200
x-cache-hits
0
content-length
163
x-served-by
cache-fra19156-FRA
access-control-allow-origin
*
x-timer
S1571758232.277743,VS0,VE554
vary
Origin, Access-Control-Request-Headers, Access-Control-Request-Method, Accept-Encoding
content-type
application/json
via
1.1 varnish (Varnish/6.0), 1.1 varnish
cache-control
no-store, no-cache, must-revalidate, max-age=0, s-maxage=0
accept-ranges
bytes
expires
Sun, 20 Oct 2019 15:30:32 GMT
www-widgetapi.js
s.ytimg.com/yts/jsbin/www-widgetapi-vfloS5Wsk/
23 KB
9 KB
Script
General
Full URL
https://s.ytimg.com/yts/jsbin/www-widgetapi-vfloS5Wsk/www-widgetapi.js
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/iframe_api
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
b631fccbe48b26dccef2b6eedeed2d6fb9020daf34dbc8010e587e280b6f498e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 11:18:24 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
15128
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
8680
x-xss-protection
0
last-modified
Mon, 21 Oct 2019 15:44:35 GMT
server
sffe
vary
Accept-Encoding, Origin
content-type
text/javascript
cache-control
public, max-age=691200
accept-ranges
bytes
timing-allow-origin
https://www.youtube.com
expires
Wed, 30 Oct 2019 11:18:24 GMT
truncated
/
49 KB
49 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
f01d25f7a76e0682a7a43230c32bef653eaf28b8a6f7a683ebb88bf8c6aa4f50

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Origin
https://www.reuters.com

Response headers

Content-Type
application/font-woff
truncated
/
49 KB
49 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
d7d62426c6b87d35cef5c2c873355aa44edffcf4a7f927f1c51b10694ea4f6ed

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Origin
https://www.reuters.com

Response headers

Content-Type
application/font-woff
truncated
/
71 KB
71 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ee0768f9d2def8b13df284410776f5d755109e77b5c0ca17d8895f65b343a0cd

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Origin
https://www.reuters.com

Response headers

Content-Type
application/font-woff
service
async01.admantx.com/admantx/
167 B
363 B
Script
General
Full URL
https://async01.admantx.com/admantx/service?request=%7B%22key%22%3A%22234330834c41105ad5ed794fa036e085b40225c44f9228bb9e2692f427917605%22%2C%20%22decorator%22%3A%22template.reuters%22%2C%20%22filter%22%3A%5B%22default%22%5D%2C%20%22method%22%3A%22descriptor%22%2C%20%22mode%22%3A%22async%22%2C%20%22type%22%3A%22URL%22%2C%20%22body%22%3A%22https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-vertex-pharms-fda%252Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U%22%7D
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.228.221.127 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-228-221-127.eu-west-1.compute.amazonaws.com
Software
nginx/1.12.2 /
Resource Hash
0cfc36510d222641115a1c26859bd49c37be811b7efe7186f13957c43eec7198

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Access-Control-Allow-Origin
*
Date
Tue, 22 Oct 2019 15:30:32 GMT
Server
nginx/1.12.2
Connection
keep-alive
Content-Length
167
Content-Type
text/plain; charset=UTF-8
evidon-sitenotice-tag.js
c.evidon.com/sitenotice/
44 KB
12 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
311f7c035bd8e2e36fdef1962231c004e48199087b73427a87499997210bfe16

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
11996
last-modified
Wed, 16 Oct 2019 16:58:44 GMT
server
AkamaiNetStorage
etag
"b42c671932dcdded523f9b56fb2dc206:1571245124"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Wed, 23 Oct 2019 15:30:32 GMT
country.js
c.evidon.com/geo/
260 B
512 B
Script
General
Full URL
https://c.evidon.com/geo/country.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
f9784f57729f84391b084eed9e944e048f771129d65e9b58f34095fdfba86473

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
last-modified
Wed, 30 May 2018 22:23:16 GMT
server
AkamaiNetStorage
status
200
etag
"c1e367d098d326049811561575dbda4a:1527718996"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
accept-ranges
bytes
access-control-allow-headers
*
content-length
260
snthemes.js
c.evidon.com/sitenotice/1237/
47 KB
4 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/1237/snthemes.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
9acfa6b6f02010f813de948aa45812ab104fcbfd5a75d11b71574d0654b6edff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
3321
last-modified
Tue, 22 Oct 2019 14:50:17 GMT
server
AkamaiNetStorage
etag
"f9ff12f5449c57350ebacf667963ce79:1571755817"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Wed, 23 Oct 2019 15:30:32 GMT
settings.js
c.evidon.com/sitenotice/1237/reuters/
7 KB
2 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/1237/reuters/settings.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
d317a796ec71a426b54a0d428e6f89ac3a593e4c95a9083d648ff3b59a561834

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
1856
last-modified
Tue, 22 Oct 2019 14:23:10 GMT
server
AkamaiNetStorage
etag
"a5a0770f4f82e6e927147e8aa98e9b4f:1571754190"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Wed, 23 Oct 2019 15:30:32 GMT
analytics.min.js
cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/
332 KB
71 KB
Script
General
Full URL
https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.99.83 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-99-83.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
b5eb1036a718795af24a1b9aaba0ce2cf74384aea489fac422467c3b6066e7e4

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
GWwT2wYzPv7nRke6aNi9WO4FQDe2D3uI
content-encoding
gzip
etag
"c858c6d81fad609f6cf9c6b955a2eeed"
age
225
x-cache
Hit from cloudfront
status
200
x-amz-replication-status
COMPLETED
content-length
71907
access-control-allow-origin
*
last-modified
Mon, 21 Oct 2019 21:55:19 GMT
server
AmazonS3
date
Tue, 22 Oct 2019 15:26:48 GMT
access-control-max-age
3000
access-control-allow-methods
GET, HEAD
content-type
text/javascript; charset=utf-8
via
1.1 5d8c59c4e33ff30f6610982ac8ad0232.cloudfront.net (CloudFront)
cache-control
public, max-age=300
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
ZuiizVsuMuOVC3Qt-DVCU8Uag2vG_wOgMD5dYc9whXWDzk0gbCpJDw==
finance
wireapi.reuters.com/v7/feed/rcom/us/top-nav/
50 B
508 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.103 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-103.fra2.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:27:29 GMT
via
1.1 linkerd, 1.1 217b7bc19321a4945b685521fa4f11ac.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
x-amzn-remapped-date
Tue, 22 Oct 2019 15:27:29 GMT
x-amz-cf-pop
FRA2-C2
x-amzn-requestid
70cfa8d6-2461-4281-b8ad-e0a00c1275b8
x-cache
Error from cloudfront
status
404
l5d-success-class
1.0
x-amz-apigw-id
B-HrMH9yjoEFuVw=
content-length
50
vary
Origin
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
x-amz-cf-id
2HG3RsJH82BaZIoQHdHxl31lQJOaHTBZeQE2uR8ZSeSk91RoXcvnMQ==
x-amzn-remapped-connection
keep-alive
markets
wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance/
50 B
510 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance/markets?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.103 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-103.fra2.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:27:29 GMT
via
1.1 linkerd, 1.1 217b7bc19321a4945b685521fa4f11ac.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
x-amzn-remapped-date
Tue, 22 Oct 2019 15:27:29 GMT
x-amz-cf-pop
FRA2-C2
x-amzn-requestid
a1e408ea-78e8-4b08-904c-824a50398d39
x-cache
Error from cloudfront
status
404
l5d-success-class
1.0
x-amz-apigw-id
B-HrMEjDIAMF-QA=
content-length
50
vary
Origin
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
x-amz-cf-id
Bk90U5YXRWbWSG_TTtqs7yRXfuL1h1XHm6C6QaPsQhTlVSVHjmJqtQ==
x-amzn-remapped-connection
keep-alive
world
wireapi.reuters.com/v7/feed/rcom/us/top-nav/news/
50 B
509 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/us/top-nav/news/world?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.103 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-103.fra2.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:27:29 GMT
via
1.1 linkerd, 1.1 217b7bc19321a4945b685521fa4f11ac.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
x-amzn-remapped-date
Tue, 22 Oct 2019 15:27:29 GMT
x-amz-cf-pop
FRA2-C2
x-amzn-requestid
f1c793bb-7bd8-4b6c-8bb4-86d5f8b2404f
x-cache
Error from cloudfront
status
404
l5d-success-class
1.0
x-amz-apigw-id
B-HrOFpUoAMF0Kg=
content-length
50
vary
Origin
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
x-amz-cf-id
8wUV9a1T6cHldiPAAd-lmRkx2zHZ85Cd1iGMp3C2DvNP1R4SzxXr4w==
x-amzn-remapped-connection
keep-alive
politics
wireapi.reuters.com/v7/feed/rcom/us/top-nav/
50 B
508 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/us/top-nav/politics?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.103 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-103.fra2.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:27:29 GMT
via
1.1 linkerd, 1.1 217b7bc19321a4945b685521fa4f11ac.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
x-amzn-remapped-date
Tue, 22 Oct 2019 15:27:29 GMT
x-amz-cf-pop
FRA2-C2
x-amzn-requestid
93d23b80-735f-4a4a-aa91-a79ca358c451
x-cache
Error from cloudfront
status
404
l5d-success-class
1.0
x-amz-apigw-id
B-HrMEolIAMF_lA=
content-length
50
vary
Origin
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
x-amz-cf-id
gLkvFd1OlkzyYoCeiru-H3B6b8XtaCwqr9MYykfELAqH0nRAdimzyw==
x-amzn-remapped-connection
keep-alive
contextfeed.js
www.dianomi.com/js/
9 KB
3 KB
Script
General
Full URL
https://www.dianomi.com/js/contextfeed.js?
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/article.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
7a736b2f2091be24fcca895da408ed1bf5b0a66dbc3e27522864fe29652db3c8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
age
521
cf-polished
origSize=11527
status
200
x-xss-protection
1; mode=block
last-modified
Wed, 16 Oct 2019 11:34:07 GMT
server
cloudflare
etag
W/"2d07-595057a8e8736"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
expires
Tue, 22 Oct 2019 19:30:32 GMT
cache-control
public, max-age=14400
access-control-allow-credentials
true
cf-ray
529c83598cbad6c5-FRA
cf-bgj
minify
breakingNews
www.reuters.com/assets/
1 B
361 B
Fetch
General
Full URL
https://www.reuters.com/assets/breakingNews?view=json
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.132 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-132.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
01ba4719c80b6fe911b091a7c05124b64eeece964e09c058ef8f9805daca546b

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
via
1.1 7b88ef0d81161ffd0111d52a2de2bd25.cloudfront.net (CloudFront)
server
nginx
x-amz-cf-pop
FRA2
status
200
x-cache
Miss from cloudfront
content-type
application/json;charset=UTF-8
access-control-allow-origin
http://admin.reuters.com
access-control-allow-headers
Access-Control-Allow-Origin,charset
content-length
1
x-amz-cf-id
mKCuOwgebFze58W-8iU_avmGEkBhzDsiKNQVG-Els70NAmzuVkwpdA==
expires
Tue, 22 Oct 2019 15:30:09 GMT
/
s2.reutersmedia.net/resources/r/
135 KB
135 KB
Image
General
Full URL
https://s2.reutersmedia.net/resources/r/?m=02&d=20191021&t=2&i=1443461056&r=LYNXMPEF9K1MF&w=1280
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.70 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-70.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
277d6fe3bad0b7cccb0ed3c3ffaf0423d631206b337b0b23cac930a47f935f08

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 19:23:22 GMT
via
1.1 590590f04f79f692591f9db0e720a31d.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Thu, 21 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Mon, 21 Oct 2019 19:22:00 GMT
server
nginx
age
56436
etag
"f6922630774542cd3fb0ae449e6921b9"
x-cache
Hit from cloudfront
x-amz-version-id
aDNWcJWyHYVc_B541c9fkVhgCL7XiZ8d
status
200
x-amz-cf-pop
FRA2-C2
content-type
image/jpeg
content-length
137956
x-amz-cf-id
vtx1a78grqE4FpCnZUMwtMsY-4zDQDa0XxZPjKT3sfnBWePYHsVF8w==
hotjar-65715.js
static.hotjar.com/c/
5 KB
3 KB
Script
General
Full URL
https://static.hotjar.com/c/hotjar-65715.js?sv=5
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.85.25 Parsippany, United States, ASN54825 (PACKET - Packet Host, Inc., US),
Reverse DNS
pkt-ams-k1-9
Software
openresty /
Resource Hash
7732aecc587b25f4d4b429fa86c05eb183b146476e9a25e6b9f3d5f19b680801
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
gzip
x-content-type-options
nosniff
section-io-tag
hotjar
age
59
status
200
section-io-cache
Hit
vary
Accept-Encoding
content-length
2392
server
openresty
cache-control
max-age=60
x-frame-options
SAMEORIGIN
etag
W/d8c24d1ea75f723b71d94adbd6348cbd
access-control-max-age
600
section-io-origin-status
304
access-control-allow-origin
*
x-cache-hit
1
section-io-origin-time-seconds
0.079
section-io-id
2a217ab986255549f6d5bd1f08151f86
accept-ranges
bytes
content-type
application/javascript
reuters.js
tru.am/scripts/custom/
1 KB
787 B
Script
General
Full URL
https://tru.am/scripts/custom/reuters.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:a322 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6f23d93c9b8e3ca26f6fcc6be6a8d087e43a3f5795daa3c61017071642f66f3c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Thu, 14 Jun 2018 18:27:56 GMT
server
cloudflare
age
933
etag
W/"40b7d4de06dae04ec0d6537ef2f54db8"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=86400
cf-ray
529c8359de0acba8-VIE
expires
Wed, 23 Oct 2019 15:30:32 GMT
load
experience.tinypass.com/xbuilder/experience/
4 KB
1 KB
Script
General
Full URL
https://experience.tinypass.com/xbuilder/experience/load?aid=TIDovF4cqC
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:4c33 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
bd1dc64fac45e75fffefbd76f176c6ea118ab79b88b3efddc5642d4e7c76d4fe

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
br
cf-cache-status
HIT
age
1521
p3p
CP="NON DSP COR OUR IND"
status
200
x-forwarded-https
on
x-request-id
Cj77szpYpRz
wn
prod-exp-10-0-6-10
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
accept-encoding
content-type
application/javascript;charset=utf-8
cache-control
public, max-age=1800
cf-ray
529c8359bfabcbc4-VIE
expires
Tue, 22 Oct 2019 16:00:32 GMT
en.js
c.evidon.com/sitenotice/1237/translations/
55 KB
5 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/1237/translations/en.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
42ebce48f38ca99ec71f9cdc53e4555d4d0fbd8bdd1a0740e123e32d1b58502d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
4709
last-modified
Mon, 14 Oct 2019 18:54:07 GMT
server
AkamaiNetStorage
etag
"bcc188e94557debbc19be771b7b3cee8:1571079247"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Wed, 23 Oct 2019 15:30:32 GMT
js
www.google-analytics.com/gtm/
60 KB
22 KB
Script
General
Full URL
https://www.google-analytics.com/gtm/js?id=GTM-KBK7743&cid=2132169831.1571758232
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
605b6328846dedec173402f4dadfaf7bc7fb60b8ae0087f2f9cc03fc44248219
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
br
last-modified
Tue, 22 Oct 2019 15:00:00 GMT
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
22752
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:32 GMT
linkid.js
www.google-analytics.com/plugins/ua/
2 KB
920 B
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/linkid.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 14:50:00 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 21 Apr 2016 03:17:22 GMT
server
sffe
age
2432
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=3600
accept-ranges
bytes
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
856
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:50:00 GMT
iabevidonmapping.js
iabmap.evidon.com/
7 KB
3 KB
Script
General
Full URL
https://iabmap.evidon.com/iabevidonmapping.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20eb:5a00:10:27b4:f500:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
a092021e174c55591059b1000001f762a8f9dfb2620a5ab7a402ded82046192b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 23:24:38 GMT
content-encoding
gzip
last-modified
Tue, 08 Oct 2019 17:18:25 GMT
server
AmazonS3
age
73567
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
x-amz-cf-pop
FRA2-C1
x-amz-cf-id
v8MtXCVUy0w8HrlhSCkj1AdDvtZ1kJ3gX89qh8b3RJhLR7Ei0JW4ag==
via
1.1 3aed5a4f89d72775aaf2cc5a5f642386.cloudfront.net (CloudFront)
evidon-cmp.js
c.evidon.com/sitenotice/
23 KB
7 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/evidon-cmp.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
2c0255dc71491f7eb909fabf7c2a4111eb30b4373097086c5bf04e93804057dc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
6652
last-modified
Wed, 16 Oct 2019 16:58:46 GMT
server
AkamaiNetStorage
etag
"cf000373b0fd7b697588ee13bd7024a8:1571245126"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Wed, 23 Oct 2019 15:30:32 GMT
evidon-banner.js
c.evidon.com/sitenotice/
10 KB
3 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/evidon-banner.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
06d56458db165cd0ede7a6c23b441e81d0269feac7f8793d582253cc63e9db38

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
2958
last-modified
Wed, 16 Oct 2019 16:58:45 GMT
server
AkamaiNetStorage
etag
"119ff1c01eb744dc72c66e4d7f49b38b:1571245125"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Wed, 23 Oct 2019 15:30:32 GMT
2
l.betrad.com/site/v3/1237/5669/3/1/2/
0
120 B
Image
General
Full URL
https://l.betrad.com/site/v3/1237/5669/3/1/2/2?consent=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.72.30.216 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-72-30-216.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
gzip
x-powered-by
Express
etag
W/"a-bAsFyilMr4Ra1hIU5PyoyFRunpI"
vary
Accept-Encoding
fbevents.js
connect.facebook.net/en_US/
103 KB
22 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
9404cee30e4489a7ed4d6de2dd92aa8e4386fd5ff1c81ebcea77f581952eac31
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-23=":443"; ma=3600
content-length
22458
x-xss-protection
0
pragma
public
x-fb-debug
VcexrozG5sCFwl2RmYBPmbPgiBwYdniztsMlnZsSaG7dKNmuwoym0QBOa0gJ7mjekd2scji+FNNBMIDpXKCTCA==
x-fb-trip-id
1850256238
x-frame-options
DENY
date
Tue, 22 Oct 2019 15:30:32 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
expires
Sat, 01 Jan 2000 00:00:00 GMT
61500
l.betrad.com/site/v3/1237/5669/3/1/2/2/
0
120 B
Image
General
Full URL
https://l.betrad.com/site/v3/1237/5669/3/1/2/2/61500?consent=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.72.30.216 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-72-30-216.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
gzip
x-powered-by
Express
etag
W/"a-bAsFyilMr4Ra1hIU5PyoyFRunpI"
vary
Accept-Encoding
context.pl
www.dianomi.com/cgi-bin/
2 KB
769 B
XHR
General
Full URL
https://www.dianomi.com/cgi-bin/context.pl?id=4&h=www.reuters.com
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
20a6d2b7cfb04122ea4af740a815984fc15ffe7cbde0f298d70301b04fe27ff0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
content-type
application/json; charset=ISO-8859-1
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=600
access-control-allow-credentials
true
cf-ray
529c835a3b7cd6d9-FRA
x-xss-protection
1; mode=block
expires
Tue, 22 Oct 2019 15:31:32 GMT
tinypass.min.js
cdn.tinypass.com/api/
366 KB
116 KB
Script
General
Full URL
https://cdn.tinypass.com/api/tinypass.min.js
Requested by
Host: experience.tinypass.com
URL: https://experience.tinypass.com/xbuilder/experience/load?aid=TIDovF4cqC
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:4c33 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
249eca16ce578de148647856386d86fe20acbfa3a02b6618c90a1d5faedbbeb7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
br
cf-cache-status
HIT
age
166
p3p
CP="NON DSP COR OUR IND"
status
200
wn
prod-dash-10-0-1-142
last-modified
Mon, 21 Oct 2019 15:16:06 GMT
server
cloudflare
etag
W/"374421-1571670966000-gzip"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=300
cf-ray
529c835a48f1cbc4-VIE
expires
Tue, 22 Oct 2019 15:35:32 GMT
modules.cf993f1180b3bef0c641.js
script.hotjar.com/
436 KB
74 KB
Script
General
Full URL
https://script.hotjar.com/modules.cf993f1180b3bef0c641.js
Requested by
Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-65715.js?sv=5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.85.103 Parsippany, United States, ASN54825 (PACKET - Packet Host, Inc., US),
Reverse DNS
pkt-ams-k1-11
Software
/
Resource Hash
2a87d714442a06af96c943556506ce28717d07ad7142535cf4701848aa8895ac

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
br
last-modified
Tue, 22 Oct 2019 09:13:46 GMT
status
200
etag
"aa85afd469cc0ddf58f41b335baa4d85"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
max-age=31536000
section-io-origin-time-seconds
0.047
section-io-origin-status
200
accept-ranges
bytes
section-io-id
6b25e8cfd76f23fdbb1f65ad2d28b4dd
content-length
75465
312961195854690
connect.facebook.net/signals/config/
280 KB
65 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/312961195854690?v=2.9.5&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
f0accb42c769145b6d141864835eba045063021590a01aa8bcce348573ebb188
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-23=":443"; ma=3600
content-length
66234
x-xss-protection
0
pragma
public
x-fb-debug
51cv88GEbYFwvn6JY3QKD57kvQjCJ/S9/rdYffFONLUlW05shCr4qpwa3H5bPXUZqjY+FVMZqTlnvG/RDbRrTg==
x-fb-trip-id
1850256238
x-frame-options
DENY
date
Tue, 22 Oct 2019 15:30:32 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
article-recirc
sope.prod.reuters.tv/program/rcom/v1/
13 KB
13 KB
Fetch
General
Full URL
https://sope.prod.reuters.tv/program/rcom/v1/article-recirc?edition=us&pageid=USKBN1X024U&modules=rightrail,ribbon,bottom
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f18:624f:b000:4319:b1c8:f4e4:70ed Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
Software
nginx/1.14.0 (Ubuntu) /
Resource Hash
c20c78f76e72e601d21a05e37138aa5c104c023f4241dc160a0378ca9c66092f

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
seq
1e3b7c2e-d0f1-478f-9bc5-ab436b478792

Response headers

date
Tue, 22 Oct 2019 15:30:33 GMT
x-origin
i-066a9bd6909ed8c8a.sope.prod.us.reuters.tv
server
nginx/1.14.0 (Ubuntu)
x-amzn-trace-id
Root=1-5daf2099-d81d9523ffb863bd2c866bbd
status
200
content-type
application/json
access-control-allow-origin
*
access-control-allow-headers
connection, range, accept-encoding, user-agent, referer, seq
content-length
12868
ta-pagesocial-sdk.js
tru.am/scripts/
35 KB
12 KB
Script
General
Full URL
https://tru.am/scripts/ta-pagesocial-sdk.js
Requested by
Host: tru.am
URL: https://tru.am/scripts/custom/reuters.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:a322 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
2b8d8ef7fec86e16424f0c6be7f0471a0c29256e074e1336d92876ddb4bc09ff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Thu, 18 Apr 2019 03:51:14 GMT
server
cloudflare
age
5822
etag
W/"942d5ae1e512ccdf18813550428dd002"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=86400
cf-ray
529c835a5f44cba8-VIE
expires
Wed, 23 Oct 2019 15:30:32 GMT
nativeai.js
cdn.native.ai/js/current/
130 KB
43 KB
Script
General
Full URL
https://cdn.native.ai/js/current/nativeai.js?1571270400000
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.12 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-12.fra50.r.cloudfront.net
Software
nginx / ASP.NET
Resource Hash
bfcea73208d9a1f1a1f89d306cdff89c8d4a8740f0e7ab8b84501c1b86f3fd94

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:20:23 GMT
Content-Encoding
gzip
Last-Modified
Fri, 12 Jul 2019 21:55:34 GMT
Server
nginx
X-Amz-Cf-Pop
FRA50-C1
X-Powered-By
ASP.NET
Vary
Accept-Encoding
X-Cache
RefreshHit from cloudfront
Content-Type
application/javascript
Via
1.1 58bcd6f2e1bc29fb83f080f1743cfeca.cloudfront.net (CloudFront)
Cache-Control
max-age=0,must-revalidate
Transfer-Encoding
chunked
Connection
keep-alive
X-Amz-Cf-Id
EI60yTqZ7H_w5-G9o5uqDPfTcFVuwFsDTD6hUul7_uQ8TURZi5J3_g==
ads.js
www.reuters.com/
112 B
512 B
Script
General
Full URL
https://www.reuters.com/ads.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.132 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-132.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
7464555aae6d8d87b77f7170fba1698ff64f7454ded58627ca1819246e9a9969

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
gzip
server
nginx
x-amz-cf-pop
FRA2
status
200
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
http://admin.reuters.com
access-control-allow-headers
Access-Control-Allow-Origin,charset
content-length
116
via
1.1 7b88ef0d81161ffd0111d52a2de2bd25.cloudfront.net (CloudFront)
x-amz-cf-id
2e4NbUpZvXiRZ62SCTAAL95iQ5ZUlC4rDd2O3Grkc3nPr2zR0HkLyA==
expires
Tue, 22 Oct 2019 15:28:24 GMT
61500
l.betrad.com/site/v3/1237/5669/3/4/2/2/
0
120 B
Image
General
Full URL
https://l.betrad.com/site/v3/1237/5669/3/4/2/2/61500?consent=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.72.30.216 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-72-30-216.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
gzip
x-powered-by
Express
etag
W/"a-bAsFyilMr4Ra1hIU5PyoyFRunpI"
vary
Accept-Encoding
vendorlist.json
vendorlist.consensu.org/
88 KB
17 KB
XHR
General
Full URL
https://vendorlist.consensu.org/vendorlist.json
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-cmp.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:b200:1:af78:4c0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
3e25214e79eab3cf412ea2fec1eee887baf77be4448461d72f2af47ee093128a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
dDurJJk9w9s3FJNGQzpcI8tyg.M9IFSK
content-encoding
gzip
vary
Origin,Access-Control-Request-Headers,Access-Control-Request-Method
age
27141
x-cache
Hit from cloudfront
status
200
access-control-allow-origin
*
last-modified
Fri, 18 Oct 2019 08:50:37 GMT
server
AmazonS3
date
Tue, 22 Oct 2019 07:58:12 GMT
access-control-max-age
86400
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
via
1.1 147e057d2f96cf5a0082d96978e38a5b.cloudfront.net (CloudFront)
cache-control
max-age=259200
x-amz-cf-pop
FRA50
x-amz-cf-id
V4c60YPF5n1rNgWvGNftyhfc2DnZagJ7GvsumNQ0HtP-ApH78e-z5A==
box-74dcf4e32eff343c96838bf3a780ac1d.html
vars.hotjar.com/ Frame 5FE6
0
0
Document
General
Full URL
https://vars.hotjar.com/box-74dcf4e32eff343c96838bf3a780ac1d.html
Requested by
Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-65715.js?sv=5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.33.59 Amsterdam, Netherlands, ASN54825 (PACKET - Packet Host, Inc., US),
Reverse DNS
pkt-ams-k1-4
Software
/
Resource Hash

Request headers

:method
GET
:authority
vars.hotjar.com
:scheme
https
:path
/box-74dcf4e32eff343c96838bf3a780ac1d.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:32 GMT
content-type
text/html
content-length
808
cache-control
max-age=31536000
content-encoding
br
last-modified
Tue, 22 Oct 2019 14:07:08 GMT
etag
"e97b43816dfbff056689db51ae5cdfc7"
section-io-origin-status
200
section-io-origin-time-seconds
0.029
vary
Accept-Encoding
accept-ranges
bytes
section-io-id
350ced2b3a23a9e09b917816661efac9
execute
experience.tinypass.com/xbuilder/experience/
2 KB
1 KB
XHR
General
Full URL
https://experience.tinypass.com/xbuilder/experience/execute?aid=TIDovF4cqC
Requested by
Host: cdn.tinypass.com
URL: https://cdn.tinypass.com/api/tinypass.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:4c33 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
1074e38533de415b5f9617c971324f491142bf83e7c647e7138a8ce8b270b767

Request headers

Accept
*/*
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
br
cf-cache-status
DYNAMIC
p3p
CP="NON DSP COR OUR IND"
status
200
x-forwarded-https
on
x-request-id
Cwe8szpsq2W
pragma
no-cache
wn
prod-exp-10-0-1-208
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
access-control-allow-methods
POST, GET, OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cf-ray
529c835b0aa7cbc4-VIE
expires
Thu, 01 Jan 1970 00:00:00 GMT
beacon
beacon.tru.am/
0
352 B
Fetch
General
Full URL
https://beacon.tru.am/beacon
Requested by
Host: tru.am
URL: https://tru.am/scripts/ta-pagesocial-sdk.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:a322 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded;charset=UTF-8

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:33 GMT
via
1.1 google
cf-cache-status
DYNAMIC
server
cloudflare
status
200
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Origin
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, private, max-age=0
cf-ray
529c835b7910cbc8-VIE
content-length
0
expires
Thu, 01 Jan 1970 00:00:00 UTC
dianomi-context.css
www.dianomi.com/partner/dianomi/css/
169 B
246 B
Stylesheet
General
Full URL
https://www.dianomi.com/partner/dianomi/css/dianomi-context.css?v=1.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
99781410070a5dd4d753fdb8a46f4272082b5be64541dcfcb1b2d3c4aea09c6c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
age
524
cf-polished
origSize=199
status
200
x-xss-protection
1; mode=block
last-modified
Mon, 21 Jan 2019 12:43:41 GMT
server
cloudflare
etag
W/"c7-57ff735e16ce7"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css; charset=utf-8
access-control-allow-origin
*
expires
Tue, 22 Oct 2019 19:30:32 GMT
cache-control
public, max-age=14400
access-control-allow-credentials
true
cf-ray
529c835b4a77d6c5-FRA
cf-bgj
minify
smartads.epl
www.dianomi.com/ Frame ABBA
0
0
Document
General
Full URL
https://www.dianomi.com/smartads.epl?id=4728&num_ads=5&shuffle=0&cf=545.4.Reuters%20v3.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

:method
GET
:authority
www.dianomi.com
:scheme
https
:path
/smartads.epl?id=4728&num_ads=5&shuffle=0&cf=545.4.Reuters%20v3.1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
accept-encoding
gzip, deflate, br
cookie
__cfduid=dee4859796249e2130a5a8fcddb70662a1571758232
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:33 GMT
content-type
text/html; charset=UTF-8
x-content-type-options
nosniff
x-xss-protection
1; mode=block
access-control-allow-origin
*
access-control-allow-credentials
true
expires
now
pragma
no-cache
cache-control
no-cache,no-store,private
link
</img/a/pss/2649/23.css>;rel=preload;as=style
vary
Accept-Encoding, User-Agent
cf-cache-status
DYNAMIC
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
529c835b4a8bd6c5-FRA
content-encoding
br
cf-h2-pushed
</img/a/pss/2649/23.css>
videofeed-combined.js
www.dianomi.com/js/
15 KB
4 KB
Script
General
Full URL
https://www.dianomi.com/js/videofeed-combined.js?id=33
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
d31b1f947a51cfdc97520d53eb6610e8abf104e48569fb8069e917ffe5c7a617
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
age
524
cf-polished
origSize=20718
status
200
x-xss-protection
1; mode=block
last-modified
Wed, 09 Oct 2019 10:58:47 GMT
server
cloudflare
etag
W/"50ee-594782b536c0d"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
expires
Tue, 22 Oct 2019 19:30:32 GMT
cache-control
public, max-age=14400
access-control-allow-credentials
true
cf-ray
529c835b4a84d6c5-FRA
cf-bgj
minify
recirculation.epl
www.dianomi.com/ Frame 2E74
0
0
Document
General
Full URL
https://www.dianomi.com/recirculation.epl?id=98&cf=545.4.Reuters%20v3.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

:method
GET
:authority
www.dianomi.com
:scheme
https
:path
/recirculation.epl?id=98&cf=545.4.Reuters%20v3.1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
accept-encoding
gzip, deflate, br
cookie
__cfduid=dee4859796249e2130a5a8fcddb70662a1571758232
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:33 GMT
content-type
text/html; charset=utf-8
x-content-type-options
nosniff
x-xss-protection
1; mode=block
access-control-allow-origin
*
access-control-allow-credentials
true
vary
Accept-Encoding, User-Agent
cf-cache-status
DYNAMIC
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
529c835b5aa5d6c5-FRA
content-encoding
br
recirculation.epl
www.dianomi.com/ Frame 3E89
0
0
Document
General
Full URL
https://www.dianomi.com/recirculation.epl?id=99&start=6&cf=545.4.Reuters%20v3.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

:method
GET
:authority
www.dianomi.com
:scheme
https
:path
/recirculation.epl?id=99&start=6&cf=545.4.Reuters%20v3.1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
accept-encoding
gzip, deflate, br
cookie
__cfduid=dee4859796249e2130a5a8fcddb70662a1571758232
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:33 GMT
content-type
text/html; charset=utf-8
x-content-type-options
nosniff
x-xss-protection
1; mode=block
access-control-allow-origin
*
access-control-allow-credentials
true
vary
Accept-Encoding, User-Agent
cf-cache-status
DYNAMIC
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
529c835b6ad5d6c5-FRA
content-encoding
br
lazyload.iife.min.js
cdnjs.cloudflare.com/ajax/libs/vanilla-lazyload/10.20.1/
5 KB
2 KB
Script
General
Full URL
https://cdnjs.cloudflare.com/ajax/libs/vanilla-lazyload/10.20.1/lazyload.iife.min.js
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:c597 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
3c514d4fb8244af230a89d2203522c6a67a55a3f161cfd4fca9f53301c0588ff
Security Headers
Name Value
Strict-Transport-Security max-age=15780000; includeSubDomains

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
br
vary
Accept-Encoding
cf-cache-status
HIT
age
16392086
status
200
alt-svc
h3-23=":443"; ma=86400
served-in-seconds
0.028
timing-allow-origin
*
last-modified
Sun, 17 Feb 2019 22:45:49 GMT
server
cloudflare
etag
W/"5c69e41d-14cf"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=15780000; includeSubDomains
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=30672000
cf-ray
529c835b9d64cbc0-VIE
expires
Sun, 11 Oct 2020 15:30:32 GMT
dianomi-max-200x38.png
www.dianomi.com/img/
9 KB
9 KB
Image
General
Full URL
https://www.dianomi.com/img/dianomi-max-200x38.png
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
e4ec107483b9a2de4a043bad835b700257cfac8308ec6d00f760f1ff6eccfc6e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
x-content-type-options
nosniff
cf-cache-status
HIT
age
22140
cf-polished
origFmt=png, origSize=31456
status
200
content-disposition
inline; filename="dianomi-max-200x38.webp"
content-length
8976
x-xss-protection
1; mode=block
last-modified
Tue, 23 May 2017 10:48:47 GMT
server
cloudflare
etag
"7ae0-5502ebb78747a"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept
content-type
image/webp
access-control-allow-origin
*
expires
Fri, 22 Nov 2019 01:30:32 GMT
cache-control
public, max-age=2628000
access-control-allow-credentials
true
accept-ranges
bytes
cf-ray
529c835b6ad2d6c5-FRA
cf-bgj
imgq:85
pixeltrack.pl
www.dianomi.com/cgi-bin/
77 B
184 B
Image
General
Full URL
https://www.dianomi.com/cgi-bin/pixeltrack.pl?cf=545.4.Reuters%20v3.1
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
d4fa79afcf5a5cc5a0f12dedaf825f11530e6397d723fe7044cd37ba3c248e57
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:33 GMT
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
content-type
image/gif; charset=ISO-8859-1
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
529c835b6ad7d6c5-FRA
content-length
77
x-xss-protection
1; mode=block
expires
Mon, 21 Oct 2019 15:30:33 GMT
truncated
/
49 KB
49 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
45610b21279531a97f9566b0f0f8a1d287a45ae4bc6bc545971af5cd7e393cc6

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Origin
https://www.reuters.com

Response headers

Content-Type
application/font-woff
getcookie
evidon.mgr.consensu.org/iab/
169 B
380 B
Script
General
Full URL
https://evidon.mgr.consensu.org/iab/getcookie
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-cmp.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.199.180.208 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-199-180-208.compute-1.amazonaws.com
Software
/
Resource Hash
9b133863146a5f391e8cee0842cafc7498ae89b6f79edbecfc842055342c1fe2

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:33 GMT
x-amzn-requestid
22130fb1-92a0-4953-b0ad-c5af7a4c0464
status
200
content-type
text/javascript
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5daf2099-ef32a4dc868d1560895f654c;Sampled=0
x-amz-apigw-id
B-IH8Gs8IAMFVGg=
content-length
169
beacon.js
sb.scorecardresearch.com/
1 KB
1 KB
Script
General
Full URL
https://sb.scorecardresearch.com/beacon.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.19.43.224 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-19-43-224.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
d0fd74148f4cbe78bd0e6328dc5ce5955f0a0ecdb1eb2919da4a7e596ac65912

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:32 GMT
Content-Encoding
gzip
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
private, no-transform, max-age=86400
Connection
keep-alive
Content-Length
901
Expires
Wed, 23 Oct 2019 15:30:32 GMT
gwiq.js
gwiqcdn.globalwebindex.net/gwiq/
14 KB
15 KB
Script
General
Full URL
https://gwiqcdn.globalwebindex.net/gwiq/gwiq.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.201.93.216 , Ascension Island, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
216.93.201.35.bc.googleusercontent.com
Software
UploadServer /
Resource Hash
2f78a9f3d1d4b5078213d39c3f51ea1f5b72d91793a9e3fa14612e9d1add543d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:15:59 GMT
age
873
x-guploader-uploadid
AEnB2UoXz7VFff2CqRn6vRTrwc7f-s672hkD1aw9p_8Wz6fmmCCJCcfJ_wjE3r2IFkzuE_e2YI4GaR4ghCQdThoFo06fnUBx2g
x-goog-storage-class
MULTI_REGIONAL
status
200
x-goog-metageneration
3
x-goog-stored-content-encoding
identity
alt-svc
clear
content-length
14561
last-modified
Fri, 22 Mar 2019 17:21:14 GMT
server
UploadServer
etag
"7bb2a0f8543ca52adc2740318f3b8331"
x-goog-hash
crc32c=CMb65Q==, md5=e7Kg+FQ8pSrcJ0AxjzuDMQ==
x-goog-generation
1553275274038866
cache-control
public, max-age=3600
x-goog-stored-content-length
14561
accept-ranges
bytes
content-type
application/javascript
expires
Tue, 22 Oct 2019 16:15:59 GMT
smartads_video_json.pl
www.dianomi.com/cgi-bin/
3 B
171 B
XHR
General
Full URL
https://www.dianomi.com/cgi-bin/smartads_video_json.pl?id=4729&cf=545.4.Reuters%20v3.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/videofeed-combined.js?id=33
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
ca3d163bab055381827226140568f3bef7eaac187cebd76878e0b63e9e442356
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:33 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.reuters.com
cache-control
private, no-cache, no-store, must-revalidate, max-age=0, pre-check=0, post-check=0
access-control-allow-credentials
true
cf-ray
529c835c0824d6d9-FRA
x-xss-protection
1; mode=block
truncated
/
38 B
38 B
Other
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
52dc24c0429ea6ccc5b579a6da8bb79bf41e471fe5108a62009f3c2e195551c0

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/webp
b2
sb.scorecardresearch.com/
Redirect Chain
  • https://sb.scorecardresearch.com/b?c1=2&c2=6035630&ns__t=1571758232923&ns_c=UTF-8&cv=3.1&c8=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year%20-%20Reuters&c7=htt...
  • https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1571758232923&ns_c=UTF-8&cv=3.1&c8=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year%20-%20Reuters&c7=ht...
0
248 B
Image
General
Full URL
https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1571758232923&ns_c=UTF-8&cv=3.1&c8=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year%20-%20Reuters&c7=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&c9=
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.19.43.224 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-19-43-224.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:32 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1571758232923&ns_c=UTF-8&cv=3.1&c8=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year%20-%20Reuters&c7=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&c9=
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:32 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
p
api.segment.io/v1/
21 B
141 B
XHR
General
Full URL
https://api.segment.io/v1/p
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.26.147.254 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-26-147-254.us-west-2.compute.amazonaws.com
Software
/
Resource Hash
12f71cb993958eefc4bdb41d7dbbda490779a9c7aba448f7be52bb63912e0254

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:33 GMT
access-control-allow-origin
https://www.reuters.com
content-length
21
vary
Origin
content-type
application/json
/
www.facebook.com/tr/
44 B
320 B
Image
General
Full URL
https://www.facebook.com/tr/?id=312961195854690&ev=PageView&dl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&rl=&if=false&ts=1571758233089&sw=1600&sh=1200&v=2.9.5&r=stable&a=seg&ec=0&o=30&fbp=fb.1.1571758233089.2068739142&it=1571758232690&coo=false&rqm=GET
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:33 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
status
200
cache-control
no-cache, must-revalidate, max-age=0
alt-svc
h3-23=":443"; ma=3600
content-length
44
expires
Tue, 22 Oct 2019 15:30:33 GMT
collect
www.google-analytics.com/
35 B
99 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=289823103&t=pageview&_s=1&dl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Fvertex-prices-cystic-fibrosis-combo-treatment-at-311000-per-year-idUSKBN1X024U&dp=%2Farticle%2Fus-vertex-pharms-fda%2Fvertex-prices-cystic-fibrosis-combo-treatment-at-311000-per-year-idUSKBN1X024U&ul=en-us&de=UTF-8&dt=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&_u=aGDAiEAjR~&jid=1248493107&gjid=391411436&cid=2132169831.1571758232&tid=UA-24152976-22&_gid=1362649515.1571758232&cd2=Homepage&cd11=us-vertex-pharms-fda%2Fvertex-prices-cystic-fibrosis-combo-treatment-at-311000-per-year&cd4=News&cd8=0&cd10=False&cd9=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Fvertex-prices-cystic-fibrosis-combo-treatment-at-311000-per-year-idUSKBN1X024U&cd19=Page%20Load&cd7=Desktop&cd14=USKBN1X024U&cd6=U.S.&cd5=Article&cd17=Manojna%20Maddipatla%2C%20Carl%20O%27Donnell&cd3=Homepage%20-%20Homepage&cd1=Homepage&cd13=386&cd18=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year&z=803032855
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 11 Oct 2019 16:28:36 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
946917
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://stats.g.doubleclick.net/r/collect?t=dc&aip=1&_r=3&v=1&_v=j79&tid=UA-24152976-22&cid=2132169831.1571758232&jid=1248493107&gjid=391411436&_gid=1362649515.1571758232&_u=aGDAiEAjR~&z=1602535941
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=2132169831.1571758232&jid=1248493107&_v=j79&z=1602535941
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=2132169831.1571758232&jid=1248493107&_v=j79&z=1602535941&slf_rd=1&random=1900890762
42 B
109 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=2132169831.1571758232&jid=1248493107&_v=j79&z=1602535941&slf_rd=1&random=1900890762
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:33 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:33 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=2132169831.1571758232&jid=1248493107&_v=j79&z=1602535941&slf_rd=1&random=1900890762
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
0b9ae0631dc9cb1d12dd2eb240ef07bb.png
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
22 KB
9 KB
Image
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/0b9ae0631dc9cb1d12dd2eb240ef07bb.png
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
9f9104dee58871cdb561e4f139fcf095a2fc1fcb0a7778a964975e6b12059c6a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/article.bundle.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 19:00:31 GMT
content-encoding
gzip
age
73802
x-cache
Hit from cloudfront
status
200
content-length
9050
last-modified
Fri, 18 Oct 2019 18:58:43 GMT
server
nginx
vary
Accept-Encoding
content-type
image/png
via
1.1 a1098f0eeab192209962e3a9d76d0339.cloudfront.net (CloudFront)
cache-control
max-age=86400
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
iKNfwM-VoHjF76xcrKs66ZB8rkWrlPsMZx6NwUFm4wa5qF_qpX_9Xg==
expires
Tue, 22 Oct 2019 19:00:24 GMT
/
static.reuters.com/resources/r/
3 KB
4 KB
Image
General
Full URL
https://static.reuters.com/resources/r/?m=02&d=20191021&t=2&i=1443416505&r=LYNXMPEF9K1AY&w=120
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
d90d7d5ced0f4fbd1be3ac5c73c3a1be826082e352fd219e987682de3ba00f95

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 16:39:50 GMT
via
1.1 a1098f0eeab192209962e3a9d76d0339.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Thu, 21 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Mon, 21 Oct 2019 16:27:57 GMT
server
nginx
age
82240
etag
"6244ccc53daab6e1fa861e036141b20f"
x-cache
Hit from cloudfront
x-amz-version-id
x7oZbTHICwJXx3ZIIj1ETtPTIJL_W4UD
status
200
x-amz-cf-pop
FRA50-C1
content-type
image/jpeg
content-length
3389
x-amz-cf-id
yhq7yFdR6yZRyuMJ0xSE_zl7XeAhGf9geKdlbw6pOuDBn7UB5pWihg==
/
static.reuters.com/resources/r/
2 KB
3 KB
Image
General
Full URL
https://static.reuters.com/resources/r/?m=02&d=20191022&t=2&i=1443692184&r=LYNXMPEF9L0UM&w=120
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
5d4679a9bd79e6cae720fe200458a84f582ef16845e1cbe8945bdea7bb789ac4

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 14:05:23 GMT
via
1.1 a1098f0eeab192209962e3a9d76d0339.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Fri, 22 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Tue, 22 Oct 2019 14:05:23 GMT
server
nginx
age
5110
etag
"6d285dc553b8d459e9aaefed5ea11da8"
x-cache
Hit from cloudfront
x-amz-version-id
pKVedSiyPoMfBB_rADxt1ursJGrWuxu8
status
200
x-amz-cf-pop
FRA50-C1
content-type
image/jpeg
content-length
2234
x-amz-cf-id
l_Qi1FRbBf_ZaWhHHWvAt7dWVz8RFjLHwSIU6Muv8OhTrtaLoeT0bw==
/
static.reuters.com/resources/r/
2 KB
2 KB
Image
General
Full URL
https://static.reuters.com/resources/r/?m=02&d=20191021&t=2&i=1443309572&r=LYNXMPEF9K0O2&w=120
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
0cc9a65e6796a338995b77f195f6fe62ac4fbceb148bc859748ab517a754b102

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
iPD74NC9v1UM8wE_DMT0wTkXnsxCMWAd
via
1.1 a1098f0eeab192209962e3a9d76d0339.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Thu, 21 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Mon, 21 Oct 2019 10:36:12 GMT
server
nginx
age
17610
etag
"a4086eba2f12a0644e7f0606dcb3a060"
x-cache
Hit from cloudfront
content-type
image/jpeg
status
200
date
Tue, 22 Oct 2019 10:37:03 GMT
x-amz-cf-pop
FRA50-C1
content-length
1724
x-amz-cf-id
OQy4Gj-3-KXVI2XiqJpFscgGt3a0nj-5LUrXF-AKaN82OpFu0VbouQ==
/
static.reuters.com/resources/r/
3 KB
3 KB
Image
General
Full URL
https://static.reuters.com/resources/r/?m=02&d=20191021&t=2&i=1443509558&r=LYNXMPEF9K12A&w=120
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
c961286c83894d917256687b9b1ec26ac25240eac083b4ae762030e9dd98ca33

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 22:32:33 GMT
via
1.1 a1098f0eeab192209962e3a9d76d0339.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Thu, 21 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Mon, 21 Oct 2019 22:31:37 GMT
server
nginx
age
61021
etag
"97012a762769a6ac0dcb6b41ab930023"
x-cache
Hit from cloudfront
x-amz-version-id
xEiGlSXL8MjPfhu2Tf9Uam2Pj9.bwjaU
status
200
x-amz-cf-pop
FRA50-C1
content-type
image/jpeg
content-length
2866
x-amz-cf-id
3N2L_6EjDZEd7Cxolhdncp9hfR1rkGNn4n8b5dpT3725tewDL-i1rg==
chartbeat_video.js
static.chartbeat.com/js/
66 KB
23 KB
Script
General
Full URL
https://static.chartbeat.com/js/chartbeat_video.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:3800:18:1fcd:349:ca21 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx /
Resource Hash
88762480fb084c0725cf9c3abde10e540ebf64884fd50a86789b5eb661c38cdd

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:13:34 GMT
content-encoding
gzip
last-modified
Thu, 01 Aug 2019 01:36:07 GMT
server
nginx
age
1018
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/x-javascript
status
200
cache-control
max-age=7200
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
iaWBWZe4w4AkWV9FSLmNI3usahNkCYbBdWdJ0ImviZd3VTQCgZsnGQ==
via
1.1 f7b7cf90592cf6a380fd34cc45e9c4b5.cloudfront.net (CloudFront)
expires
Tue, 22 Oct 2019 17:13:34 GMT
id
dpm.demdex.net/
3 KB
2 KB
XHR
General
Full URL
https://dpm.demdex.net/id?d_visid_ver=4.4.0&d_fieldgroup=MC&d_rtbd=json&d_ver=2&d_orgid=4579BF7A580A3C6A0A495DAF%40AdobeOrg&d_nsid=0&ts=1571758233266
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.253.43.81 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-253-43-81.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
a8b582a5cd3f145f6d8371bc43c23b0b549f0eb546be026736b5f295fcf56f92
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

DCS
dcs-prod-irl1-v048-0adba7cef.edge-irl1.demdex.com 5.61.0.20191015084456 3ms (+0ms)
Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains
Content-Encoding
gzip
X-TID
6FU884JqQ6g=
Vary
Origin, Accept-Encoding, User-Agent
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Access-Control-Allow-Origin
https://www.reuters.com
Cache-Control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json;charset=utf-8
Content-Length
961
Expires
Thu, 01 Jan 1970 00:00:00 GMT
tag.min.js
get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/
41 KB
13 KB
Script
General
Full URL
https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:21f3:2800:1f:287:d20a:ce1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
a5537aed93100c34cdea277b5b092c37b6de90f11339384634a76a035030f7f0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
B0GnU21j5XMDwAuNEC12S2upHRxtcWd0
content-encoding
gzip
last-modified
Mon, 09 Sep 2019 10:39:51 GMT
server
AmazonS3
age
2610
date
Tue, 22 Oct 2019 14:47:04 GMT
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/javascript
status
200
cache-control
max-age=3600
x-amz-cf-pop
FRA2-C2
x-amz-cf-id
lBTG3X6jiD0PrbiTgzArzJ3HrXZ07J-rIkNjcU2juFRJjxu9rJ-sKg==
via
1.1 999a435eb37a050d3de26fe63534c416.cloudfront.net (CloudFront)
collect
www.google-analytics.com/
35 B
93 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=289823103&t=timing&_s=2&dl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&dp=%2Farticle%2Fus-vertex-pharms-fda%2Fvertex-prices-cystic-fibrosis-combo-treatment-at-311000-per-year-idUSKBN1X024U&ul=en-us&de=UTF-8&dt=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&plt=1360&pdt=7&dns=1&rrt=195&srt=53&tcp=13&dit=603&clt=603&_gst=307&_gbt=322&_cst=270&_cbt=300&_u=aGDAiEAjR~&jid=&gjid=&cid=2132169831.1571758232&tid=UA-24152976-22&_gid=1362649515.1571758232&cd2=Homepage&cd11=us-vertex-pharms-fda%2Fvertex-prices-cystic-fibrosis-combo-treatment-at-311000-per-year&cd4=News&cd8=0&cd10=False&cd9=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Fvertex-prices-cystic-fibrosis-combo-treatment-at-311000-per-year-idUSKBN1X024U&cd19=Page%20Load&cd7=Desktop&cd14=USKBN1X024U&cd6=U.S.&cd5=Article&cd17=Manojna%20Maddipatla%2C%20Carl%20O%27Donnell&cd3=Homepage%20-%20Homepage&cd1=Homepage&cd13=386&cd18=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year&z=1271080346
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 11 Oct 2019 16:28:36 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
946917
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
i
api.segment.io/v1/
21 B
141 B
XHR
General
Full URL
https://api.segment.io/v1/i
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.26.147.254 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-26-147-254.us-west-2.compute.amazonaws.com
Software
/
Resource Hash
12f71cb993958eefc4bdb41d7dbbda490779a9c7aba448f7be52bb63912e0254

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:33 GMT
access-control-allow-origin
https://www.reuters.com
content-length
21
vary
Origin
content-type
application/json
ping
ping.chartbeat.net/
43 B
168 B
Image
General
Full URL
https://ping.chartbeat.net/ping?h=reuters.com&p=reuters.com%2Farticle%2Fus-vertex-pharms-fda-idUSKBN1X024U&u=fGrWvDKYiWG5zMrJ&d=reuters.com&g=52639&g0=Homepage&g1=Manojna%20Maddipatla&g4=Article&n=1&f=00001&c=0&x=0&m=0&y=6341&o=1600&w=1200&j=45&R=1&W=0&I=0&E=0&e=0&r=&b=1360&t=CgC8FrCPOOXXB0gtgpxrfZQDblfky&V=116&i=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year%20-%20Reuters&tz=-120&sn=1&sv=Dt7hJKIiw1kBfxi35BwSb8aBuRnwj&sd=1&im=06679cf0&_
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.20.123.7 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-20-123-7.compute-1.amazonaws.com
Software
/
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Tue, 22 Oct 2019 15:30:33 GMT
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
content-length
43
expires
0
beacon.min.js
beacon.s-onetag.com/
18 KB
6 KB
Script
General
Full URL
https://beacon.s-onetag.com/beacon.min.js
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:21f3:e400:5:9a4c:9b00:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
662fa6bcdf71d8f92e29010d3e2e270e0071e5d19b1d14ce205654a78aa0a7a9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
dQ2IPgbwW_sArXQW0CBb3eN5W57SqoQ0
content-encoding
gzip
last-modified
Thu, 04 Apr 2019 09:35:05 GMT
server
AmazonS3
age
56
date
Tue, 22 Oct 2019 15:29:41 GMT
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=3600
x-amz-cf-pop
FRA2-C2
x-amz-cf-id
qtGpcr4-n2SrhtFHdW9x0hPSyJWjxvhaaRn-eSSj7V23cyTt7vgq3g==
via
1.1 e5b93012e2bfb81dc9846f43efd610a6.cloudfront.net (CloudFront)
Cookie set dest5.html
reuters.demdex.net/ Frame 6B4A
0
0
Document
General
Full URL
https://reuters.demdex.net/dest5.html?d_nsid=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.253.43.81 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-253-43-81.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Host
reuters.demdex.net
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Accept-Encoding
gzip, deflate, br
Cookie
demdex=17420010982148861100682802213572882302
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U

Response headers

Accept-Ranges
bytes
Cache-Control
max-age=21600
Content-Encoding
gzip
Content-Type
text/html
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Last-Modified
Wed, 16 Oct 2019 09:00:36 GMT
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Pragma
no-cache
Set-Cookie
demdex=17420010982148861100682802213572882302;Path=/;Domain=.demdex.net;Expires=Sun, 19-Apr-2020 15:30:33 GMT;Max-Age=15552000
Strict-Transport-Security
max-age=31536000; includeSubDomains
Vary
Accept-Encoding, User-Agent
X-TID
zYnjAinrSwA=
Content-Length
2764
Connection
keep-alive
/
s2.reutersmedia.net/resources/r/
68 B
459 B
Image
General
Full URL
https://s2.reutersmedia.net/resources/r/?f=19&m=19&d=20181016&t=7&i=5036238605&w=001&r=NVEEIBEiVO6hd
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.70 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-70.fra2.r.cloudfront.net
Software
ADFCDN/5.2.3 / AdDefend GmbH
Resource Hash
adfa0c7de03bc3bea3de80b4a4514881c8b6296568f43a5acd5cd7a16fffd1c9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:33 GMT
via
1.1 590590f04f79f692591f9db0e720a31d.cloudfront.net (CloudFront)
server
ADFCDN/5.2.3
x-amz-cf-pop
FRA2-C2
x-powered-by
AdDefend GmbH
x-cache
Miss from cloudfront
content-type
image/png
status
200
cache-control
max-age=0, max-stale=0, must-revalidate, no-cache, no-store, no-transform, post-check=0, pre-check=0, private
accept-ranges
bytes
content-length
68
x-amz-cf-id
3yNmvDkyf6K8yxOddWE_gwbf3dBQqiUc1dWdN3Ax-vPwMonwKq-Bzg==
expires
0
/
www.facebook.com/tr/ Frame B902
0
0
Document
General
Full URL
https://www.facebook.com/tr/
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

:method
POST
:authority
www.facebook.com
:scheme
https
:path
/tr/
content-length
2932
pragma
no-cache
cache-control
no-cache
origin
https://www.reuters.com
upgrade-insecure-requests
1
content-type
application/x-www-form-urlencoded
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
accept-encoding
gzip, deflate, br
cookie
fr=03DlCjET4uJ1dicZ1..BdryCZ...1.0.BdryCZ.
Origin
https://www.reuters.com
Upgrade-Insecure-Requests
1
Content-Type
application/x-www-form-urlencoded
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U

Response headers

status
200
content-type
text/plain
access-control-allow-origin
https://www.reuters.com
access-control-allow-credentials
true
strict-transport-security
max-age=31536000; includeSubDomains
content-length
0
server
proxygen-bolt
alt-svc
h3-23=":443"; ma=3600
date
Tue, 22 Oct 2019 15:30:33 GMT
/
utoumine.net/s/ad-time/
68 B
422 B
Image
General
Full URL
https://utoumine.net/s/ad-time/?e=19&m=17&d=20180927&t=5&i=6607220805&w=001&r=EIHCDBEiVO6hd.jpg
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
136.243.25.83 , Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS
api.addefend.com
Software
ADFCDN/5.2.3 / AdDefend GmbH
Resource Hash
adfa0c7de03bc3bea3de80b4a4514881c8b6296568f43a5acd5cd7a16fffd1c9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:33 GMT
Server
ADFCDN/5.2.3
X-Powered-By
AdDefend GmbH
Content-Type
image/png
Cache-Control
max-age=0, max-stale=0, must-revalidate, no-cache, no-store, no-transform, post-check=0, pre-check=0, private
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
68
Expires
0
event
reuters.demdex.net/
3 KB
3 KB
XHR
General
Full URL
https://reuters.demdex.net/event?d_dil_ver=9.3&_ts=1571758233761
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.253.43.81 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-253-43-81.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
eddd4ed4cbcc0a9990730f758d9eeaaee85985cc01ad0a62a9b410a669357471
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

DCS
dcs-prod-irl1-v048-09697bb8e.edge-irl1.demdex.com 5.61.0.20191015084456 4ms (+1ms)
Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains
X-TID
Mb/vAO95TGs=
Vary
Origin
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Access-Control-Allow-Origin
https://www.reuters.com
Cache-Control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json;charset=utf-8
Content-Length
2669
Expires
Thu, 01 Jan 1970 00:00:00 GMT
bidexchange.js
contextual.media.net/
397 KB
113 KB
Script
General
Full URL
https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
52d9c98181e92807d2d38679b1afb60451cc0db712a37a48c45cdc9309ae1583

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:34 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/javascript; charset=utf-8
status
200
cache-control
max-age=1800
expires
Tue, 22 Oct 2019 16:00:34 GMT
iasPET.1.js
cdn.adsafeprotected.com/
19 KB
6 KB
Script
General
Full URL
https://cdn.adsafeprotected.com/iasPET.1.js
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.224.196.35 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-224-196-35.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
0e9324325e7bad86597c91ee8cf9e7f6bc0b83c6e03f29415e48511d19e64856

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 17:06:06 GMT
Content-Encoding
gzip
Connection
keep-alive
Last-Modified
Mon, 21 Oct 2019 17:06:03 GMT
Server
AmazonS3
Age
80669
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Content-Type
application/javascript
Via
1.1 9568a708c8ab21597698ebe7dce6c42e.cloudfront.net (CloudFront)
Cache-Control
max-age=604800
Transfer-Encoding
chunked
X-Amz-Cf-Pop
FRA2-C1
X-Amz-Cf-Id
0WCFAmuyaTd6Vk7cLNl_Hm2mEjVFYc9YUUcgixdiVhYw0LWESY1low==
tc.js
contextual.media.net/
12 KB
7 KB
Script
General
Full URL
https://contextual.media.net/tc.js?&tpkey=TB4M82W&size=300x250&v=17&nat=1&https=1
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
5d23dafa2c443b2dfaeb848fea20fdfacf73479fa6c6070c01c7f713c40311bd

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:34 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/javascript; charset=utf-8
status
200
cache-control
max-age=172800
content-length
6675
expires
Thu, 24 Oct 2019 15:30:34 GMT
tc.js
contextual.media.net/
13 KB
7 KB
Script
General
Full URL
https://contextual.media.net/tc.js?&tpkey=T645KQG&size=728x90&v=17&nat=1&https=1
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
61880e6272da762d94c13369e078e5b16d940c992f64debc61bd56a027cb2638

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:34 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/javascript; charset=utf-8
status
200
cache-control
max-age=172800
content-length
7433
expires
Thu, 24 Oct 2019 15:30:34 GMT
checksync.php
contextual.media.net/ Frame 8478
0
0
Document
General
Full URL
https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=25&https=1&gdpr=1&gdprconsent=0
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

:method
GET
:authority
contextual.media.net
:scheme
https
:path
/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=25&https=1&gdpr=1&gdprconsent=0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
accept-encoding
gzip, deflate, br
cookie
gdpr_status=1
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U

Response headers

status
200
server
Apache
content-type
text/html; charset=UTF-8
set-cookie
gdpr_status=1; Expires=Fri, 24 Apr 2020 15:30:34 GMT; domain=.media.net; Path=/;
x-mnet-hl2
E
vary
Accept-Encoding
content-encoding
gzip
cache-control
max-age=604800
expires
Tue, 29 Oct 2019 15:30:34 GMT
date
Tue, 22 Oct 2019 15:30:34 GMT
content-length
4592
hmmaster.js
contextual.media.net/
19 KB
7 KB
Script
General
Full URL
https://contextual.media.net/hmmaster.js?cid=8CUF1VN4G&p=hb&v=3.1.3&https=1&adt=1
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cc11628ee489395e239bc94ea6dc8d5b1908e6b957cc5c9a9e05a64793f77e28

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:34 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/html; charset=UTF-8
status
200
cache-control
max-age=1800
content-length
7348
expires
Tue, 22 Oct 2019 16:00:34 GMT
px.gif
contextual.media.net/
43 B
193 B
Image
General
Full URL
https://contextual.media.net/px.gif?&ch=1&vn=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
8ac1703c1c34b2be426deda409d39258f82fae17f13e645f377f337a954aedde

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:34 GMT
last-modified
Wed, 19 Jul 2017 10:11:12 GMT
server
Apache
content-type
image/gif
status
200
cache-control
max-age=1209600
accept-ranges
bytes
content-length
43
expires
Tue, 05 Nov 2019 15:30:34 GMT
px.gif
s.mnet-ad.net/
43 B
356 B
Image
General
Full URL
https://s.mnet-ad.net/px.gif?&ch=2&vn=1
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
66.81.204.228 , Virgin Islands (British), ASN40034 (CONFLUENCE-NETWORK-INC - Confluence Networks Inc, VG),
Reverse DNS
o1-66-81-204-228.static.o1.com
Software
Apache /
Resource Hash
8ac1703c1c34b2be426deda409d39258f82fae17f13e645f377f337a954aedde

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:35 GMT
Last-Modified
Wed, 19 Jul 2017 10:11:12 GMT
Server
Apache
Content-Type
image/gif
Cache-Control
max-age=1209600
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=2, max=128
Content-Length
43
Expires
Tue, 05 Nov 2019 15:30:35 GMT
rtbsspub
cdneast2-xch.media.net/AdExchange/
41 KB
3 KB
EventSource
General
Full URL
https://cdneast2-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&region=nv&ptrid=8PRL4E7N3&requestString=267235141*4%7C300x250%7C8CUD609M7%7C976846895%40267235141*29%7C300x250%7C11384%7C31484_232454_15%40267235141*38%7C300x250%7C8CUF1VN4G%7C267235141_8CUF1VN4G%40267235141*51%7C300x250%7C973973%7C11084976%7C0.07%40267235141*59%7C300x250%7C8CUF1VN4G%7C_112891%7C0.07%40267235141*74%7C300x250%7C1113800%7C12209124%40267235141*97%7C300x250%7C8CUF1VN4G%7C267235141_8CUF1VN4G%40267235141*122%7C300x250%7C8CUF1VN4G%7C8CUF1VN4G_fFuYfaVC4aA86N9xVFo929Yk%7C1.22%40267235141*145%7C300x250%7C100600%7C147215%40267235141*172%7C300x250%7C8CUF1VN4G%7C15331955%7C0.06%40267235141*175%7C300x250%7C8CUF1VN4G%7C267235141_8CUF1VN4G%7C0.01%40267235141*178%7C300x250%7C8CUF1VN4G%7C267235141_8CUF1VN4G%40313743496*4%7C728x90%7C8CUD609M7%7C536231532%40313743496*29%7C728x90~970x250%7C11384%7C31484_232454_2~31484_232454_57%40313743496*38%7C970x250~728x90%7C8CUF1VN4G%7C313743496_8CUF1VN4G~313743496_8CUF1VN4G%40313743496*51%7C728x90%7C973973%7C11084975%7C0.69%40313743496*59%7C728x90~970x250%7C8CUF1VN4G%7C_112891~_112891%7C0.07%40313743496*74%7C728x90~970x250%7C1113800%7C12209125~12209125%40313743496*97%7C728x90~970x250%7C8CUF1VN4G%7C313743496_8CUF1VN4G~313743496_8CUF1VN4G%40313743496*122%7C728x90%7C8CUF1VN4G%7C8CUF1VN4G_LKbKv9hpus2aba7C923hUsFj%7C1.22%40313743496*145%7C970x250~728x90%7C100600%7C147214~147214%40313743496*172%7C728x90~970x250%7C8CUF1VN4G%7C15303527~15303527%7C0.06%40313743496*175%7C728x90%7C8CUF1VN4G%7C313743496_8CUF1VN4G%7C0.01%40313743496*178%7C728x90%7C8CUF1VN4G%7C313743496_8CUF1VN4G%40391166652*4%7C160x600%7C8CUD609M7%7C712281133%40391166652*29%7C300x250~160x600~300x600%7C11384%7C31484_232454_15~31484_232454_9~31484_232454_10%40391166652*38%7C300x600~160x600~300x250%7C8CUF1VN4G%7C391166652_8CUF1VN4G~391166652_8CUF1VN4G~391166652_8CUF1VN4G%40391166652*51%7C300x250~160x600~300x600%7C973973%7C11084976~11084976~11084976%7C0.07%40391166652*59%7C300x250~160x600~300x600%7C8CUF1VN4G%7C_112891~_112891~_112891%7C0.07%40391166652*74%7C300x250~300x600%7C1113800%7C12209124~12209124%40391166652*97%7C300x250~300x600~160x600%7C8CUF1VN4G%7C391166652_8CUF1VN4G~391166652_8CUF1VN4G~391166652_8CUF1VN4G%40391166652*122%7C300x250%7C8CUF1VN4G%7C8CUF1VN4G_fFuYfaVC4aA86N9xVFo929Yk%7C1.22%40391166652*145%7C300x600~160x600~300x250%7C100600%7C147215~147215~147215%40391166652*172%7C160x600~300x250~300x600%7C8CUF1VN4G%7C15331955~15331955~15331955%7C0.06%40391166652*175%7C300x600~160x600~300x250%7C8CUF1VN4G%7C391166652_8CUF1VN4G~391166652_8CUF1VN4G~391166652_8CUF1VN4G%7C0.01%40391166652*178%7C300x600~300x250~160x600%7C8CUF1VN4G%7C391166652_8CUF1VN4G~391166652_8CUF1VN4G~391166652_8CUF1VN4G%40451439109*4%7C300x250%7C8CUD609M7%7C155187763%40451439109*29%7C300x250%7C11384%7C31484_123998_15%40451439109*38%7C300x250%7C8CUF1VN4G%7C451439109_8CUF1VN4G%40451439109*51%7C300x250%7C973973%7C11084979%7C0.07%40451439109*59%7C300x250%7C8CUF1VN4G%7C_112891%7C0.07%40451439109*97%7C300x250%7C8CUF1VN4G%7C451439109_8CUF1VN4G%40451439109*122%7C300x250%7C8CUF1VN4G%7C8CUF1VN4G_fFuYfaVC4aA86N9xVFo929Yk%7C1.22%40451439109*145%7C300x250%7C100600%7C147218%40451439109*172%7C300x250%7C8CUF1VN4G%7C15331958%7C0.06%40451439109*175%7C300x250%7C8CUF1VN4G%7C451439109_8CUF1VN4G%7C0.01%40451439109*178%7C300x250%7C8CUF1VN4G%7C451439109_8CUF1VN4G%40612341223*4%7C728x90%7C8CUD609M7%7C813012502%40612341223*29%7C728x90~970x250%7C11384%7C31484_232454_2~31484_232454_57%40612341223*38%7C970x250~728x90%7C8CUF1VN4G%7C612341223_8CUF1VN4G~612341223_8CUF1VN4G%40612341223*51%7C728x90%7C973973%7C11084975%7C0.69%40612341223*59%7C728x90~970x250%7C8CUF1VN4G%7C_112891~_112891%7C0.07%40612341223*74%7C728x90~970x250%7C1113800%7C12209125~12209125%40612341223*97%7C728x90~970x250%7C8CUF1VN4G%7C612341223_8CUF1VN4G~612341223_8CUF1VN4G%40612341223*122%7C728x90%7C8CUF1VN4G%7C8CUF1VN4G_LKbKv9hpus2aba7C923hUsFj%7C1.22%40612341223*145%7C728x90~970x250%7C100600%7C147214~147214%40612341223*172%7C728x90~970x250%7C8CUF1VN4G%7C15303527~15303527%7C0.06%40612341223*175%7C728x90%7C8CUF1VN4G%7C612341223_8CUF1VN4G%7C0.01%40612341223*178%7C728x90%7C8CUF1VN4G%7C612341223_8CUF1VN4G&crid=267235141%2C313743496%2C391166652%2C451439109%2C612341223&sd=1&requrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&bl=1&rt=5&dn=https://www.reuters.com&https=1&act=headerBid&prvReqId=278263829529758891571758234747&erTr=0&hlt=1&ugd=4&adt=desktop&tr=0.5768691838454412&ndec=1&scrsize=1600x1200&taginfo=%7B%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A6341%7D&itype=HB&sid=8973&scc=1&tmt=200&section=us.reuters%2Flife%2Fhealth%2Farticle&prid=8PRVCXX19&wo=1&isRefresh=0&switch=1&cc=DE&rc=HE&ct=FRANKFURT
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
5ec7cfc1f96b95d31fa6d683612a8cab3282a48283f177a5f6e8d331a7be7c76

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:34 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*, *
expires
Tue, 22 Oct 2019 15:30:34 GMT
rtbsspub
cdneast2-xch.media.net/AdExchange/
3 KB
1 KB
EventSource
General
Full URL
https://cdneast2-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&region=nv&ptrid=8PRL4E7N3&requestString=267235141*84%7C1x1_TB4M82W_1%7C8CUF1VN4G%7C267235141%40313743496*84%7C1x1_T645KQG_1%7C8CUF1VN4G%7C313743496%40391166652*84%7C1x1_TB4M82W_1%7C8CUF1VN4G%7C391166652%40451439109*84%7C1x1_TB4M82W_1%7C8CUF1VN4G%7C451439109%40612341223*84%7C1x1_T645KQG_1%7C8CUF1VN4G%7C612341223&crid=267235141%2C313743496%2C391166652%2C451439109%2C612341223&sd=1&requrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&bl=1&rt=5&dn=https://www.reuters.com&https=1&act=headerBid&prvReqId=181651705564355571571758234750&erTr=0&hlt=1&ugd=4&adt=desktop&tr=0.1836026955817629&ndec=1&scrsize=1600x1200&taginfo=%7B%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A6341%7D&itype=HB&sid=8973&scc=1&tmt=200&section=us.reuters%2Flife%2Fhealth%2Farticle&at=3&prid=8PRVCXX19&wo=1&cc=DE&rc=HE&ct=FRANKFURT
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
14ae7840a92f47c9500ec737ef76528dc13e42930827b5ab97850ea35e100f97

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:34 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*, *
expires
Tue, 22 Oct 2019 15:30:34 GMT
checksync.php
contextual.media.net/ Frame 0406
0
0
Document
General
Full URL
https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=101&https=1&gdpr=1&gdprconsent=0
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

:method
GET
:authority
contextual.media.net
:scheme
https
:path
/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=101&https=1&gdpr=1&gdprconsent=0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
accept-encoding
gzip, deflate, br
cookie
gdpr_status=1
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U

Response headers

status
200
server
Apache
content-type
text/html; charset=UTF-8
set-cookie
gdpr_status=1; Expires=Fri, 24 Apr 2020 15:30:34 GMT; domain=.media.net; Path=/;
x-mnet-hl2
E
vary
Accept-Encoding
content-encoding
gzip
cache-control
max-age=604800
expires
Tue, 29 Oct 2019 15:30:34 GMT
date
Tue, 22 Oct 2019 15:30:34 GMT
content-length
4592
gpt.js
www.googletagservices.com/tag/js/
46 KB
15 KB
Script
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
13426ba13e9862a0e6f6e2c9af87cce602482e4fd64aa5419bea6d0f449e7c70
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:34 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"314 / 228 of 1000 / last-modified: 1571691975"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
14762
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:34 GMT
integrator.js
adservice.google.de/adsid/
109 B
171 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:34 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
109 B
171 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:34 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
pubads_impl_2019101401.js
securepubads.g.doubleclick.net/gpt/
156 KB
57 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.23.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s45-in-f2.1e100.net
Software
sffe /
Resource Hash
f8800772f0dd827877029d9d634a170a156ff82b6b6bdf251b62c750b73cfe93
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:34 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
58589
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:34 GMT
show_companion_ad.js
pagead2.googlesyndication.com/pagead/
188 KB
70 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/show_companion_ad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
1ce29feca8520c47fcbdbb7b8b795314102f36cf2e9f44924f6f07e0796b4343
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:29:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
71
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
71218
x-xss-protection
0
server
cafe
etag
17977282172821756952
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=3600
timing-allow-origin
*
expires
Tue, 22 Oct 2019 16:29:23 GMT
pub
pixel.adsafeprotected.com/services/
325 B
710 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_mpu_15662074_USKBN1X024U,s:300.250,p:/4735792/us.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=42789de7-7bf9-34de-6599-57c70dee1e42&url=https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-vertex-pharms-fda%252Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
c6bbba8a86b613d64182e1e54f6248a5241497115cfa403316dc28a92f6a1a23

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:34 GMT
X-Server-Name
app23ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
pub
pixel.adsafeprotected.com/services/
331 B
716 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:canvas_leaderboard_9940707285467228_USKBN1X024U,s:728.90,p:/4735792/us.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=42789de7-7bf9-34de-6599-57c70dee1e42&url=https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-vertex-pharms-fda%252Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
9d6130d2fdeb2c2097f1bd16ecdf8e074c2f0938aee50a6a46e7dc90f76f5166

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:34 GMT
X-Server-Name
app05ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
pub
pixel.adsafeprotected.com/services/
320 B
705 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_connatix_11431383_USKBN1X024U,s:1100.420,p:/4735792/us.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=42789de7-7bf9-34de-6599-57c70dee1e42&url=https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-vertex-pharms-fda%252Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
8aaae43833df66033f505e90b8fcaf1413ae4ffb1ff1e8fbae56bd65330a1f4c

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:34 GMT
X-Server-Name
app16ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
pub
pixel.adsafeprotected.com/services/
309 B
694 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_bizdev_article_rr2_8723880_USKBN1X024U,s:300.280,p:/4735792/us.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=42789de7-7bf9-34de-6599-57c70dee1e42&url=https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-vertex-pharms-fda%252Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
d433c13cffbafda08e095766353586a2c680fb0cad68b0409c543267125fa083

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:34 GMT
X-Server-Name
app30ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
ads
securepubads.g.doubleclick.net/gampad/
14 KB
4 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=1930905596449981&correlator=2105707175260363&output=ldjh&impl=fifs&adsid=NT&eid=21064792&vrg=2019101401&npa=1&guci=1.2.0.0.2.1.0.0&plat=1%3A536903688%2C2%3A536903688%2C8%3A134250504&sc=1&sfv=1-0-36&ecs=20191022&iu_parts=4735792%2Cus.reuters%2Clife%2Chealth%2Carticle&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=300x250%7C300x600%7C1x1%2C728x90%7C970x250%7C970x90%7C1100x100%7C1100x90%7C1100x250%7C1x1%2C320x50%7C1100x420%7C1100x400%2C300x280&fluid=0%2C0%2Cheight%2C0&prev_scp=type%3Dmpu%26div_id%3D15662074%26pixel_distance%3D400%26articleID%3DUSKBN1X024U%26storychannel%3Dhealthcare-upclose%253Bmedical-research%253Bcompanies-mrch%253Bcompanies-phar%253BeverythingNews%253BhealthNews%253Bdrug-pricing1%253Bconsolidated-business%26story%3D0%26template%3Darticle%26p_count%3D13%26asset%3Dimage%26id%3De42fa4dd-f4e0-11e9-9948-00259086cbca%26vw%3D40%2C50%2C60%2C70%2C80%26grm%3D40%2C50%2C60%2C70%2C80%26pub%3D40%2C50%2C60%2C70%2C80%26mnetDNB%3D1%26mnetPageID%3D1%26mnetCV%3D3%26mnetCC%3DDE%26mnetUGD%3D4%7Ctype%3Dleaderboard%26div_id%3D9940707285467228%26articleID%3DUSKBN1X024U%26storychannel%3Dhealthcare-upclose%253Bmedical-research%253Bcompanies-mrch%253Bcompanies-phar%253BeverythingNews%253BhealthNews%253Bdrug-pricing1%253Bconsolidated-business%26story%3D0%26template%3Darticle%26p_count%3D13%26asset%3Dimage%26id%3De42f567d-f4e0-11e9-96d8-00259086ca74%26vw%3D40%2C50%2C60%2C70%2C80%26grm%3D40%2C50%2C60%2C70%26pub%3D40%2C50%2C60%2C70%26mnetDNB%3D1%26mnetPageID%3D2%26mnetCV%3D3%26mnetCC%3DDE%26mnetUGD%3D4%7Ctype%3Dconnatix%26div_id%3D11431383%26pixel_distance%3D20000%26articleID%3DUSKBN1X024U%26storychannel%3Dhealthcare-upclose%253Bmedical-research%253Bcompanies-mrch%253Bcompanies-phar%253BeverythingNews%253BhealthNews%253Bdrug-pricing1%253Bconsolidated-business%26story%3D0%26template%3Darticle%26p_count%3D13%26asset%3Dimage%26id%3De4315326-f4e0-11e9-a40b-002590882ecc%26vw%3D40%2C50%2C60%2C70%2C80%26grm%3D40%2C50%2C60%2C70%26pub%3D40%2C50%2C60%2C70%7Ctype%3Dbizdev_article_rr2%26div_id%3D8723880%26pixel_distance%3D20000%26articleID%3DUSKBN1X024U%26storychannel%3Dhealthcare-upclose%253Bmedical-research%253Bcompanies-mrch%253Bcompanies-phar%253BeverythingNews%253BhealthNews%253Bdrug-pricing1%253Bconsolidated-business%26story%3D0%26template%3Darticle%26p_count%3D13%26asset%3Dimage%26id%3De42e934b-f4e0-11e9-b31e-382c4ac6318d%26vw%3D40%2C50%2C60%26grm%3D40%2C50%2C60%26pub%3D40%2C50%2C60&cust_params=bidxc%3D1%26ntvPlacement%3D1093478%26admant%3DBarclays%252CExxon_Negative%252CIBM%252CJLR_Negative%252CJPMorgan_Neg%252CMSFT_Neg%252CNomura_Negative%252CWorkdayPG_Neg%26fr%3Dtrue%26adt%3DveryLow%26alc%3DveryLow%26dlm%3DveryLow%26drg%3DveryLow%26hat%3DveryLow%26off%3DveryLow%26vio%3Dlow&cookie_enabled=1&bc=31&abxe=1&lmt=1571758235&dt=1571758235068&dlt=1571758232157&idt=2754&frm=20&biw=1585&bih=1200&oid=3&adxs=-12245933%2C-12245933%2C-12245933%2C-12245933&adys=-12245933%2C-12245933%2C-12245933%2C-12245933&adks=3633717877%2C764363170%2C43858290%2C1604576235&ucis=1%7C2%7C3%7C4&ifi=1&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&dssz=76&icsg=2818575360&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x-1%7C0x-1%7C754x0%7C300x-1&msz=300x-1%7C0x-1%7C1100x420%7C300x-1&ga_vid=2001646232.1571758235&ga_sid=1571758235&ga_hid=289823103&fws=132%2C132%2C132%2C132&ohw=1585%2C1585%2C1585%2C1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.23.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s45-in-f2.1e100.net
Software
cafe /
Resource Hash
5df8cbbe7491c70252ce758a631700a61e5cf04929ae02bf43b9ccabcedf6765
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:35 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2,-2,-2,-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
4366
x-xss-protection
0
google-lineitem-id
5189420777,-2,-2,139199112
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138289622787,-2,-2,138204787707
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_2019101401.js
securepubads.g.doubleclick.net/gpt/
64 KB
24 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.23.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s45-in-f2.1e100.net
Software
sffe /
Resource Hash
f123fae1ceff20dea7ee2ff8895276a22cddecc8e0ef503b5e95419e76909a54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:35 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
24836
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:35 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-36/html/
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-36/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

view
securepubads.g.doubleclick.net/pcs/ Frame E6D5
0
264 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsu17QDoyUyAytxLjXycPXC00EL1q69zHZaMfGyZcp4zBgD3lJzwwff3EVh-GhRfQt-NcUJkdBTVQaP-1yc5Dj5TTr2Gl73VZYF9DYWmSr2fpv05v1IpEoYUfFFO1NSS5eOStWnGhXEoY166-u8rU21GBjTehXBxpFFdwgdbQB-ymOcadWiRSLDkIBr4s13jUrOddFmgBN16oYupxUibu0M5oN7I6xY-aMDf_9s7UtUpJVStvhhytA3-MjI3WuUmJlpPSoseJf6y5lrnWqWASdlV3KozmMHI-aoffg&sai=AMfl-YRjnBMHsDD_jgFnc9zjWIvdpLxJIaOTLlbaxhVGtJLtkt1JP5iDWb34_6He_hAh84nt9Sd_0UWvKNZnMWKurvpfyCXfu5Z9OC4saFDk6A&sig=Cg0ArKJSzE9RspHzoNrBEAE&urlfix=1&adurl=
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.23.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s45-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:35 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:35 GMT
brid.outstream.min.js
services.brid.tv/player/build/ Frame E6D5
234 KB
65 KB
Script
General
Full URL
https://services.brid.tv/player/build/brid.outstream.min.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.85.183.199 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-52-85-183-199.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
2dd9aa6fe3335b6436351937950a94a47ad3819fa22fb2f074c4b21ebde8ab38

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:28:41 GMT
content-encoding
gzip
last-modified
Tue, 22 Oct 2019 08:14:07 GMT
server
AmazonS3
age
417
etag
"e656811ddfb8493924b3e9ed326581c0"
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=1200, public
x-amz-cf-pop
FRA50
accept-ranges
bytes
content-length
65992
via
1.1 017ee4b2e5ba6b7a7dd1443f39b6e832.cloudfront.net (CloudFront)
x-amz-cf-id
KLwCEE-lLKXIm7s89eirLC1krP5TpxT0ZebJg7PbRo1yB-LGaXeN7w==
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame E6D5
78 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
c1c53a4d300ac7532bec2ed085532b2fe66d27f2b592b3a9383aa649e42ed6fb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:35 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1571656559023965"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29691
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:35 GMT
moatad.js
z.moatads.com/reutersdfpcw319687550988/ Frame E6D5
297 KB
99 KB
Script
General
Full URL
https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
6b173d87763629cab6332e13f5fce375f0656baff43c8696995f6e42d8470565

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:35 GMT
Content-Encoding
gzip
Last-Modified
Sat, 19 Oct 2019 00:56:56 GMT
Server
AmazonS3
x-amz-request-id
CC87214EF5D132A9
ETag
"2187b9aaeaf01529cfc067f12de264d2"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=45207
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
101024
x-amz-id-2
WqW+qP2m7ZeBhE7hIFQ+9pkKpIDMNnHK/BJxvlVvj3DHUMNJH9XzSe054NVTgzkA
osd.js
www.googletagservices.com/activeview/js/current/
77 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
a1999737449d990f86a266a62e57fb225dd6e5d5521da2358d967c6bd662b314
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:35 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1571656559023965"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29155
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:35 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 3796
0
246 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsudqolrdEBeZr-XPYtj2Ws2Wf_hUkrZpwLeQDsReC2r_E4t1i397DFPr_DnwGuUE4Yy0_o5MFpHYfehm3AG1mPRPCp7ocDzPyGsGVclLuEG_omQ4DJdD9C-90kLzRkCdCN73hDkhdxx9IdD_fqQwCcZSJWSTdHh-YFqHHMqcAAVUSc2sUIMd1nGLPEYP_B-cZcGrP5kyEcPlgcEgzHIHXF4fs9FkA716ZYFaE1PfvfgzLFlvJs-YuhcFjpqfNxRqv-l809xAzguqIJy8mdfY3hkWb2xZ5A&sai=AMfl-YSEf_b0dph5vnIuRwDGPYoiKlvY_2U6acdpDx3xEJNzfcbFs9-uF86zW54XDYOgrSdLVLzXiweLjcEiWjBj6hjW7lzRctegEcMMvbUZYg&sig=Cg0ArKJSzKGEOohhSo3MEAE&urlfix=1&adurl=
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.23.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s45-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:35 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:35 GMT
Carambola_layer_152.min.js
cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/ Frame 3796
Redirect Chain
  • https://route.carambo.la/inimage/getlayer?pid=thms97&did=112441&wid=3&rdn=[RANDOM_NUMBER]
  • https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
445 KB
112 KB
Script
General
Full URL
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40D8) /
Resource Hash
35ecea6b7f7b94fb88fd898d4af61f64aa7b353fbc8aafafd03a5f3f11fb7204

Request headers

Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:36 GMT
content-encoding
deflate
vary
Accept-Encoding
x-amz-request-id
153409E1BF7FEBEE
x-cache
HIT
status
200
content-length
113841
x-amz-id-2
V865sMdx3k/t3D5lrABPDE+/WuUUQ/8AKIupBflK34tUpj/Ukbfq0kicUK0ioNi4ZtvpZDfsX9I=
last-modified
Mon, 12 Aug 2019 09:30:10 GMT
server
ECS (fcn/40D8)
etag
"e54fd03b3325e7a3cefa8816a52dbd14"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=63072000,s-maxage=63072000
accept-ranges
bytes

Redirect headers

Location
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Date
Tue, 22 Oct 2019 15:30:35 GMT
Server
nginx/1.14.1
Connection
keep-alive
X-Powered-By
Express
Content-Length
0
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 3796
78 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
c1c53a4d300ac7532bec2ed085532b2fe66d27f2b592b3a9383aa649e42ed6fb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:35 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1571656559023965"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29691
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:35 GMT
moatad.js
z.moatads.com/reutersdfpcw319687550988/ Frame 3796
297 KB
99 KB
Script
General
Full URL
https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
6b173d87763629cab6332e13f5fce375f0656baff43c8696995f6e42d8470565

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:35 GMT
Content-Encoding
gzip
Last-Modified
Sat, 19 Oct 2019 00:56:56 GMT
Server
AmazonS3
x-amz-request-id
CC87214EF5D132A9
ETag
"2187b9aaeaf01529cfc067f12de264d2"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=45207
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
101024
x-amz-id-2
WqW+qP2m7ZeBhE7hIFQ+9pkKpIDMNnHK/BJxvlVvj3DHUMNJH9XzSe054NVTgzkA
pixelNew.js
s3.amazonaws.com/scripts-clickmeter-com/js/ Frame 3796
Redirect Chain
  • https://pixel.watch/q4m9
  • https://s3.amazonaws.com/scripts-clickmeter-com/js/pixelNew.js
2 KB
2 KB
Image
General
Full URL
https://s3.amazonaws.com/scripts-clickmeter-com/js/pixelNew.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.113.117 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:37 GMT
Last-Modified
Wed, 17 Dec 2014 10:04:21 GMT
Server
AmazonS3
x-amz-request-id
53DF9925F4079902
ETag
"5ecfcd6d8fa19e88256687ff922f77d0"
Content-Type
application/x-javascript
x-amz-storage-class
REDUCED_REDUNDANCY
Accept-Ranges
bytes
Content-Length
2271
x-amz-id-2
f2x39NJvkGgcGCOR8YiJmLWFpHBCdJnxtkIwUj2HDlujBm9Zm59B0C/eXAvqtZAm/oAjVyqeJMk=

Redirect headers

Date
Tue, 22 Oct 2019 15:30:35 GMT
X-Rate-Limit-Limit
20s
X-Rate-Limit-Remaining
299
Location
https://s3.amazonaws.com/scripts-clickmeter-com/js/pixelNew.js
X-Rate-Limit-Reset
2019-10-22T15:30:55.6976820Z
Engine
clickmeter.redirect, version 2.0
Connection
keep-alive
Content-Length
0
gen_204
pagead2.googlesyndication.com/pagead/
0
58 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=gpt_sz&r=300x250%7C300x600%7C1x1&w=300&h=250
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:35 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
204
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
5189420777
dfp-gateway.s-onetag.com/1/4735792/
112 B
579 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/5189420777
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:21f3:dc00:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
8a4d12e5be972c41fafa90e374ff50d36d59f1a0d15af42e0083ef7b0ed0e25b

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:02:57 GMT
via
1.1 bab8148a65b29113f79cf2725076287d.cloudfront.net (CloudFront), 1.1 eb1a8c1b1275e33a016e623478052111.cloudfront.net (CloudFront)
age
1302
x-amzn-requestid
4ed65906-7554-4cd6-8139-29bcc38e0d42
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5daf1a21-7c4ceef42f24836018848ba9;Sampled=0
x-amz-cf-pop
FRA50-C1, FRA2-C2
x-amz-apigw-id
B-EFMGrWyK4FfHg=
content-length
112
x-amz-cf-id
frsP8WdZEBYyXh6J8cD8TRXtVI_45HbzemiAEwi69j2BKGpbYr3s2Q==
139199112
dfp-gateway.s-onetag.com/1/4735792/
114 B
583 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/139199112
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:21f3:dc00:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
58d94b06f15b9a1ea02b26e3a0454a7921cda64a5769657e333cba9d9a0bb485

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:08:53 GMT
via
1.1 ad46d498157a92ab1076f74db460670d.cloudfront.net (CloudFront), 1.1 eb1a8c1b1275e33a016e623478052111.cloudfront.net (CloudFront)
age
1302
x-amzn-requestid
8b99bffd-4f6a-48c9-a8a4-83308c70ebaa
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5daf1b85-12891924c50ebcf067f8a804;Sampled=0
x-amz-cf-pop
FRA50-C1, FRA2-C2
x-amz-apigw-id
B-E84HrTSK4FngQ=
content-length
114
x-amz-cf-id
6o7GdlfYpIXTUZOdJoNyHf8Fyh54dGHqd3rZSZPjFWhQRrxOBSe5Qw==
truncated
/ Frame 3796
210 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
263e45fbd05bdca06e0ffc1651a6895da186465662dce86076f41853f8d77553

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
jload
pixel.adsafeprotected.com/ Frame 7F7F
45 KB
13 KB
Script
General
Full URL
https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x280&pubId=20159232&chanId=37592232&placementId=139199112&pubCreative=138204787707&pubOrder=277213512&cb=20506831&custom=bizdev_article_rr2&custom2=20000&custom3=0&adsafe_par&impId=e42e934b-f4e0-11e9-b31e-382c4ac6318d
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
9a54429ec04079fe1180c47d112d4b0f63e2d5be64bb4f73dc40a56f4055edc7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:35 GMT
Content-Encoding
gzip
X-Server-Name
app23ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/javascript;charset=utf-8
Access-Control-Allow-Origin
pixel.adsafeprotected.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Server
nginx
Expires
Wed, 31 Dec 1969 23:59:59 GMT
adunit.js
services.brid.tv/player/build/plugins/ Frame E6D5
30 B
427 B
Script
General
Full URL
https://services.brid.tv/player/build/plugins/adunit.js
Requested by
Host: services.brid.tv
URL: https://services.brid.tv/player/build/brid.outstream.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.85.183.199 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-52-85-183-199.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
9c25c4e240bd28a308851f487711c88680072496bf9865fb73a258dff5ca3fd9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 08:23:17 GMT
content-encoding
gzip
last-modified
Wed, 06 Jun 2018 07:10:50 GMT
server
AmazonS3
age
25684
etag
"00472f99064e3d4328bd208da8c0b958"
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
public, max-age=31536000
x-amz-cf-pop
FRA50
accept-ranges
bytes
content-length
50
via
1.1 017ee4b2e5ba6b7a7dd1443f39b6e832.cloudfront.net (CloudFront)
x-amz-cf-id
nnbMTNndKBeYolem_HI117wccOry-Sjw4YvT6gA57uhXHw4W4a95eQ==
n.js
geo.moatads.com/
112 B
286 B
Script
General
Full URL
https://geo.moatads.com/n.js?e=35&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%7DGH%3Ch%2Cqkc!p!ny%7BiY81%22ASYUby%3D(tN%23V.x%3Bm_Qrw5.W%2F84VKp%40i6AKx!f%3EUYoo813_xB%2CN%7CDoD%3DhA&qp=00000&is=hBBnjB7GsBpBBBPY2CEBsCybBqw776Kqi7gBooCvBOCiCOB6sCqGBgiBBs0fW0glMfcxnBBBkB0BYBny6BsNBmB0ziw7pCr6yC6rO24xXmYyBdfEC2BBBBBjzmBktCP97GBBBGwRmmEBBBBBBBBBBBnaBW35CeFaBBBpx0OFiBBBT5392tavKc5KCdzzFs7nBBBBBBBBRcQyRBBBCpjOBBBBBBBBBTLF6GfC6Jn7O0EYkCBB0IofRfBBPCxB7UBbjtBbBBC0dL9TRhq8K55G96Lo0eIRTzBiqeuSBBBBBB&iv=7&qt=0&gz=0&hh=0&hn=0&tw=%3BG~eA.(HAS&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&i=REUTERSDFPCW3&hp=1&wf=1&vb=4&cm=9&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&t=1571758235452&de=779462343036&m=0&ar=6907c9d928-clean&iw=6919a0a&q=2&cb=0&ym=0&cu=1571758235452&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=20159232%3A277213512%3A139199112%3A138204787707&zMoatTP=bizdev_article_rr2&zMoatStory=0&zMoatAU=%2F4735792%2Fus.reuters%2Flife%2Fhealth%2Farticle&zMoatPixelDistance=20000&zMoatRawSlicer1=3735912&zMoatRawSlicer2=37592232&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=37592232&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=37592232&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&id=1&bo=3735912&bd=37592232&dfp=0%2C1&la=37592232&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&ti=0&ih=1&fs=173050&na=147734329&cs=0&callback=DOMlessLLDcallback_46948823
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.9.140.177 London, United Kingdom, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-3-9-140-177.eu-west-2.compute.amazonaws.com
Software
TornadoServer/4.5.3 /
Resource Hash
8805523b232ea65fedb5bcd12d7cdc2c4b817766fcdf72484aa3a77a28607cd4

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:35 GMT
server
TornadoServer/4.5.3
etag
"8d864639f3747578bea15090c4f246e8822e2a63"
content-type
text/html; charset=UTF-8
status
200
cache-control
max-age=900
timing-allow-origin
*
content-length
112
n.js
geo.moatads.com/
114 B
288 B
Script
General
Full URL
https://geo.moatads.com/n.js?e=35&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%7DGH%3Ch%2Cqkc!p!ny%7BiY81%22ASYUby%3D(tN%23V.x%3Bm_Qrw5.W%2F84VKp%40i6AKx!f%3EUYoo813_xB%2CN%7CDoD%3DhA&qp=00000&is=hBBnjB7GsBpBBBPY2CEBsCybBqw776Kqi7gBooCvBOCiCOB6sCqGBgiBBs0fW0glMfcxnBBBkB0BYBny6BsNBmB0ziw7pCr6yC6rO24xXmYyBdfEC2BBBBBjzmBktCP97GBBBGwRmmEBBBBBBBBBBBnaBW35CeFaBBBpx0OFiBBBT5392tavKc5KCdzzFs7nBBBBBBBBRcQyRBBBCpjOBBBBBBBBBTLF6GfC6Jn7O0EYkCBB0IofRfBBPCxB7UBbjtBbBBC0dL9TRhq8K55G96Lo0eIRTzBiqeuSBBBBBB&iv=7&qt=0&gz=0&hh=0&hn=0&tw=%3BG~eA.(HAS&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&i=REUTERSDFPCW3&hp=1&wf=1&vb=4&cm=9&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&t=1571758235452&de=779462343036&m=0&ar=6907c9d928-clean&iw=6919a0a&q=3&cb=0&ym=0&cu=1571758235452&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=20159232%3A277213512%3A139199112%3A138204787707&zMoatTP=bizdev_article_rr2&zMoatStory=0&zMoatAU=%2F4735792%2Fus.reuters%2Flife%2Fhealth%2Farticle&zMoatPixelDistance=20000&zMoatRawSlicer1=3735912&zMoatRawSlicer2=37592232&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=37592232&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=37592232&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&id=1&bo=3735912&bd=37592232&dfp=0%2C1&la=37592232&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&ti=0&ih=1&fs=173050&na=298674424&cs=0&callback=MoatDataJsonpRequest_46948823
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.9.140.177 London, United Kingdom, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-3-9-140-177.eu-west-2.compute.amazonaws.com
Software
TornadoServer/4.5.3 /
Resource Hash
23084b00f94c0951d0dec7f91b4d2e8a83abe11ac4f3c5f4c538e6cf3fa2bd6d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:35 GMT
server
TornadoServer/4.5.3
etag
"59e04acfb9cd415ac8b923960feeee7483abc6d0"
content-type
text/html; charset=UTF-8
status
200
cache-control
max-age=900
timing-allow-origin
*
content-length
114
11615.json
services.brid.tv/services/unit/ Frame E6D5
2 KB
1 KB
XHR
General
Full URL
https://services.brid.tv/services/unit/11615.json
Requested by
Host: services.brid.tv
URL: https://services.brid.tv/player/build/brid.outstream.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.85.183.199 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-52-85-183-199.fra50.r.cloudfront.net
Software
Apache /
Resource Hash
fb2c8395640565b0f734e404d34f7f8d7246bf847a96d0d0ef83f265e6844771

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:17:52 GMT
content-encoding
gzip
age
333
x-cache
Hit from cloudfront
status
200
content-length
825
x-served-by
media-lb-2
access-control-allow-origin
*
server
Apache
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS
content-type
application/json; charset=UTF-8
via
1.1 017ee4b2e5ba6b7a7dd1443f39b6e832.cloudfront.net (CloudFront)
cache-control
no-store, no-cache, must-revalidate, post-check=0, pre-check=0
x-amz-cf-pop
FRA50
access-control-allow-headers
origin, x-requested-with, content-type, accept
x-amz-cf-id
NhA2GYdQnHNDOEnq-eVU6RlnEyLPTTIBEF3NUVGOWp3y8jlmmsGgLA==
truncated
/ Frame E6D5
218 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ec0451de86ef300f08cd09c10ef81bf4943ac8ba5f95349b13b79f2f9582aed9

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
jload
pixel.adsafeprotected.com/ Frame 7476
45 KB
13 KB
Script
General
Full URL
https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x250&pubId=4789302609&chanId=37592232&placementId=5189420777&pubCreative=138289622787&pubOrder=2599246982&cb=875247425&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=e42fa4dd-f4e0-11e9-9948-00259086cbca
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
b42919f1872be0a3a87941fbe031935f3f9263e52579c869383073fd8bdbb1c8

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:35 GMT
Content-Encoding
gzip
X-Server-Name
app23ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/javascript;charset=utf-8
Access-Control-Allow-Origin
pixel.adsafeprotected.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Server
nginx
Expires
Wed, 31 Dec 1969 23:59:59 GMT
5189420777
dfp-gateway.s-onetag.com/1/4735792/
112 B
579 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/5189420777
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:21f3:dc00:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
8a4d12e5be972c41fafa90e374ff50d36d59f1a0d15af42e0083ef7b0ed0e25b

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:02:57 GMT
via
1.1 bab8148a65b29113f79cf2725076287d.cloudfront.net (CloudFront), 1.1 eb1a8c1b1275e33a016e623478052111.cloudfront.net (CloudFront)
age
1302
x-amzn-requestid
4ed65906-7554-4cd6-8139-29bcc38e0d42
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5daf1a21-7c4ceef42f24836018848ba9;Sampled=0
x-amz-cf-pop
FRA50-C1, FRA2-C2
x-amz-apigw-id
B-EFMGrWyK4FfHg=
content-length
112
x-amz-cf-id
_wMoTXlsqWSR948V8AcINbVUTr72Bgy7w_lxo-WiwwEYE174jQa3lg==
139199112
dfp-gateway.s-onetag.com/1/4735792/
114 B
581 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/139199112
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:21f3:dc00:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
58d94b06f15b9a1ea02b26e3a0454a7921cda64a5769657e333cba9d9a0bb485

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:08:53 GMT
via
1.1 ad46d498157a92ab1076f74db460670d.cloudfront.net (CloudFront), 1.1 eb1a8c1b1275e33a016e623478052111.cloudfront.net (CloudFront)
age
1302
x-amzn-requestid
8b99bffd-4f6a-48c9-a8a4-83308c70ebaa
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5daf1b85-12891924c50ebcf067f8a804;Sampled=0
x-amz-cf-pop
FRA50-C1, FRA2-C2
x-amz-apigw-id
B-E84HrTSK4FngQ=
content-length
114
x-amz-cf-id
4q820uCWOGsWjTsjkKblUXMPU4oh01hiFYAbpVF9-SWOcCMs1DLrkQ==
main.19.8.22.js
static.adsafeprotected.com/ Frame 7F7F
158 KB
50 KB
Script
General
Full URL
https://static.adsafeprotected.com/main.19.8.22.js
Requested by
Host: pixel.adsafeprotected.com
URL: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x280&pubId=20159232&chanId=37592232&placementId=139199112&pubCreative=138204787707&pubOrder=277213512&cb=20506831&custom=bizdev_article_rr2&custom2=20000&custom3=0&adsafe_par&impId=e42e934b-f4e0-11e9-b31e-382c4ac6318d
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
5df41461e8c29072a827d5fd000d2506238b77e767a34642d6613b79ce49134c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:35 GMT
Content-Encoding
gzip
Last-Modified
Wed, 09 Oct 2019 16:27:21 GMT
X-Server-Name
app14ami.ami.303net.pvt
ETag
"5d9e0a69-c7d3"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
51155
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
brid.parser.min.js
p.brid.tv/player/build/plugins/parser/1.1.42/ Frame E6D5
83 KB
24 KB
Script
General
Full URL
https://p.brid.tv/player/build/plugins/parser/1.1.42/brid.parser.min.js
Requested by
Host: services.brid.tv
URL: https://services.brid.tv/player/build/brid.outstream.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.90 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-90.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
37642757d1d414dac352b8cc0869fa65b771300432e518e0e6ac6551b55181d5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 08:26:26 GMT
content-encoding
gzip
last-modified
Fri, 27 Sep 2019 08:25:48 GMT
server
AmazonS3
age
25472
etag
"b79fb9eed71dd061b0ed7d88150263de"
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=31536000, public, immutable
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-length
24072
via
1.1 d627b75d0c1aedd3691390ac8498d3b0.cloudfront.net (CloudFront)
x-amz-cf-id
3_UVuxpFBgzDBptU7FHXhRJ6Q0wyQXoT4O8LqPLwlPB-6pMBfLBK5w==
main.19.8.22.js
static.adsafeprotected.com/ Frame 7476
158 KB
50 KB
Script
General
Full URL
https://static.adsafeprotected.com/main.19.8.22.js
Requested by
Host: pixel.adsafeprotected.com
URL: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x250&pubId=4789302609&chanId=37592232&placementId=5189420777&pubCreative=138289622787&pubOrder=2599246982&cb=875247425&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=e42fa4dd-f4e0-11e9-9948-00259086cbca
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
5df41461e8c29072a827d5fd000d2506238b77e767a34642d6613b79ce49134c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:35 GMT
Content-Encoding
gzip
Last-Modified
Wed, 09 Oct 2019 16:27:21 GMT
X-Server-Name
app12ami.ami.303net.pvt
ETag
"5d9e0a69-c7d3"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
51155
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
truncated
/
2 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
9d02d662da8a47fb5fb610b545007507b6017028043dbb63cd09ec897d3b9627

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
truncated
/
715 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
5a3f1dd74233f605e511f1b5b244bedf85ac88ba264caf4d6401bc7ec2017dcd

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
ping.gif
stats-dev.brid.tv/ Frame E6D5
0
348 B
Image
General
Full URL
https://stats-dev.brid.tv/ping.gif?p=14815&pr=o&b=c&pid=11615&s=undefined|undefined&apa=0&df=1&os=l&m=0&ow=14120&e=l
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.224.196.105 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-224-196-105.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 23:26:45 GMT
via
1.1 430fc75cac3bdd04869a39405c45fba2.cloudfront.net (CloudFront)
last-modified
Tue, 04 Dec 2018 09:25:32 GMT
server
AmazonS3
age
70059
etag
"d41d8cd98f00b204e9800998ecf8427e"
x-cache
Hit from cloudfront
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
x-amz-cf-pop
FRA2-C1
accept-ranges
bytes
content-length
0
x-amz-cf-id
B6KZmkkEmQYmrMN5Xx9Bfz-IgmdZSVIUCNzCYjCpmT_OFtzIzTW74Q==
ping.gif
stats-dev.brid.tv/ Frame E6D5
0
346 B
Image
General
Full URL
https://stats-dev.brid.tv/ping.gif?p=14815&pr=o&b=c&pid=11615&s=undefined|undefined&os=l&m=0&apa=0&df=1&ow=14120&pub=p&e=r&aid=9261&par=b&wp=0&at=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.224.196.105 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-224-196-105.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 23:26:45 GMT
via
1.1 430fc75cac3bdd04869a39405c45fba2.cloudfront.net (CloudFront)
last-modified
Tue, 04 Dec 2018 09:25:32 GMT
server
AmazonS3
age
70059
etag
"d41d8cd98f00b204e9800998ecf8427e"
x-cache
Hit from cloudfront
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
x-amz-cf-pop
FRA2-C1
accept-ranges
bytes
content-length
0
x-amz-cf-id
pSIj78sbdWKG1mnEPAT7BiWe8jUVyZOLeMPQzJC9id64Iy622Bnmxw==
xml;dc_sdk_apis=[APIFRAMEWORKS];dc_omid_p=[OMIDPARTNER]
ad.doubleclick.net/ddm/pfadx/N1181610.3639REUTERS.COM/B23276979.256194050;sz=0x0;ord=1571758235579;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;dcmt=text/ Frame E6D5
32 KB
9 KB
XHR
General
Full URL
https://ad.doubleclick.net/ddm/pfadx/N1181610.3639REUTERS.COM/B23276979.256194050;sz=0x0;ord=1571758235579;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;dcmt=text/xml;dc_sdk_apis=[APIFRAMEWORKS];dc_omid_p=[OMIDPARTNER]
Requested by
Host: services.brid.tv
URL: https://services.brid.tv/player/build/brid.outstream.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.18.102 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s42-in-f6.1e100.net
Software
cafe /
Resource Hash
023cebf730049987cb83ba584a72923109f31ef302a6505a6664c1341180c786
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:35 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
8892
x-xss-protection
0
pragma
no-cache
server
cafe
content-type
text/xml; charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
sca.17.4.95.js
static.adsafeprotected.com/ Frame D3D9
81 KB
20 KB
Script
General
Full URL
https://static.adsafeprotected.com/sca.17.4.95.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
149c8d10677f2f6979fa28c078cf832f575ee53c397d791b739e7c4c687fe7bc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:35 GMT
Content-Encoding
gzip
Last-Modified
Tue, 19 Jun 2018 17:20:43 GMT
X-Server-Name
app12ami.ami.303net.pvt
ETag
"5b293b6b-4fda"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
20442
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
mon
pixel.adsafeprotected.com/
43 B
309 B
Image
General
Full URL
https://pixel.adsafeprotected.com/mon?anId=10764&campId=300x250&pubId=4789302609&chanId=37592232&placementId=5189420777&pubCreative=138289622787&pubOrder=2599246982&cb=875247425&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=e42fa4dd-f4e0-11e9-9948-00259086cbca&adsafe_url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&adsafe_type=abdfq&adsafe_jsinfo=,id:22c25fc9-6d8b-d6c4-ab65-21f1aeb2c6d2,c:rN5UsP,sl:inView,em:true,fr:true,mn:app23ami,pt:1-5-15,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,br:u,abv:na,an:n,scm:publ1.grpm1,fm:rFDXnsK+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d1|1e,idMap:1c*,pl:,rend:1,renddet:DIV.qs.sn,rmeas:1,es:0,sc:1,ha:1,gm:1,tt:jload,thd:1,et:90,oid:e481e421-f4e0-11e9-9454-00259086cbca,v:19.8.22,sp:1,wr:1600.1200,sr:1600.1200,ov:0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:35 GMT
X-Server-Name
app23ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
sca.17.4.95.js
static.adsafeprotected.com/ Frame CC9F
81 KB
20 KB
Script
General
Full URL
https://static.adsafeprotected.com/sca.17.4.95.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
149c8d10677f2f6979fa28c078cf832f575ee53c397d791b739e7c4c687fe7bc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:35 GMT
Content-Encoding
gzip
Last-Modified
Tue, 19 Jun 2018 17:20:43 GMT
X-Server-Name
app14ami.ami.303net.pvt
ETag
"5b293b6b-4fda"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
20442
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
mon
pixel.adsafeprotected.com/
43 B
309 B
Image
General
Full URL
https://pixel.adsafeprotected.com/mon?anId=10764&campId=300x280&pubId=20159232&chanId=37592232&placementId=139199112&pubCreative=138204787707&pubOrder=277213512&cb=20506831&custom=bizdev_article_rr2&custom2=20000&custom3=0&adsafe_par&impId=e42e934b-f4e0-11e9-b31e-382c4ac6318d&adsafe_url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&adsafe_type=abdfq&adsafe_jsinfo=,id:a1df68eb-305c-15de-9984-66603a644620,c:rN5Ut2,sl:outOfView,em:true,fr:true,mn:app23ami,pt:1-5-15,wc:0.0.1600.1200,ac:1140.3076.300.280,am:i,cc:1140.3076.300.280,piv:0,obst:0,th:0,reas:l,br:u,abv:na,an:n,scm:publ1.grpm1,fm:rFDXnsk+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d*.10764|1d1|1e,idMap:1d*,pl:,rend:1,renddet:DIV.qs.sn,rmeas:1,es:0,sc:1,ha:1,gm:1,tt:jload,thd:1,et:128,oid:e4797ef8-f4e0-11e9-9a00-00259086cbca,v:19.8.22,sp:1,wr:1600.1200,sr:1600.1200,ov:0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:35 GMT
X-Server-Name
app23ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=22c25fc9-6d8b-d6c4-ab65-21f1aeb2c6d2&tv={c:rN5Ute,pingTime:0,time:114,type:pf,clog:[{piv:100,vs:i,r:,w:300,h:250,t:89}],es:0,sc:1,ha:1,gm:1,slTimes:{i:114,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:89,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[37~100],as:[37~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFDXnsK+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d1|1e,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:35 GMT
X-Server-Name
dt46.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=22c25fc9-6d8b-d6c4-ab65-21f1aeb2c6d2&tv={c:rN5UtE,pingTime:-2,time:140,type:a,im:{sf:0,pom:1,prf:{beA:38,beZ:39,mfA:112,cmA:112,inA:113,inZ:117,prA:117,prZ:121,si:127,poA:128,poZ:133,cmZ:133,mfZ:133,loA:153,loZ:155,ltA:178,ltZ:178,mdA:39,mdZ:106}},sca:{dfp:{df:4,sz:300.250,dom:div}},env:{gca:1},clog:[{piv:100,vs:i,r:,w:300,h:250,t:89}],es:0,sc:1,ha:1,gm:1,slTimes:{i:140,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:89,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[63~100],as:[63~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFDXnsk+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1d1|1e,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1,slid:[google_ads_iframe_/4735792/us.reuters/life/health/article_0,google_ads_iframe_/4735792/us.reuters/life/health/article_0__container__,dpslot_mpu_15662074_USKBN1X024U,USKBN1X024U],sinceFw:50,readyFired:true}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:35 GMT
X-Server-Name
dt37.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=a1df68eb-305c-15de-9984-66603a644620&tv={c:rN5UtJ,pingTime:-2,time:171,type:a,im:{sf:0,pom:1,prf:{beA:83,beZ:84,mfA:206,cmA:206,inA:206,inZ:207,prA:207,prZ:210,si:211,poA:211,poZ:215,cmZ:215,mfZ:215,loA:244,loZ:245,ltA:253,ltZ:253,mdA:84,mdZ:152}},sca:{dfp:{df:4,sz:300.280,dom:div}},env:{gca:1},clog:[{piv:0,vs:o,r:l,w:300,h:280,t:128}],es:0,sc:1,ha:1,gm:1,slTimes:{i:0,o:171,n:0,pp:0,pm:0},slEvents:[{sl:o,t:128,wc:0.0.1600.1200,ac:1140.3076.300.280,am:i,cc:1140.3076.300.280,piv:0,obst:0,th:0,reas:l,bkn:{piv:[48~0],as:[48~300.280]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFDXnsk+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e,idMap:1d*,rend:1,renddet:DIV.qs.sn,rmeas:1,slid:[google_ads_iframe_/4735792/us.reuters/life/health/article_3,google_ads_iframe_/4735792/us.reuters/life/health/article_3__container__,dpslot_bizdev_article_rr2_8723880_USKBN1X024U,USKBN1X024U],sinceFw:43,readyFired:true}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:35 GMT
X-Server-Name
dt07.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
file.mp4
r4---sn-4g5ednee.c.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/acao,ctier,expire,id,ip,ipbits,itag,mip,...
Redirect Chain
  • https://gcdn.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/id,itag,source,ctier,acao,ip,ipbits,expire/sig...
  • https://r4---sn-4g5ednee.c.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/acao,ctier,expire,id,ip,ipbits,i...
2 MB
2 MB
Media
General
Full URL
https://r4---sn-4g5ednee.c.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/acao,ctier,expire,id,ip,ipbits,itag,mip,mm,mn,ms,mv,mvi,pl,source/signature/813AEF3C4A7EFC89895FEEDA4ED836099D2806BE.45FD87517AAA1E28CF3BE59DB738A7EF70754A93/key/cms1/cms_redirect/yes/mip/2a01:4f8:192:5414::2/mm/42/mn/sn-4g5ednee/ms/onc/mt/1571758061/mv/m/mvi/3/pl/41/file/file.mp4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:45::a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
gvs 1.0 /
Resource Hash
7efb76927b67f50c1411403ed0710462fb8ea3319d2f893067e4a5d342ae7a43
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:35 GMT
X-Content-Type-Options
nosniff
Last-Modified
Wed, 25 Sep 2019 17:03:56 GMT
Server
gvs 1.0
Content-Type
video/mp4
Content-Range
bytes 0-2268496/2268497
Cache-Control
private, max-age=86400
Connection
close
Accept-Ranges
bytes
Alt-Svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
Content-Length
2268497
Expires
Tue, 22 Oct 2019 15:30:35 GMT

Redirect headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:35 GMT
server
ClientMapServer
status
302
x-frame-options
SAMEORIGIN
content-type
text/html; charset=UTF-8
location
https://r4---sn-4g5ednee.c.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/acao,ctier,expire,id,ip,ipbits,itag,mip,mm,mn,ms,mv,mvi,pl,source/signature/813AEF3C4A7EFC89895FEEDA4ED836099D2806BE.45FD87517AAA1E28CF3BE59DB738A7EF70754A93/key/cms1/cms_redirect/yes/mip/2a01:4f8:192:5414::2/mm/42/mn/sn-4g5ednee/ms/onc/mt/1571758061/mv/m/mvi/3/pl/41/file/file.mp4
cache-control
no-cache, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
643
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=22c25fc9-6d8b-d6c4-ab65-21f1aeb2c6d2&tv={c:rN5Uuq,time:188,type:e,env:{ar:self.0},es:0,sc:1,ha:1,gm:1,slTimes:{i:188,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:89,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[111~100],as:[111~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFDXnsk+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1d1|1e,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:35 GMT
X-Server-Name
dt41.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=a1df68eb-305c-15de-9984-66603a644620&tv={c:rN5Uur,time:215,type:e,env:{ar:22c25fc9-6d8b-d6c4-ab65-21f1aeb2c6d2.1},es:0,sc:1,ha:1,gm:1,slTimes:{i:0,o:215,n:0,pp:0,pm:0},slEvents:[{sl:o,t:128,wc:0.0.1600.1200,ac:1140.3076.300.280,am:i,cc:1140.3076.300.280,piv:0,obst:0,th:0,reas:l,bkn:{piv:[92~0],as:[92~300.280]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFDXnsk+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e,idMap:1d*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:35 GMT
X-Server-Name
dt24.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
view
googleads4.g.doubleclick.net/pcs/ Frame E6D5
0
536 B
Image
General
Full URL
https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjsvGMA-5NZSvGGDUsUEbycQ9Y48jovKxzKh2IaiwJzbeu3aoAd1BErsjTQJWUlzPvqOzG68dI008vRjctRt6wjEuIYOgXW_l7Cg7YDpFUua8QEWi-yr_gFVxottS9XxChes0eQF3ToaitYqLSVw&sig=Cg0ArKJSzAq2RvUl5I4PEAE&urlfix=1&adurl=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.23.162 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s22-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:35 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
ping.gif
stats-dev.brid.tv/ Frame E6D5
0
346 B
Image
General
Full URL
https://stats-dev.brid.tv/ping.gif?p=14815&pr=o&b=c&pid=11615&s=undefined|undefined&os=l&m=0&apa=0&df=1&ow=14120&pub=p&e=i&aid=9261&par=b&wp=0&at=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.224.196.105 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-224-196-105.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 23:26:45 GMT
via
1.1 430fc75cac3bdd04869a39405c45fba2.cloudfront.net (CloudFront)
last-modified
Tue, 04 Dec 2018 09:25:32 GMT
server
AmazonS3
age
70059
etag
"d41d8cd98f00b204e9800998ecf8427e"
x-cache
Hit from cloudfront
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
x-amz-cf-pop
FRA2-C1
accept-ranges
bytes
content-length
0
x-amz-cf-id
OQehfamqLwgkIWGJoXWmhOEY0JA-k3aTT_Yqr1mayXuDkacu6da_vA==
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=22c25fc9-6d8b-d6c4-ab65-21f1aeb2c6d2&tv={c:rN5Uyk,pingTime:-10,time:430,type:s,mvn:ZnNjPTEyLHNkPTMsbm89Nyxhc3A9MQ--,fsc:17.4.95v220002022020220000022002222000022220202020222220222220002222022002222200002220222022222222222000220200000022220222220222222222222202222222222222222222222222222222222222200000022022020020000002002202022022022222222000000000020222202022022222000000020000000000000000000002220002220000022200222202220022200200222022202220022222220020222222000220000222202222202222000002002002222222222220022202200022002220222202,sd:MTcuNC45NXYxMjAwfHwxNjAwfHwxfHwxfHwyNHx8MTIwMHx8MHx8MHx8MXx8bGFuZHNjYXBlLXByaW1hcnl8fDI0fHw0LzN8fDQvM3x8MHx8MTYwMA--,no:MTcuNC45NXZNb3ppbGxhfHxOZXRzY2FwZXx8bnx8MTZ8fG58fDB8fG58fExpbnV4IHg4Nl82NHx8R2Vja298fDIwMDMwMTA3fHwtMTIwfHxNb3ppbGxhLzUuMCAoTWFjaW50b3NoOyBJbnRlbCBNYWMgT1MgWCAxMF8xNF81KSBBcHBsZVdlYktpdC81MzcuMzYgKEtIVE1MLCBsaWtlIEdlY2tvKSBDaHJvbWUvNzQuMC4zNzI5LjE2OSBTYWZhcmkvNTM3LjM2fHwxfHwxfHxHb29nbGUgSW5jLnx8bg--,asp:1571758235959||9d41ffd1d25177b6c05a1bddc435916c||675c74d5f114ba25a49fb0f4cb02f70f||e5f40bcb0c1f5ee2e7e50f302a361c93||120f2c8a484f9d0b4ba704105588212a||3463d8dde5e17b9574de88f5b4f6fd90||8eb6025cf48ebc6855576af25feaffb8||f4d06bc88cfe5dfac3dde3c840e49d91||1529428597}
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:36 GMT
X-Server-Name
dt07.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dc_oe=ChMIuKW52pew5QIVlzrgCh1Omg9DEAAYACD34546;met=1;ecn1=1;etm1=0;eid1=11;
ade.googlesyndication.com/ddm/activity/ Frame E6D5
42 B
597 B
Image
General
Full URL
https://ade.googlesyndication.com/ddm/activity/dc_oe=ChMIuKW52pew5QIVlzrgCh1Omg9DEAAYACD34546;met=1;ecn1=1;etm1=0;eid1=11;
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:36 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
AddLogs
logging.carambo.la/ Frame 3796
0
176 B
XHR
General
Full URL
https://logging.carambo.la/AddLogs
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.224.94.188 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-224-94-188.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/x-www-form-urlencoded

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:33 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
d8ba0cf3ce1f648ea2ee63fa2e356746_ffb49d59a6980401ce271b6445a7714c29346c8f_incontent_unified_3.json
inimage.carambo.la/1/thms97/112441/ Frame 3796
3 KB
1 KB
XHR
General
Full URL
https://inimage.carambo.la/1/thms97/112441/d8ba0cf3ce1f648ea2ee63fa2e356746_ffb49d59a6980401ce271b6445a7714c29346c8f_incontent_unified_3.json
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40D6) /
Resource Hash
2614a8fe705a894ae259151da3eb80e657a9eb305f9f176bcf0b78a162ac068a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:29:48 GMT
content-encoding
deflate
vary
Accept-Encoding
x-amz-request-id
6A86548B7CFFEF46
x-cache
HIT
status
200
content-length
995
x-amz-id-2
gZo+Z+hhGK6PwmGQo7uKaHCiyWCHs0dgGqb6SM+2k35H3PVc56F65Xyskld2SumO+Ti2oPBsWc4=
x-amz-expiration
expiry-date="Wed, 23 Oct 2019 00:00:00 GMT", rule-id="delete files after 24 hours"
last-modified
Mon, 21 Oct 2019 22:23:33 GMT
server
ECS (fcn/40D6)
etag
"4cef4a707929fac27913a955d2ca35e2"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, s-maxage=14400
accept-ranges
bytes
SetPageRequestGeo
analytics.carambo.la/ Frame 3796
35 B
332 B
Fetch
General
Full URL
https://analytics.carambo.la/SetPageRequestGeo
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.173.24.113 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-173-24-113.compute-1.amazonaws.com
Software
/
Resource Hash
a3b59cf3c15a5896f4224c367d24e647fe14e411b8024dcc87aa37783e0cf110

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:36 GMT
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://www.reuters.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
35
Expires
-1
css
fonts.googleapis.com/ Frame 3796
9 KB
780 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:500,300,700,400
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:821::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
33e2656713e8648323bd5193b2e314db7df61f4d37d5df4ce22ad72b04a1166a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Tue, 22 Oct 2019 15:30:36 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Tue, 22 Oct 2019 15:30:36 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:36 GMT
css
fonts.googleapis.com/
9 KB
734 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:500,300,700,400
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:821::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
33e2656713e8648323bd5193b2e314db7df61f4d37d5df4ce22ad72b04a1166a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Tue, 22 Oct 2019 15:30:36 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Tue, 22 Oct 2019 15:30:36 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:36 GMT
css
fonts.googleapis.com/ Frame 3796
24 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Open+Sans:300italic,400italic,600italic,700italic,800italic,400,600,300,700,800
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:821::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
0a733c9a259685cf9a9816145434c0087227f35400e16208e7e63e58ccd44538
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Tue, 22 Oct 2019 15:30:36 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Tue, 22 Oct 2019 15:30:36 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:36 GMT
css
fonts.googleapis.com/
24 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Open+Sans:300italic,400italic,600italic,700italic,800italic,400,600,300,700,800
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:821::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
0a733c9a259685cf9a9816145434c0087227f35400e16208e7e63e58ccd44538
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Tue, 22 Oct 2019 15:30:36 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Tue, 22 Oct 2019 15:30:36 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:36 GMT
Knowledge-Medium.woff
static.reutersmedia.net/resources_v2/fonts/ Frame 3796
24 KB
24 KB
Font
General
Full URL
https://static.reutersmedia.net/resources_v2/fonts/Knowledge-Medium.woff
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.70 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-70.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
ae62fb7dca96004b13d628bf9deaa48d592259489d50369e6998929cfafe590f

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Origin
https://www.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 20 Oct 2019 01:22:55 GMT
content-encoding
gzip
age
223661
x-cache
Hit from cloudfront
status
200
content-length
24497
access-control-allow-origin
*
last-modified
Wed, 29 Mar 2017 00:52:23 GMT
server
nginx
vary
Accept-Encoding
content-type
application/x-font-woff
via
1.1 e5b747ffd1713cb17ddd7d55234a3301.cloudfront.net (CloudFront)
cache-control
max-age=604800
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
x-amz-cf-id
P2S1Xbb9AOZ9Uzfb0VSnLkYHd7TrTE6HL1-Iw52GEvbxWXgZkNlLbA==
expires
Tue, 08 Oct 2019 18:56:35 GMT
Knowledge-Regular.woff
static.reutersmedia.net/resources_v2/fonts/ Frame 3796
24 KB
24 KB
Font
General
Full URL
https://static.reutersmedia.net/resources_v2/fonts/Knowledge-Regular.woff
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.70 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-70.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
4e75f5bbf505e72bd2fc760536a94e16ee82202ec60757a8815a0273dc5ae85d

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Origin
https://www.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 20 Oct 2019 00:10:39 GMT
content-encoding
gzip
age
227997
x-cache
Hit from cloudfront
status
200
content-length
24249
access-control-allow-origin
*
last-modified
Wed, 29 Mar 2017 00:52:26 GMT
server
nginx
vary
Accept-Encoding
content-type
application/x-font-woff
via
1.1 e5b747ffd1713cb17ddd7d55234a3301.cloudfront.net (CloudFront)
cache-control
max-age=604800
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
x-amz-cf-id
N-uvwsfyLfdxjkVboKXFjaV-j9TtLwPH4jqSQ9YA5v83rq436GcwSA==
expires
Fri, 25 Oct 2019 19:41:43 GMT
cbolaIcons.woff
cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/css/fonts/ Frame 3796
4 KB
4 KB
Font
General
Full URL
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/css/fonts/cbolaIcons.woff?phtwnv
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40DA) /
Resource Hash
c85a8e7c2d1d0583578b2afd3a1ce469797bfa5c9d5598cba25f51f839348ec8

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Origin
https://www.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:36 GMT
last-modified
Mon, 12 Aug 2019 09:30:07 GMT
server
ECS (fcn/40DA)
x-amz-request-id
EB7763FE05F63708
status
200
etag
"dae3eb8c820d3bbb16a17610dece1c88"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
application/octet-stream
access-control-allow-origin
*
cache-control
max-age=63072000,s-maxage=63072000
x-cache
HIT
accept-ranges
bytes
content-length
3832
x-amz-id-2
7MUht4mVKz4ngR9jgyvmir1wZGEjO9QI/rIZ/srGx3xO9UJu61r4NOknLMNQ46mu1ltfrbqjbSk=
SetPageElementsRequestNew
analytics.carambo.la/ Frame 3796
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetPageElementsRequestNew
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.173.24.113 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-173-24-113.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:36 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
GetAds
xtr.carambo.la/ Frame 3796
10 KB
2 KB
Fetch
General
Full URL
https://xtr.carambo.la/GetAds
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.239.9.60 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-239-9-60.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
1299e53ba1649682c4f25d89297450860f282b07a71388be8509635f4b991f2d

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:36 GMT
Content-Encoding
deflate
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
text/html
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Connection
keep-alive
Content-Length
2198
Expires
-1
2186_3_10.jpg
media.carambo.la/Images/ Frame 3796
8 KB
8 KB
Image
General
Full URL
https://media.carambo.la/Images/2186_3_10.jpg
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40AD) /
Resource Hash
8525532639ee2044ec8bbcd37c99226bc0d48bc973dea14178d13c6f93ddb02c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:36 GMT
last-modified
Thu, 11 May 2017 11:07:08 GMT
server
ECS (fcn/40AD)
x-amz-request-id
66D3BA1A0691BDE9
status
200
etag
"bb3913bd6f88416f003e14bd5bdef4ce"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
image/jpeg
access-control-allow-origin
*
x-cache
HIT
accept-ranges
bytes
content-length
8355
x-amz-id-2
xpt8O9Ac6vL0FO9jHccIZr7mlZhsVbugVQAZynfKu9sSgzS8ADU0wT+p/2Ur4774bs3DfmsVGP4=
3416_3_10.jpg
media.carambo.la/Images/ Frame 3796
10 KB
11 KB
Image
General
Full URL
https://media.carambo.la/Images/3416_3_10.jpg
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/418B) /
Resource Hash
64d149eb162e7815255c1431fb2ba07c00b871f3146bd1c889c89851ec302ff5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:36 GMT
last-modified
Thu, 11 May 2017 11:05:47 GMT
server
ECS (fcn/418B)
x-amz-request-id
8B29F51538678986
status
200
etag
"dfd485bbfe66d217e73da9de01623ff7"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
image/jpeg
access-control-allow-origin
*
x-cache
HIT
accept-ranges
bytes
content-length
10658
x-amz-id-2
bv5XX/E4EFD5f7+A3/lZ5/NxAxyTgf1q7sfAAaFS/dzXBVIyt3g8GekhOdksgIQtaauQ62O/Ox0=
2167_3_10.jpg
media.carambo.la/Images/ Frame 3796
10 KB
10 KB
Image
General
Full URL
https://media.carambo.la/Images/2167_3_10.jpg
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40B3) /
Resource Hash
cbb37284830fb7b15bcc3a315f36e5c7b2796585425fa49da55e92515f94023a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:36 GMT
last-modified
Thu, 11 May 2017 11:07:00 GMT
server
ECS (fcn/40B3)
x-amz-request-id
9D7C83044633929A
status
200
etag
"24212ca8e9e2274c49601c62d53490be"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
image/jpeg
access-control-allow-origin
*
x-cache
HIT
accept-ranges
bytes
content-length
10205
x-amz-id-2
Xwl1zOYaFcokVysXokD2eHcumdxX7CwyxVlUr9pIjWY++MSJjdQDsv+tBTSNHTK5xkkf+Gc4mGA=
SetEvent
analytics.carambo.la/ Frame 3796
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetEvent
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.173.24.113 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-173-24-113.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:35 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
2186_3_10.jpg
media.carambo.la/Images/ Frame 3796
8 KB
8 KB
Image
General
Full URL
https://media.carambo.la/Images/2186_3_10.jpg
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40AD) /
Resource Hash
8525532639ee2044ec8bbcd37c99226bc0d48bc973dea14178d13c6f93ddb02c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:36 GMT
last-modified
Thu, 11 May 2017 11:07:08 GMT
server
ECS (fcn/40AD)
x-amz-request-id
66D3BA1A0691BDE9
status
200
etag
"bb3913bd6f88416f003e14bd5bdef4ce"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
image/jpeg
access-control-allow-origin
*
x-cache
HIT
accept-ranges
bytes
content-length
8355
x-amz-id-2
xpt8O9Ac6vL0FO9jHccIZr7mlZhsVbugVQAZynfKu9sSgzS8ADU0wT+p/2Ur4774bs3DfmsVGP4=
2167_3_10.jpg
media.carambo.la/Images/ Frame 3796
10 KB
10 KB
Image
General
Full URL
https://media.carambo.la/Images/2167_3_10.jpg
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40B3) /
Resource Hash
cbb37284830fb7b15bcc3a315f36e5c7b2796585425fa49da55e92515f94023a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:36 GMT
last-modified
Thu, 11 May 2017 11:07:00 GMT
server
ECS (fcn/40B3)
x-amz-request-id
9D7C83044633929A
status
200
etag
"24212ca8e9e2274c49601c62d53490be"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
image/jpeg
access-control-allow-origin
*
x-cache
HIT
accept-ranges
bytes
content-length
10205
x-amz-id-2
Xwl1zOYaFcokVysXokD2eHcumdxX7CwyxVlUr9pIjWY++MSJjdQDsv+tBTSNHTK5xkkf+Gc4mGA=
3416_3_10.jpg
media.carambo.la/Images/ Frame 3796
10 KB
10 KB
Image
General
Full URL
https://media.carambo.la/Images/3416_3_10.jpg
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/418B) /
Resource Hash
64d149eb162e7815255c1431fb2ba07c00b871f3146bd1c889c89851ec302ff5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:36 GMT
last-modified
Thu, 11 May 2017 11:05:47 GMT
server
ECS (fcn/418B)
x-amz-request-id
8B29F51538678986
status
200
etag
"dfd485bbfe66d217e73da9de01623ff7"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
image/jpeg
access-control-allow-origin
*
x-cache
HIT
accept-ranges
bytes
content-length
10658
x-amz-id-2
bv5XX/E4EFD5f7+A3/lZ5/NxAxyTgf1q7sfAAaFS/dzXBVIyt3g8GekhOdksgIQtaauQ62O/Ox0=
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=0&fi=0&apd=33&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=1&d=reuters.com&L1id=20159232&L2id=277213512&L3id=139199112&L4id=138204787707&S1id=3735912&S2id=37592232&ord=1571758235452&r=779462343036&t=meas&bedc=1&q=1&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:36 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Tue, 22 Oct 2019 15:30:36 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=0&fi=0&apd=33&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=1&d=reuters.com&L1id=20159232&L2id=277213512&L3id=139199112&L4id=138204787707&S1id=3735912&S2id=37592232&ord=1571758235452&r=779462343036&t=nht&bedc=1&q=2&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:36 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Tue, 22 Oct 2019 15:30:36 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame E6D5
42 B
110 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsvHgSPzwRnjZWvwSGhyvx1mlVsawvEI6YeKfAyEqy5atHd9sU8kojM13KfFk79YHbW2fhNY-Qk8NOSuph7DaAEpLCq95CrS0xHZF2Z0jR0&sig=Cg0ArKJSzPQBWlN9xGVcEAE&adk=3633717877&tt=1163&bs=1585%2C1200&mtos=1050,1050,1050,1050,1050&tos=1050,0,0,0,0&p=436,1140,686,1440&mcvt=1050&rs=3&ht=0&tfs=123&tls=1173&mc=1&lte=1&bas=0&bac=0&met=no&avms=nio&niot_obs=9&niot_cbk=15&md=2&lm=2&rst=1571758235379&rpt=122&isd=0&msd=0&oseid=3&xdi=0&ps=1600%2C6341&ss=1600%2C1200&pt=11&bin=1&deb=1-2-2-5-13-11-35-11-0-0-0&tvt=1168&r=v&id=osdim&vs=4&uc=11&upc=1&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=0x0&itpl=19&v=20191021
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:36 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=22c25fc9-6d8b-d6c4-ab65-21f1aeb2c6d2&tv={c:rN5UJn,pingTime:1,time:1115,type:p,clog:[{piv:100,vs:i,r:,w:300,h:250,t:89}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1115,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:89,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1039~100],as:[1039~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:95,fm:rFDXnsk+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1d1|1e,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:36 GMT
X-Server-Name
dt07.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=22c25fc9-6d8b-d6c4-ab65-21f1aeb2c6d2&tv={c:rN5UJo,pingTime:1,time:1116,type:pf,clog:[{piv:100,vs:i,r:,w:300,h:250,t:89}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1116,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:89,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1039~100],as:[1039~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:95,fm:rFDXnsk+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1d1|1e,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:36 GMT
X-Server-Name
dt24.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=22c25fc9-6d8b-d6c4-ab65-21f1aeb2c6d2&tv={c:rN5UJo,pingTime:1,time:1116,type:c,clog:[{piv:100,vs:i,r:,w:300,h:250,t:89}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1116,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:89,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1039~100],as:[1039~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:95,fm:rFDXnsk+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1d1|1e,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1,metricId:publ1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:36 GMT
X-Server-Name
dt41.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=22c25fc9-6d8b-d6c4-ab65-21f1aeb2c6d2&tv={c:rN5UJp,pingTime:1,time:1117,type:c,clog:[{piv:100,vs:i,r:,w:300,h:250,t:89}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1117,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:89,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1040~100],as:[1040~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:95,fm:rFDXnsk+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1d1|1e,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1,metricId:grpm1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:36 GMT
X-Server-Name
dt37.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=0&fi=0&apd=201&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=1&d=reuters.com&L1id=20159232&L2id=277213512&L3id=139199112&L4id=138204787707&S1id=3735912&S2id=37592232&ord=1571758235452&r=779462343036&t=hdn&bedc=1&q=3&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:36 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Tue, 22 Oct 2019 15:30:36 GMT
SetConsentStatus
analytics.carambo.la/ Frame 3796
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetConsentStatus
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.173.24.113 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-173-24-113.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:36 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
prebid.min.js
cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/external/ Frame 3796
205 KB
65 KB
XHR
General
Full URL
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/external/prebid.min.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/41AF) /
Resource Hash
6249458482797d7ee8be4da01d4f549ba9994927d14ae92404e0c08181b36206

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:36 GMT
content-encoding
deflate
vary
Accept-Encoding
x-amz-request-id
236064E292235027
x-cache
HIT
status
200
content-length
66427
x-amz-id-2
gQOHFoWiQl7MuJsnFumpDKPDx3zkFHuCxg7YTlszlPMNIizc+Re98cyLiaDVBqa77L9vFdeBxPs=
last-modified
Mon, 12 Aug 2019 09:30:09 GMT
server
ECS (fcn/41AF)
etag
"ea1eea13d68e95de7e03abe6a748ad70"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=63072000,s-maxage=63072000
accept-ranges
bytes
ping.gif
stats-dev.brid.tv/ Frame E6D5
0
346 B
Image
General
Full URL
https://stats-dev.brid.tv/ping.gif?p=14815&pr=o&b=c&pid=11615&s=undefined|undefined&os=l&m=0&apa=0&df=1&ow=14120&pub=p&e=vi&aid=9261&par=b&wp=0&at=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.224.196.105 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-224-196-105.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 23:26:45 GMT
via
1.1 430fc75cac3bdd04869a39405c45fba2.cloudfront.net (CloudFront)
last-modified
Tue, 04 Dec 2018 09:25:32 GMT
server
AmazonS3
age
70061
etag
"d41d8cd98f00b204e9800998ecf8427e"
x-cache
Hit from cloudfront
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
x-amz-cf-pop
FRA2-C1
accept-ranges
bytes
content-length
0
x-amz-cf-id
4E-az7_wDOXD-ujikTLuXOCzye-43OfCXtn0VpCypu8_2rPEH90n9g==
protobuf.min.js
cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/external/ Frame 3796
69 KB
21 KB
XHR
General
Full URL
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/external/protobuf.min.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/41A4) /
Resource Hash
04b075859121bd8bae2825f760da6f0a2f0a5e9c7755370a55d51c961e41354c

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:38 GMT
content-encoding
deflate
vary
Accept-Encoding
x-amz-request-id
A8B632884A513621
x-cache
HIT
status
200
content-length
21141
x-amz-id-2
LIxM34qSYgQSMFcnE5VM++HTN095A+Z4uJMIBCtIWHZQWZTGDiXjKlxTSn8vBhFTYGzXUrX0RN0=
last-modified
Mon, 12 Aug 2019 09:30:10 GMT
server
ECS (fcn/41A4)
etag
"0b2aa9f2e7a587c31a287a8c3cdc3acd"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=63072000,s-maxage=63072000
accept-ranges
bytes
KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
fonts.gstatic.com/s/roboto/v20/ Frame 3796
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v20/KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
5d1bc9b443f3f81fa4b4ad4634c1bb9702194c1898e3a9de0ab5e2cdc0e9f479
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Roboto:500,300,700,400
Origin
https://www.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 11 Oct 2019 15:58:20 GMT
x-content-type-options
nosniff
last-modified
Wed, 24 Jul 2019 01:18:50 GMT
server
sffe
age
948738
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
11016
x-xss-protection
0
expires
Sat, 10 Oct 2020 15:58:20 GMT
mem5YaGs126MiZpBA-UNirkOUuhpKKSTjw.woff2
fonts.gstatic.com/s/opensans/v17/ Frame 3796
9 KB
9 KB
Font
General
Full URL
https://fonts.gstatic.com/s/opensans/v17/mem5YaGs126MiZpBA-UNirkOUuhpKKSTjw.woff2
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
b8e23a845bc6b7fd417d29182e0e38d353e64b5e12e06bb1de2b5ce063db1dcc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Open+Sans:300italic,400italic,600italic,700italic,800italic,400,600,300,700,800
Origin
https://www.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 11 Oct 2019 14:51:43 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 19:30:44 GMT
server
sffe
age
952735
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
9180
x-xss-protection
0
expires
Sat, 10 Oct 2020 14:51:43 GMT
blacklist_script.js
tagan.adlightning.com/carambola/ Frame DE1E
67 KB
26 KB
Script
General
Full URL
https://tagan.adlightning.com/carambola/blacklist_script.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.152 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-152.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
25d9fc9dab1f829f422558fdb2c7158a5a6aaeff10e2ae6186f1c208297ad6dd

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
FtarD2LS_BF9hp5iWzNqaJ7bvNOVIi_4
content-encoding
gzip
etag
"c0f662b8b5a44b01afd54345f4eb8de5"
x-amz-cf-pop
FRA2
x-cache
Hit from cloudfront
status
200
content-length
25701
x-amz-meta-git_commit
e5df4b9
last-modified
Tue, 22 Oct 2019 01:12:44 GMT
server
AmazonS3
date
Tue, 22 Oct 2019 15:30:38 GMT
content-type
application/javascript
via
1.1 e621b964f8c348548e0b42950cc55248.cloudfront.net (CloudFront)
cache-control
max-age=900
accept-ranges
bytes
x-amz-cf-id
MrhcTKECiVFTv-QZ_lxWu13FWUTqXJdJZvNXoX9bn--NZyLRL4xCIw==
blocking_script.js
tagan.adlightning.com/carambola/ Frame DE1E
51 KB
14 KB
Script
General
Full URL
https://tagan.adlightning.com/carambola/blocking_script.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.152 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-152.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
89e2a6149ffa9306be8353f88f60111c9976ef77681059262318551fc3ff1a45

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
R4ROrLSRtw9OG4KaHY69v06kGYSAlhfQ
content-encoding
gzip
etag
"c7306f799f7635ded477731fe3e0138b"
age
73516
x-cache
Hit from cloudfront
status
200
content-length
13901
x-amz-meta-git_commit
e5df4b9
last-modified
Tue, 15 Oct 2019 19:04:40 GMT
server
AmazonS3
date
Mon, 21 Oct 2019 19:05:22 GMT
content-type
application/javascript
via
1.1 e621b964f8c348548e0b42950cc55248.cloudfront.net (CloudFront)
cache-control
max-age=86400
x-amz-cf-pop
FRA2
accept-ranges
bytes
x-amz-cf-id
G2kG-Sg6il9CDwkYMAGq8kpuVjeqUq-n4G1HPITdJ9PX6IQo61trOw==
showad.js
ads.pubmatic.com/AdServer/js/ Frame DE1E
39 KB
15 KB
Script
General
Full URL
https://ads.pubmatic.com/AdServer/js/showad.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.233.180 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-233-180.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash
5c2e5ba634ec3f23bea93de95ca5d970cc9905c2d01944f230e60c7b5e7d4363

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:38 GMT
Content-Encoding
gzip
Last-Modified
Fri, 26 Jul 2019 09:39:45 GMT
Server
Apache/2.2.15 (CentOS)
ETag
"13006b6-9bf6-58e925294ef26"
Vary
Accept-Encoding
P3P
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
Cache-Control
public, max-age=33278
Connection
keep-alive
Accept-Ranges
bytes
Content-Type
text/html; charset=UTF-8
Content-Length
14898
Expires
Wed, 23 Oct 2019 00:45:16 GMT
SetAdsRequest
analytics.carambo.la/ Frame 3796
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetAdsRequest
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.173.24.113 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-173-24-113.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:38 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
blacklist_script.js
tagan.adlightning.com/carambola/ Frame 6FF7
67 KB
26 KB
Script
General
Full URL
https://tagan.adlightning.com/carambola/blacklist_script.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.152 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-152.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
25d9fc9dab1f829f422558fdb2c7158a5a6aaeff10e2ae6186f1c208297ad6dd

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
FtarD2LS_BF9hp5iWzNqaJ7bvNOVIi_4
content-encoding
gzip
etag
"c0f662b8b5a44b01afd54345f4eb8de5"
x-amz-cf-pop
FRA2
x-cache
Hit from cloudfront
status
200
content-length
25701
x-amz-meta-git_commit
e5df4b9
last-modified
Tue, 22 Oct 2019 01:12:44 GMT
server
AmazonS3
date
Tue, 22 Oct 2019 03:02:27 GMT
content-type
application/javascript
via
1.1 e621b964f8c348548e0b42950cc55248.cloudfront.net (CloudFront)
cache-control
max-age=900
accept-ranges
bytes
x-amz-cf-id
Kz0gRGXIK2tZHy5o8DzJj1ozNmg3c4X_cdL6gPTKgV82T9mfoA6lHw==
blocking_script.js
tagan.adlightning.com/carambola/ Frame 6FF7
51 KB
14 KB
Script
General
Full URL
https://tagan.adlightning.com/carambola/blocking_script.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.230.95.152 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-54-230-95-152.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
89e2a6149ffa9306be8353f88f60111c9976ef77681059262318551fc3ff1a45

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
R4ROrLSRtw9OG4KaHY69v06kGYSAlhfQ
content-encoding
gzip
etag
"c7306f799f7635ded477731fe3e0138b"
age
73516
x-cache
Hit from cloudfront
status
200
content-length
13901
x-amz-meta-git_commit
e5df4b9
last-modified
Tue, 15 Oct 2019 19:04:40 GMT
server
AmazonS3
date
Mon, 21 Oct 2019 19:05:22 GMT
content-type
application/javascript
via
1.1 e621b964f8c348548e0b42950cc55248.cloudfront.net (CloudFront)
cache-control
max-age=86400
x-amz-cf-pop
FRA2
accept-ranges
bytes
x-amz-cf-id
doFFIV3xm3eKVjZEo8FdzEWIlBgmWiPwnFT0swDYNo05EnaCHUAyyQ==
SetAdsRequest
analytics.carambo.la/ Frame 3796
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetAdsRequest
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.173.24.113 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-173-24-113.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:38 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
SetHbBidRequestProto
analytics.carambo.la/ Frame 3796
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetHbBidRequestProto
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.173.24.113 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-173-24-113.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:38 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
siab.js
cdn.tynt.com/ Frame 6FF7
15 KB
6 KB
Script
General
Full URL
https://cdn.tynt.com/siab.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.87.26 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
4b3f0ca4c12f7e2cbcca6c51cda0e51542801315a1b8aaa63abbadb68da5628e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Mon, 07 Oct 2019 18:43:10 GMT
server
cloudflare
age
247613
etag
W/"5d9b873e-3c45"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=259200
cf-ray
529c8381cf06dfe7-FRA
expires
Fri, 25 Oct 2019 15:30:39 GMT
UCookieSetPug
image6.pubmatic.com/AdServer/ Frame DE1E
2 KB
2 KB
Script
General
Full URL
https://image6.pubmatic.com/AdServer/UCookieSetPug?oid=2&cb=PubMatic._uidCB
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.190.78 , United Kingdom, ASN62713 (AS-PUBMATIC - PubMatic, Inc., US),
Reverse DNS
Software
/
Resource Hash
da2f7ba97ab656f3edad785f4644bd03dfa00a522c78c4dd178524190b483d1a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:39 GMT
Cache-Control
private
Expires
Fri, 1 Nov 2019 08:04:20 GMT
P3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
Content-Length
1569
Content-Type
text/html; charset=UTF-8
bFJBfaR2Or54kOaKkv7mNO.js
sc.tynt.com/script/sc/ Frame 6FF7
2 KB
1 KB
Script
General
Full URL
https://sc.tynt.com/script/sc/bFJBfaR2Or54kOaKkv7mNO.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.87.26 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
0955d7f885f72563f66c56a86cf98c93cff8f70b50aafa307e9b715540130c66
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
age
107077
status
200, 200 OK
x-xss-protection
1; mode=block
x-request-id
327f7cff-4763-4e93-bc58-87bffa84c9d2
x-runtime
0.002089
x-content-digest
575a77f733111aa22f71abcabea9559386c79873
last-modified
Sun, 20 Oct 2019 14:09:51 GMT
server
cloudflare
x-frame-options
SAMEORIGIN
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript; charset=utf-8
cache-control
max-age=3600, public, s-maxage=172800
cf-ray
529c8382281edfe7-FRA
x-rack-cache
fresh
expires
Mon, 21 Oct 2019 08:16:12 GMT
p
ic.tynt.com/b/
0
0

sic.js
cdn-sic.33across.com/1/javascripts/ Frame 6FF7
447 KB
125 KB
Script
General
Full URL
https://cdn-sic.33across.com/1/javascripts/sic.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.39.14 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare / Love
Resource Hash
a89cd6ceb08d82e5d55e591af5e48663e1d4df60381d75d357f981fcf5a6931b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Wed, 18 Sep 2019 22:43:59 GMT
server
cloudflare
age
39
x-powered-by
Love
etag
W/"5d82b32f-6fce0"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=3600
cf-ray
529c83825e0cc2b8-FRA
expires
Tue, 22 Oct 2019 16:30:39 GMT
Cookie set showad.js
ads.pubmatic.com/AdServer/js/ Frame 79B9
0
0
Document
General
Full URL
https://ads.pubmatic.com/AdServer/js/showad.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.233.180 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-233-180.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash

Request headers

Host
ads.pubmatic.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Accept-Encoding
gzip, deflate, br
Cookie
KTPCACOOKIE=YES
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U

Response headers

Last-Modified
Fri, 26 Jul 2019 09:39:45 GMT
ETag
"13006b6-9bf6-58e925294ef26"
Server
Apache/2.2.15 (CentOS)
Set-Cookie
KTPCACOOKIE=YES; domain=.pubmatic.com; path=/; max-age=7776000;
Accept-Ranges
bytes
Content-Encoding
gzip
P3P
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
Content-Length
14898
Content-Type
text/html; charset=UTF-8
Cache-Control
public, max-age=33277
Expires
Wed, 23 Oct 2019 00:45:16 GMT
Date
Tue, 22 Oct 2019 15:30:39 GMT
Connection
keep-alive
Vary
Accept-Encoding
Cookie set showad.js
ads.pubmatic.com/AdServer/js/ Frame 6734
0
0
Document
General
Full URL
https://ads.pubmatic.com/AdServer/js/showad.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.233.180 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-233-180.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash

Request headers

Host
ads.pubmatic.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Accept-Encoding
gzip, deflate, br
Cookie
KTPCACOOKIE=YES
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U

Response headers

Last-Modified
Fri, 26 Jul 2019 09:39:45 GMT
ETag
"13006b6-9bf6-58e925294ef26"
Server
Apache/2.2.15 (CentOS)
Set-Cookie
KTPCACOOKIE=YES; domain=.pubmatic.com; path=/; max-age=7776000;
Accept-Ranges
bytes
Content-Encoding
gzip
P3P
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
Content-Length
14898
Content-Type
text/html; charset=UTF-8
Cache-Control
public, max-age=33277
Expires
Wed, 23 Oct 2019 00:45:16 GMT
Date
Tue, 22 Oct 2019 15:30:39 GMT
Connection
keep-alive
Vary
Accept-Encoding
AdServerServlet
sshowads.pubmatic.com/AdServer/ Frame DE1E
2 KB
2 KB
Script
General
Full URL
https://sshowads.pubmatic.com/AdServer/AdServerServlet?pubId=156612&siteId=251236&adId=2075066&kadwidth=300&kadheight=250&SAVersion=2&js=1&kdntuid=1&pageURL=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&inIframe=1&kadpageurl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&operId=3&sec=1&kltstamp=2019-10-22%2017%3A30%3A39&timezone=2&screenResolution=1600x1200&ranreq=0.9155429433756597&pmUniAdId=0&adVisibility=2&adPosition=3076x1440&gdpr=0&dspids=%7B%7D
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.189.111 , United Kingdom, ASN62713 (AS-PUBMATIC - PubMatic, Inc., US),
Reverse DNS
Software
nginx /
Resource Hash
e15eb043ff7b9d0cd35b8a415aa8596cf003ed02aa40582f166ddda3ffd97503

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:39 GMT
Content-Encoding
gzip
Server
nginx
Transfer-Encoding
chunked
P3P
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
Cache-Control
no-store, no-cache, private
Connection
keep-alive
Content-Type
text/html; charset=utf-8
gpt.js
securepubads.g.doubleclick.net/tag/js/ Frame CAB2
47 KB
15 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.23.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s45-in-f2.1e100.net
Software
sffe /
Resource Hash
e87ffb3988d5fbb64e187a25e8150197194ecc7990bd9b69072d0fba7fff81c8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"314 / 763 of 1000 / last-modified: 1571692025"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
14850
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:39 GMT
sic.css
cdn-sic.33across.com/1/stylesheets/ Frame 6FF7
11 KB
2 KB
Stylesheet
General
Full URL
https://cdn-sic.33across.com/1/stylesheets/sic.css
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.39.14 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare / Love
Resource Hash
81c1d3e8b32d5f970c6f4a7e971031b77d19c5570d1416b9c81e3820875a3390

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Wed, 18 Sep 2019 22:43:10 GMT
server
cloudflare
age
3196
x-powered-by
Love
etag
W/"5d82b2fe-2a1b"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css
status
200
cache-control
public, max-age=3600
cf-ray
529c83838931c2b8-FRA
expires
Tue, 22 Oct 2019 16:30:39 GMT
authorize
sic.33across.com/ Frame 6FF7
1 KB
1 KB
Script
General
Full URL
https://sic.33across.com/authorize?gdprConsentLength=0&version=2.58.0&agent=Mozilla%2F5.0%20(Macintosh%3B%20Intel%20Mac%20OS%20X%2010_14_5)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F74.0.3729.169%20Safari%2F537.36&product=siab&userId=&sessionId=&publisherURL=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&referrerURL=&publisherId=bFJBfaR2Or54kOaKkv7mNO&publisher=reuters_3_300_B.com&displayableSizes=300x250&viewportWidth=300&viewportHeight=250&screenWidth=1600&screenHeight=1200&scrollX=0&scrollY=0&pageVisibility=visible&pageWidth=300&pageHeight=250&_=1571758239265&callback=_tynt_jp.a3bjdeogf
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.180 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip180.208-100-17.static.steadfastdns.net
Software
/ Love
Resource Hash
7175bf755e304d7d148e775373dc99554e5df17df0cb4ee38987094702cc0e8a
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
status
200, 200 OK
x-powered-by
Love
etag
W/"5c4-gAxlQmFJT7igWPoPFSUYEvlDqs8"
vary
Accept-Encoding
access-control-allow-methods
GET, POST, PUT, DELETE
p3p
CP="NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA"
access-control-allow-origin
*
access-control-allow-credentials
true
content-type
text/javascript; charset=utf-8
access-control-allow-headers
X-Requested-With, Authorization
siab.js
cdn.tynt.com/ Frame DE1E
15 KB
5 KB
Script
General
Full URL
https://cdn.tynt.com/siab.js?{random}&_ADTIME_&
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.87.26 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
4b3f0ca4c12f7e2cbcca6c51cda0e51542801315a1b8aaa63abbadb68da5628e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Mon, 07 Oct 2019 18:43:10 GMT
server
cloudflare
age
247618
etag
W/"5d9b873e-3c45"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=259200
cf-ray
529c83837c2ddfe7-FRA
expires
Fri, 25 Oct 2019 15:30:39 GMT
AdDisplayTrackerServlet
aktrack.pubmatic.com/AdServer/ Frame C0D4
0
0
Document
General
Full URL
https://aktrack.pubmatic.com/AdServer/AdDisplayTrackerServlet?operId=1&pubId=156612&siteId=251236&adId=2075066&adType=3&adServerId=165&kefact=0.000000&kaxefact=0.000000&kadNetFrequecy=0&kadwidth=300&kadheight=250&kadsizeid=0&kltstamp=1571758239&indirectAdId=1840519&adServerOptimizerId=1&ranreq=0.9155429433756597&kpbmtpfact=0.000000&dcId=3&tldId=0&passback=30&svr=ADS22411U&ekefact=nyCvXaPEAgBR3Q0HZLSWcyGv5ChnqB8gxs3y0mHeyt_t8Pr1&ekaxefact=nyCvXbnEAgAQnMioScn6EQEppR7gINrKd42-PjRbzz9zB_0k&ekpbmtpfact=nyCvXcrEAgBSIimC6i9rcWwOeWzqcT-7xDELQ7bHMPQf7_W-&crID=0&campaignId=0&isRTB=0&imprId=4E335D94-813E-446D-B480-3296B597B393&oid=4E335D94-813E-446D-B480-3296B597B393&cntryId=58&domain=reuters.com&pageURL=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&sec=1&pmc=0
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.233.180 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-233-180.deploy.static.akamaitechnologies.com
Software
/
Resource Hash

Request headers

Host
aktrack.pubmatic.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Accept-Encoding
gzip, deflate, br
Cookie
KTPCACOOKIE=YES; pi=156612:2; KADUSERCOOKIE=A52A932E-9203-4777-9784-C0183E34A70E; chk=1; DPSync3=1572912000%3A201_197%7C1571788800%3A174; SyncRTB3=1572912000%3A104_3_81_204_55_5_56_54_21_176_22_166_99_64_170_195_161_71_189_13_205_8_92_194_7%7C1572566400%3A63%7C1574294400%3A203%7C1572307200%3A2_67_15; pp=156612
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U

Response headers

Content-Type
text/html
Content-Length
0
Date
Tue, 22 Oct 2019 15:30:39 GMT
Connection
keep-alive
v2
de.tynt.com/deb/
4 B
200 B
Script
General
Full URL
https://de.tynt.com/deb/v2?id=bFJBfaR2Or54kOaKkv7mNO&dn=SIAB&cc=1&r=
Requested by
Host: cdn.tynt.com
URL: https://cdn.tynt.com/siab.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.185 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip185.208-100-17.static.steadfastdns.net
Software
/
Resource Hash
d21021784cda31eeae5c8295e047a14bda6ed5a9b5963fca9e7ceb398a9c9179

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:37 GMT
cache-control
max-age=86400
content-type
application/javascript
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
content-length
4
expires
Wed, 23 Oct 2019 15:30:38 GMT
v2
de.tynt.com/deb/
4 B
200 B
Script
General
Full URL
https://de.tynt.com/deb/v2?m=xch&id=bFJBfaR2Or54kOaKkv7mNO&dn=SIAB&cc=1&r=
Requested by
Host: cdn.tynt.com
URL: https://cdn.tynt.com/siab.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.185 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip185.208-100-17.static.steadfastdns.net
Software
/
Resource Hash
d21021784cda31eeae5c8295e047a14bda6ed5a9b5963fca9e7ceb398a9c9179

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:38 GMT
cache-control
max-age=86400
content-type
application/javascript
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
content-length
4
expires
Wed, 23 Oct 2019 15:30:38 GMT
bFJBfaR2Or54kOaKkv7mNO.js
sc.tynt.com/script/sc/ Frame DE1E
2 KB
898 B
Script
General
Full URL
https://sc.tynt.com/script/sc/bFJBfaR2Or54kOaKkv7mNO.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.87.26 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
0955d7f885f72563f66c56a86cf98c93cff8f70b50aafa307e9b715540130c66
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
age
107077
status
200, 200 OK
x-xss-protection
1; mode=block
x-request-id
327f7cff-4763-4e93-bc58-87bffa84c9d2
x-runtime
0.002089
x-content-digest
575a77f733111aa22f71abcabea9559386c79873
last-modified
Sun, 20 Oct 2019 14:09:51 GMT
server
cloudflare
x-frame-options
SAMEORIGIN
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript; charset=utf-8
cache-control
max-age=3600, public, s-maxage=172800
cf-ray
529c83841dd6dfe7-FRA
x-rack-cache
fresh
expires
Mon, 21 Oct 2019 08:16:12 GMT
integrator.js
adservice.google.de/adsid/ Frame CAB2
109 B
171 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/ Frame CAB2
109 B
171 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
pubads_impl_2019101701.js
securepubads.g.doubleclick.net/gpt/ Frame CAB2
157 KB
57 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101701.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.23.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s45-in-f2.1e100.net
Software
sffe /
Resource Hash
ee9b85b63056ee85dac06408a3c33c0765f827efb47bfedf10fe266ee4566e1f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 17 Oct 2019 13:06:14 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
58640
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:39 GMT
sic.js
cdn-sic.33across.com/1/javascripts/ Frame DE1E
447 KB
125 KB
Script
General
Full URL
https://cdn-sic.33across.com/1/javascripts/sic.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.39.14 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare / Love
Resource Hash
a89cd6ceb08d82e5d55e591af5e48663e1d4df60381d75d357f981fcf5a6931b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Wed, 18 Sep 2019 22:43:59 GMT
server
cloudflare
age
39
x-powered-by
Love
etag
W/"5d82b32f-6fce0"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=3600
cf-ray
529c83857b54c2b8-FRA
expires
Tue, 22 Oct 2019 16:30:39 GMT
jpt
ib.adnxs.com/ Frame 6FF7
0
662 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251243&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&prod=SIAB&psa=0&pf=90&cc=0&ivt=18&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.assu3hpiq
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.223.202 , Netherlands, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
318.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:41 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 318.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.223.232:80
AN-X-Request-Uuid
2804d688-510d-43e1-b818-8975da2f9b91
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jpt
ib.adnxs.com/ Frame 6FF7
0
662 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251239&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&prod=SIAB&psa=0&pf=30&cc=0&ivt=18&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.a1sh5vay0
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.223.202 , Netherlands, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
318.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:41 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 318.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.149:80
AN-X-Request-Uuid
1136dbcc-e0d8-4f0e-8b87-acf8ff4fdae9
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jpt
ib.adnxs.com/ Frame 6FF7
0
661 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251244&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&prod=SIAB&psa=0&pf=30&cc=0&ivt=18&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.acqxrlv62
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.223.202 , Netherlands, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
318.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:41 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 318.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.75:80
AN-X-Request-Uuid
318b34b4-cc03-4785-a7fd-a2605d5cd2e3
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jstag
33across-d.openx.net/w/1.0/ Frame D5CB
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
95984f669613c6c03b216c179cf59ba866d30311bac31f8b16273fc3d59019c7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
server
OXGW/16.164.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57478
via
1.1 google
expires
Tue, 22 Oct 2019 16:30:39 GMT
jstag
33across-d.openx.net/w/1.0/ Frame 5210
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
d16ee1dbf8d6abf1d1ec076126510acb403646259c960014dc83d9e13266ad18

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
server
OXGW/16.164.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57474
via
1.1 google
expires
Tue, 22 Oct 2019 16:30:39 GMT
jstag
33across-d.openx.net/w/1.0/ Frame 6D14
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
7c68a7239dec6cb03612c1789750ff8ddd0cd3dab943e92b6b9bb9e101b7f0f5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
server
OXGW/16.164.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57478
via
1.1 google
expires
Tue, 22 Oct 2019 16:30:39 GMT
exchange
ssc.33across.com/api/ Frame 6FF7
141 B
417 B
XHR
General
Full URL
https://ssc.33across.com/api/exchange
Requested by
Host: cdn-sic.33across.com
URL: https://cdn-sic.33across.com/1/javascripts/sic.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.177 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip177.208-100-17.static.steadfastdns.net
Software
/ 33Across
Resource Hash
e8e2defecba0b22dbf8e95d3d8e2840053944987ad955ae2507b26c88ffbac05

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
status
200, 200 OK
x-powered-by
33Across
vary
Accept-Encoding, Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.reuters.com
access-control-allow-credentials
true
v2
de.tynt.com/deb/
4 B
200 B
Script
General
Full URL
https://de.tynt.com/deb/v2?m=xch&id=bFJBfaR2Or54kOaKkv7mNO&dn=SIAB&cc=2&r=
Requested by
Host: cdn.tynt.com
URL: https://cdn.tynt.com/siab.js?{random}&_ADTIME_&
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.185 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip185.208-100-17.static.steadfastdns.net
Software
/
Resource Hash
d21021784cda31eeae5c8295e047a14bda6ed5a9b5963fca9e7ceb398a9c9179

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:38 GMT
cache-control
max-age=86400
content-type
application/javascript
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
content-length
4
expires
Wed, 23 Oct 2019 15:30:38 GMT
acj
33across-d.openx.net/w/1.0/ Frame 6D14
Redirect Chain
  • https://33across-d.openx.net/w/1.0/acj?ai=e091fa8f-d75b-4d1b-8b9a-409793db6794&o=229d2b3fac25ea&ju=https%3A//www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment...
  • https://33across-d.openx.net/w/1.0/acj?cc=1&ai=e091fa8f-d75b-4d1b-8b9a-409793db6794&o=229d2b3fac25ea&ju=https%3A//www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-trea...
453 B
716 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?cc=1&ai=e091fa8f-d75b-4d1b-8b9a-409793db6794&o=229d2b3fac25ea&ju=https%3A//www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&jr=&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier3&c.pf=30&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
0e3a1e9b1d79931b0676368b2e6eea17b7bc9882ba2577f3f23003bfdb38afab

Request headers

Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:39 GMT
via
1.1 google
server
OXGW/16.164.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
453
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

date
Tue, 22 Oct 2019 15:30:39 GMT
via
1.1 google
server
OXGW/16.164.0
status
302
location
https://33across-d.openx.net/w/1.0/acj?cc=1&ai=e091fa8f-d75b-4d1b-8b9a-409793db6794&o=229d2b3fac25ea&ju=https%3A//www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&jr=&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier3&c.pf=30&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
access-control-allow-credentials
true
alt-svc
clear
content-length
0
acj
33across-d.openx.net/w/1.0/ Frame D5CB
454 B
642 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?ai=936bdf53-4a2e-44ee-9aa3-e2a596ed98d2&o=2099060d6f9278&ju=https%3A//www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&jr=&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier1&c.pf=90&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
2c0f35ae43be82b5c8db643590e6c5b4e235b51d4d7d522939db1531d6cce277

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:39 GMT
via
1.1 google
server
OXGW/16.164.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
454
expires
Mon, 26 Jul 1997 05:00:00 GMT
acj
33across-d.openx.net/w/1.0/ Frame 5210
454 B
638 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?ai=80a25211-d045-4ddf-a1a0-ce0bf21a40c1&o=29183d0cdcdf3&ju=https%3A//www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&jr=&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier2&c.pf=30&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
8116d4f73bc1bbaedd153b9426bd27b4a7a576c1ce0feb68fd731bf424bfa221

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:39 GMT
via
1.1 google
server
OXGW/16.164.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
454
expires
Mon, 26 Jul 1997 05:00:00 GMT
pd
eu-u.openx.net/w/1.0/ Frame CE48
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
accept-encoding
gzip, deflate, br
cookie
i=d9219787-1ae4-0460-269e-b63644213298|1571758239
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U

Response headers

status
200
vary
Accept
set-cookie
i=d9219787-1ae4-0460-269e-b63644213298|1571758239; Version=1; Expires=Wed, 21-Oct-2020 15:30:39 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571758239|mOsLgqgikin0fcmWiygu; Version=1; Expires=Wed, 06-Nov-2019 15:30:39 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.164.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 22 Oct 2019 15:30:39 GMT
content-type
text/html
content-length
862
via
1.1 google
alt-svc
clear
pd
eu-u.openx.net/w/1.0/ Frame B312
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
accept-encoding
gzip, deflate, br
cookie
i=d9219787-1ae4-0460-269e-b63644213298|1571758239
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U

Response headers

status
200
vary
Accept
set-cookie
i=d9219787-1ae4-0460-269e-b63644213298|1571758239; Version=1; Expires=Wed, 21-Oct-2020 15:30:39 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571758239|mOsLgqgikin0fcmWiygu; Version=1; Expires=Wed, 06-Nov-2019 15:30:39 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.164.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 22 Oct 2019 15:30:39 GMT
content-type
text/html
content-length
862
via
1.1 google
alt-svc
clear
gpt.js
securepubads.g.doubleclick.net/tag/js/ Frame 06ED
46 KB
15 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.23.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s45-in-f2.1e100.net
Software
sffe /
Resource Hash
dae0df258a8943f1e474c721170373a8282dd2443a714a1bb8ef9f2573bb91d5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"314 / 790 of 1000 / last-modified: 1571692025"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
14762
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:39 GMT
sic.css
cdn-sic.33across.com/1/stylesheets/ Frame DE1E
11 KB
2 KB
Stylesheet
General
Full URL
https://cdn-sic.33across.com/1/stylesheets/sic.css
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.39.14 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare / Love
Resource Hash
81c1d3e8b32d5f970c6f4a7e971031b77d19c5570d1416b9c81e3820875a3390

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Wed, 18 Sep 2019 22:43:10 GMT
server
cloudflare
age
3196
x-powered-by
Love
etag
W/"5d82b2fe-2a1b"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css
status
200
cache-control
public, max-age=3600
cf-ray
529c83873901c2b8-FRA
expires
Tue, 22 Oct 2019 16:30:39 GMT
authorize
sic.33across.com/ Frame DE1E
1 KB
1 KB
Script
General
Full URL
https://sic.33across.com/authorize?gdprConsentLength=0&version=2.58.0&agent=Mozilla%2F5.0%20(Macintosh%3B%20Intel%20Mac%20OS%20X%2010_14_5)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F74.0.3729.169%20Safari%2F537.36&product=siab&userId=&sessionId=&publisherURL=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&referrerURL=&publisherId=bFJBfaR2Or54kOaKkv7mNO&publisher=reuters_3_300_B.com&displayableSizes=300x250&viewportWidth=300&viewportHeight=250&screenWidth=1600&screenHeight=1200&scrollX=0&scrollY=0&pageVisibility=visible&pageWidth=300&pageHeight=250&_=1571758239810&callback=_tynt_jp.a7u511k2x
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.180 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip180.208-100-17.static.steadfastdns.net
Software
/ Love
Resource Hash
2ab74e5142b9621c6b709c31df8a615e0e61fb27c359499aa3a8bde6e0feed76
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
status
200, 200 OK
x-powered-by
Love
etag
W/"5c4-D9Lhn/+XsL9riBrgONe7LYGgF7M"
vary
Accept-Encoding
access-control-allow-methods
GET, POST, PUT, DELETE
p3p
CP="NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA"
access-control-allow-origin
*
access-control-allow-credentials
true
content-type
text/javascript; charset=utf-8
access-control-allow-headers
X-Requested-With, Authorization
pd
eu-u.openx.net/w/1.0/ Frame 0719
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
accept-encoding
gzip, deflate, br
cookie
i=d9219787-1ae4-0460-269e-b63644213298|1571758239; pd=v2|1571758239|mOsLgqgikin0fcmWiygu
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U

Response headers

status
200
vary
Accept
set-cookie
i=d9219787-1ae4-0460-269e-b63644213298|1571758239; Version=1; Expires=Wed, 21-Oct-2020 15:30:39 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571758239|rskimWfcvmsHqGgqmuiynIsLomgemOgunsn0oagi; Version=1; Expires=Wed, 06-Nov-2019 15:30:39 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.164.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 22 Oct 2019 15:30:39 GMT
content-type
text/html
content-length
825
via
1.1 google
alt-svc
clear
integrator.js
adservice.google.de/adsid/ Frame 06ED
109 B
171 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/ Frame 06ED
109 B
171 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
pubads_impl_2019101401.js
securepubads.g.doubleclick.net/gpt/ Frame 06ED
156 KB
57 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js?21064803
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.23.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s45-in-f2.1e100.net
Software
sffe /
Resource Hash
f8800772f0dd827877029d9d634a170a156ff82b6b6bdf251b62c750b73cfe93
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
58589
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:39 GMT
jpt
ib.adnxs.com/ Frame DE1E
0
662 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251243&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&prod=SIAB&psa=0&pf=90&cc=0&ivt=18&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.aaco0yz6d
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.223.202 , Netherlands, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
318.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:41 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 318.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.222.235:80
AN-X-Request-Uuid
27728510-be26-4522-8e01-bb2132220b1c
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jpt
ib.adnxs.com/ Frame DE1E
0
661 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251239&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&prod=SIAB&psa=0&pf=30&cc=0&ivt=18&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.ag1paz8x3
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.223.202 , Netherlands, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
318.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:41 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 318.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.223.40:80
AN-X-Request-Uuid
51afa143-5506-41dc-b183-6e6d8fce6fd5
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jpt
ib.adnxs.com/ Frame DE1E
0
662 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251244&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&prod=SIAB&psa=0&pf=30&cc=0&ivt=18&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.ajrlzh5vk
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.223.202 , Netherlands, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
318.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:41 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 318.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.223.249:80
AN-X-Request-Uuid
2ee3e8b3-209c-45df-8897-b75134819d2d
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jstag
33across-d.openx.net/w/1.0/ Frame A6DA
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
ac53b784fad37e0ff0b4442eb9550fedddf1919b235c363ec7377009cc9e1c1a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
server
OXGW/16.164.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57431
via
1.1 google
expires
Tue, 22 Oct 2019 16:30:39 GMT
jstag
33across-d.openx.net/w/1.0/ Frame 4F43
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
0c54ff6c46735cc5921d7671b275d5cc3e7826ff550679f86d68f973997d74c9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
server
OXGW/16.164.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57430
via
1.1 google
expires
Tue, 22 Oct 2019 16:30:39 GMT
jstag
33across-d.openx.net/w/1.0/ Frame 20A7
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
31365b9680817467ac925770e8eb228f3bd318420fcc7fb77fbcba5e2117aa40

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:39 GMT
content-encoding
gzip
server
OXGW/16.164.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57432
via
1.1 google
expires
Tue, 22 Oct 2019 16:30:39 GMT
exchange
ssc.33across.com/api/ Frame DE1E
0
0

acj
33across-d.openx.net/w/1.0/ Frame A6DA
0
0

acj
33across-d.openx.net/w/1.0/ Frame 4F43
0
0

acj
33across-d.openx.net/w/1.0/ Frame 20A7
Redirect Chain
  • https://33across-d.openx.net/w/1.0/acj?o=275db9797c2a71&ju=https%3A//www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&jr=&b...
  • https://33across-d.openx.net/w/1.0/acj?cc=1&o=275db9797c2a71&ju=https%3A//www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&...
453 B
716 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?cc=1&o=275db9797c2a71&ju=https%3A//www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&jr=&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier3&c.pf=30&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
c1390124e63b7c61e942ab23ed22d0222a551ff7d58b3a732c560b68baf156c2

Request headers

Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:40 GMT
via
1.1 google
server
OXGW/16.164.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
453
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

date
Tue, 22 Oct 2019 15:30:40 GMT
via
1.1 google
server
OXGW/16.164.0
status
302
location
https://33across-d.openx.net/w/1.0/acj?cc=1&o=275db9797c2a71&ju=https%3A//www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&jr=&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier3&c.pf=30&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
access-control-allow-credentials
true
alt-svc
clear
content-length
0
p
ic.tynt.com/b/
0
294 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571758239036&dn=SIAB&iso=0&img=https%3A%2F%2Fs2.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20191021%26t%3D2%26i%3D1443461056%26w%3D1200%26r%3DLYNXMPEF9K1MF&ct=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year&t=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year%20-%20Reuters&cu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda-idUSKBN1X024U
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.183 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip183.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:39 GMT
server
nginx/1.14.0
p3p
policyref="/w3c/p3p.xml", CP="CUR ADM OUR NOR STA NID", CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
pd
eu-u.openx.net/w/1.0/ Frame 10F1
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
accept-encoding
gzip, deflate, br
cookie
i=326dea95-1248-0ed5-0074-dff5d694ff10|1571758240
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U

Response headers

status
200
vary
Accept
set-cookie
i=326dea95-1248-0ed5-0074-dff5d694ff10|1571758240; Version=1; Expires=Wed, 21-Oct-2020 15:30:40 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571758240|mOsLgqgikin0fcmWiygu; Version=1; Expires=Wed, 06-Nov-2019 15:30:40 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.164.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 22 Oct 2019 15:30:40 GMT
content-type
text/html
content-length
862
via
1.1 google
alt-svc
clear
p
ic.tynt.com/b/
0
119 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571758239036&dn=SIAB&iso=0&img=https%3A%2F%2Fs2.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20191021%26t%3D2%26i%3D1443461056%26w%3D1200%26r%3DLYNXMPEF9K1MF&ct=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year&t=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year%20-%20Reuters
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.183 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip183.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:39 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
p
ic.tynt.com/b/
0
119 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571758239036&dn=SIAB&iso=0&img=https%3A%2F%2Fs2.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20191021%26t%3D2%26i%3D1443461056%26w%3D1200%26r%3DLYNXMPEF9K1MF&ct=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.183 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip183.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:39 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=22c25fc9-6d8b-d6c4-ab65-21f1aeb2c6d2&tv={c:rN5VLT,pingTime:5,time:5115,type:p,clog:[{piv:100,vs:i,r:,w:300,h:250,t:89}],es:0,sc:1,ha:1,gm:1,slTimes:{i:5115,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:89,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[5039~100],as:[5039~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:96,fm:rFDXnsk+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1d1|1e,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:40 GMT
X-Server-Name
dt17.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=22c25fc9-6d8b-d6c4-ab65-21f1aeb2c6d2&tv={c:rN5VLU,pingTime:5,time:5116,type:pf,clog:[{piv:100,vs:i,r:,w:300,h:250,t:89}],es:0,sc:1,ha:1,gm:1,slTimes:{i:5116,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:89,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[5039~100],as:[5039~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:96,fm:rFDXnsk+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1d1|1e,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:40 GMT
X-Server-Name
dt22.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
p
ic.tynt.com/b/
0
119 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571758239036&dn=SIAB&iso=0&img=https%3A%2F%2Fs2.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20191021%26t%3D2%26i%3D1443461056%26w%3D1200%26r%3DLYNXMPEF9K1MF&ct=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.183 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip183.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:39 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
p
ic.tynt.com/b/
0
119 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571758239036&dn=SIAB&iso=0&img=https%3A%2F%2Fs2.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20191021%26t%3D2%26i%3D1443461056%26w%3D1200%26r%3DLYNXMPEF9K1MF
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.183 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip183.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:39 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
p
ic.tynt.com/b/
0
294 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571758239036&dn=SIAB&iso=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.183 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip183.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:39 GMT
server
nginx/1.14.0
p3p
policyref="/w3c/p3p.xml", CP="CUR ADM OUR NOR STA NID", CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
ads
securepubads.g.doubleclick.net/gampad/ Frame CAB2
389 B
695 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2784806796816660&correlator=676463271019361&output=ldjh&impl=fif&adsid=NT&eid=21064804%2C21062832&vrg=2019101701&npa=1&guci=1.2.0.0.2.1.0.0&plat=1%3A536903688%2C2%3A536903688%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20191022&iu=%2F32867010%2FSIAB_300x250&sz=300x250&scp=c%3D50%26r%3D110%26d%3Dreuters_3_300_B.com%26g%3DbFJBfaR2Or54kOaKkv7mNO%26gd%3DbFJBfaR2Or54kOaKkv7mNO%253Adesktop%26cc%3D0%26pf%3D30%26ivt%3D18%26iva%3D4%26ivb%3D3%26ivc%3D1%26ivd%3D1%26ive%3D0%26ivp%3D6%26osr%3D6%26vis%3D0%26pre%3Dapnx%253At%2Cox%253A0%2Cttx%253A0%26pre_sz%3Dapnx%253A0x0%2Cox%253A0x0%2Cttx%253A0x0%26tier%3Dapnx%253A0%2Cox%253A0%2Cttx%253A0%26hb%3D0&cookie_enabled=1&cdm=www.reuters.com&bc=31&abxe=1&lmt=1571758241&dt=1571758241495&dlt=1571758239259&idt=394&ea=0&frm=23&biw=1585&bih=1200&isw=1&ish=1&oid=3&adx=-8560&ady=-6924&adk=62473835&uci=oq9czqoay9j4&ifi=1&ifk=2550955627&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&nhd=3&iag=63&url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&top=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&dssz=4&icsg=170&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1x0&msz=300x250&ga_vid=900434807.1571758241&ga_sid=1571758241&ga_hid=1592025076&fws=256&ohw=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101701.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
cafe /
Resource Hash
7ef923dba2c9cdf5dc1212c9db7967a5b19d92f77db2fc18bbb7e0a2810c3d28
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:41 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
202
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_2019101701.js
securepubads.g.doubleclick.net/gpt/ Frame CAB2
64 KB
25 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101701.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
sffe /
Resource Hash
a03faced3009fb10b52543aa37d64bf267dffd4ec013767368830361cc75454f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:41 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 17 Oct 2019 13:06:14 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
24885
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:41 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/ Frame CAB2
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html?n=3
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

fpi.js
ap.lijit.com/www/delivery/ Frame 6FF7
5 KB
3 KB
Script
General
Full URL
https://ap.lijit.com/www/delivery/fpi.js?{random}&_ADTIME_&z=577991&width=300&height=250
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.251.249.13 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
c7929bc3aeeaf5c76ec1fe0d01931a858083edef98f1eafabc5cbdbf9390d99b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:41 GMT
Content-Encoding
gzip
Server
nginx
ETag
W/"5d829b94-1534"
Vary
Accept-Encoding
Content-Type
text/javascript
Cache-Control
private, no-cache, no-store, must-revalidate, max-age=0
Transfer-Encoding
chunked
X-Sovrn-Pod
ap2ams1
Expires
Thu, 01 Jan 1970 00:00:01 GMT
ads
securepubads.g.doubleclick.net/gampad/ Frame 06ED
295 B
394 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2709468100075509&correlator=2668282892632426&output=ldjh&impl=fif&adsid=NT&eid=21064803%2C21063635%2C21064369%2C21064688&vrg=2019101401&npa=1&guci=1.2.0.0.2.1.0.0&plat=1%3A536903688%2C2%3A536903688%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20191022&iu=%2F32867010%2FSIAB_300x250&sz=300x250&scp=c%3D50%26r%3D110%26d%3Dreuters_3_300_B.com%26g%3DbFJBfaR2Or54kOaKkv7mNO%26gd%3DbFJBfaR2Or54kOaKkv7mNO%253Adesktop%26cc%3D0%26pf%3D30%26ivt%3D18%26iva%3D4%26ivb%3D3%26ivc%3D1%26ivd%3D1%26ive%3D0%26ivp%3D6%26osr%3D6%26vis%3D0%26pre%3Dapnx%253At%2Cox%253A0%2Cttx%253Ae100%26pre_sz%3Dapnx%253A0x0%2Cox%253A0x0%2Cttx%253A0x0%26tier%3Dapnx%253A0%2Cox%253A0%2Cttx%253A0%26hb%3D0&cookie=ID%3De534646e4c3dda4d%3AT%3D1571758241%3AS%3DALNI_MbtgyMAPAby3dTf152OvZbrV6ZxUw&cookie_enabled=1&cdm=www.reuters.com&bc=31&abxe=1&lmt=1571758241&dt=1571758241944&dlt=1571758239806&idt=106&ea=0&frm=23&biw=1585&bih=1200&isw=1&ish=1&oid=3&adx=-8560&ady=-6924&adk=62473835&uci=ux68syt5f607&ifi=1&ifk=2550955627&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_sd=1&flash=0&nhd=3&iag=63&url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&top=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda%2Ffda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&dssz=4&icsg=170&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1x0&msz=300x250&ga_vid=377634020.1571758242&ga_sid=1571758242&ga_hid=157072302&fws=256&ohw=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js?21064803
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
cafe /
Resource Hash
fb2d2ed0ddeaa6daa0f96d09d112fba5125231859755b371751f5860b36d22c6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:42 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
121
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_2019101401.js
securepubads.g.doubleclick.net/gpt/ Frame 06ED
64 KB
24 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js?21064803
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
sffe /
Resource Hash
f123fae1ceff20dea7ee2ff8895276a22cddecc8e0ef503b5e95419e76909a54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:41 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
24836
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:41 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/ Frame 06ED
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html?n=3
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

sync
ap.lijit.com/ Frame 6FF7
49 KB
16 KB
Script
General
Full URL
https://ap.lijit.com/sync
Requested by
Host: ap.lijit.com
URL: https://ap.lijit.com/www/delivery/fpi.js?{random}&_ADTIME_&z=577991&width=300&height=250
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.251.249.13 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
1d8da7a47f6af5a975ee32da2474214aa571140ec11f8232f0c9fd0aef2d02e2

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:41 GMT
Content-Encoding
gzip
Last-Modified
Wed, 18 Sep 2019 21:03:17 GMT
Server
nginx
ETag
W/"5d829b95-c373"
Vary
Accept-Encoding
Content-Type
text/javascript
Cache-Control
max-age=86400, must-revalidate
Transfer-Encoding
chunked
X-Sovrn-Pod
ap2ams1
Expires
Wed, 23 Oct 2019 15:30:41 GMT
adcfg
ap.lijit.com/ Frame 6FF7
159 B
565 B
Script
General
Full URL
https://ap.lijit.com/adcfg?zoneid=577991&tid=38fce669818048388e913c201031d939718932ff&mode=1&dmn=www.reuters.com
Requested by
Host: ap.lijit.com
URL: https://ap.lijit.com/sync
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.251.249.13 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
3798a3748904b37bfcab5d2152e5ecd952e071037884ac370c71dec3214a2156

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:41 GMT
Content-Encoding
gzip
Server
nginx
Transfer-Encoding
chunked
Vary
Accept-Encoding
Access-Control-Allow-Methods
GET, POST, DELETE, PUT
Content-Type
application/x-javascript
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
true
X-Sovrn-Pod
ap2ams1
Access-Control-Allow-Headers
X-Requested-With, Content-Type
fpi.js
ap.lijit.com/www/delivery/ Frame DE1E
5 KB
3 KB
Script
General
Full URL
https://ap.lijit.com/www/delivery/fpi.js?{random}&_ADTIME_&z=577991&width=300&height=250
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.251.249.13 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
c7929bc3aeeaf5c76ec1fe0d01931a858083edef98f1eafabc5cbdbf9390d99b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:42 GMT
Content-Encoding
gzip
Server
nginx
ETag
W/"5d829b96-1534"
Vary
Accept-Encoding
Content-Type
text/javascript
Cache-Control
private, no-cache, no-store, must-revalidate, max-age=0
Transfer-Encoding
chunked
X-Sovrn-Pod
ap2ams1
Expires
Thu, 01 Jan 1970 00:00:01 GMT
sync
ap.lijit.com/ Frame DE1E
49 KB
16 KB
Script
General
Full URL
https://ap.lijit.com/sync
Requested by
Host: ap.lijit.com
URL: https://ap.lijit.com/www/delivery/fpi.js?{random}&_ADTIME_&z=577991&width=300&height=250
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.251.249.13 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
1d8da7a47f6af5a975ee32da2474214aa571140ec11f8232f0c9fd0aef2d02e2

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:42 GMT
Content-Encoding
gzip
Last-Modified
Wed, 18 Sep 2019 21:03:17 GMT
Server
nginx
ETag
W/"5d829b95-c373"
Vary
Accept-Encoding
Content-Type
text/javascript
Cache-Control
max-age=86400, must-revalidate
Transfer-Encoding
chunked
X-Sovrn-Pod
ap2ams1
Expires
Wed, 23 Oct 2019 15:30:42 GMT
adcfg
ap.lijit.com/ Frame DE1E
159 B
566 B
Script
General
Full URL
https://ap.lijit.com/adcfg?zoneid=577991&tid=36c0db05acb64017956a3d3b0eeb42c192fad9da&mode=1&dmn=www.reuters.com
Requested by
Host: ap.lijit.com
URL: https://ap.lijit.com/sync
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.251.249.13 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
45efd11f015d7e5f147761d8abf83c5c642ce1ccfc2542bcb6177ab9560100da

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:42 GMT
Content-Encoding
gzip
Server
nginx
Transfer-Encoding
chunked
Vary
Accept-Encoding
Access-Control-Allow-Methods
GET, POST, DELETE, PUT
Content-Type
application/x-javascript
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
true
X-Sovrn-Pod
ap2ams1
Access-Control-Allow-Headers
X-Requested-With, Content-Type
/
onetag-geo.s-onetag.com/
23 B
434 B
XHR
General
Full URL
https://onetag-geo.s-onetag.com/
Requested by
Host: beacon.s-onetag.com
URL: https://beacon.s-onetag.com/beacon.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20eb:ec00:5:ae3a:ba00:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
ad16e1b37490fca28df99d039d6373d2fee4d894fcd279d95b90ae872f4d860f

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:15:56 GMT
via
1.1 1e498d046330e15095a1a2a958463bf5.cloudfront.net (CloudFront), 1.1 f7bf326347bdd7f275a38a22b5b83724.cloudfront.net (CloudFront)
age
855
x-amzn-requestid
23fcf373-ebb4-4df8-bb78-c9be713af666
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600
x-amz-cf-pop
FRA2-C2, FRA2-C1
x-amz-apigw-id
B-F-9HGcyK4FgXA=
content-length
23
x-amz-cf-id
DgqXcxd7iTFrFobfWVLOZ18rvTkSidXdQgm0n7xosyii0E5IRhWrHQ==
dc_oe=ChMIuKW52pew5QIVlzrgCh1Omg9DEAAYACD34546;met=1;ecn1=1;etm1=0;eid1=960584;
ade.googlesyndication.com/ddm/activity/ Frame E6D5
42 B
597 B
Image
General
Full URL
https://ade.googlesyndication.com/ddm/activity/dc_oe=ChMIuKW52pew5QIVlzrgCh1Omg9DEAAYACD34546;met=1;ecn1=1;etm1=0;eid1=960584;
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.23.162 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s22-in-f2.1e100.net
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:43 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
ic.tynt.com
URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571758239036&dn=SIAB&iso=0&img=https%3A%2F%2Fs2.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20191021%26t%3D2%26i%3D1443461056%26w%3D1200%26r%3DLYNXMPEF9K1MF&ct=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year&t=Vertex%20prices%20cystic%20fibrosis%20combo%20treatment%20at%20%24311%2C000-per-year%20-%20Reuters&cu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-vertex-pharms-fda-idUSKBN1X024U&ah=https%3A%2F%2Fmobile.reuters.com%2Farticle%2Famp%2FidUSKBN1X024U
Domain
ssc.33across.com
URL
https://ssc.33across.com/api/exchange
Domain
33across-d.openx.net
URL
https://33across-d.openx.net/w/1.0/acj?o=249bb08a52b661&ju=https%3A//www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&jr=&nl=18%252C18%252C19&ul=56%252C37%252C39&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier1&c.pf=90&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Domain
33across-d.openx.net
URL
https://33across-d.openx.net/w/1.0/acj?o=231f991b6a5afd&ju=https%3A//www.reuters.com/article/us-vertex-pharms-fda/fda-approves-vertex-pharmas-combo-treatment-for-cystic-fibrosis-idUSKBN1X024U&jr=&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier2&c.pf=30&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250

Verdicts & Comments Add Verdict or Comment

230 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| onformdata object| onpointerrawupdate object| analytics object| dataLayer object| google_tag_manager function| postscribe string| GoogleAnalyticsObject function| ga object| google_tag_data object| gaplugins object| gaGlobal object| gaData object| Reuters object| parallelMediaHosts object| tag object| firstScriptTag object| player function| onYouTubeIframeAPIReady function| onPlayerPlaybackQualityChange function| onPlayerReady function| onPlayerStateChange object| player2 function| onYouTubeIframeAPIReady2 function| onPlayerReady2 function| onPlayerPlaybackQualityChange2 function| onPlayerStateChange2 object| player3 function| onYouTubeIframeAPIReady3 function| onPlayerReady3 function| onPlayerPlaybackQualityChange3 function| onPlayerStateChange3 object| player4 function| onYouTubeIframeAPIReady4 function| onPlayerReady4 function| onPlayerPlaybackQualityChange4 function| onPlayerStateChange4 object| player5 function| onYouTubeIframeAPIReady5 function| onPlayerReady5 function| onPlayerPlaybackQualityChange5 function| onPlayerStateChange5 object| player7 function| onYouTubeIframeAPIReady7 function| onPlayerReady7 function| onPlayerPlaybackQualityChange7 function| onPlayerStateChange7 undefined| script object| _sf_async_config number| _sf_startpt object| _cb_shared object| google_optimize object| YT object| YTConfig function| onYTReady object| yt function| ytDomDomGetNextId object| ytEventsEventsListeners object| ytEventsEventsCounter object| __core-js_shared__ object| RTVEmbedder object| RCOM_Data function| webpackJsonp object| core object| scrollMonitor object| gptadslots object| googletag function| admantx_callback object| evidon function| __cmp function| renderComponent function| LGNWGdd object| vahfoe98Flags string| vahfoa87Rnd function| LGNWGTrkFailed object| vahfod05btc function| commonPopup boolean| vahfo94dsdl boolean| vahfo94dsdln string| vahfod05bgenat string| vahfod05bsthash boolean| vahfoc2eforceimp function| hj object| _hjSettings object| article_date object| author string| content_channel object| keywords object| tp boolean| vahfob6aBody function| _fbq function| fbq function| normalize string| dianomiContextHost function| dianomiLoadContext function| dianomiContextSetHeight function| dianomiContextSetWidth function| dianomiContextSetFloat function| dianomiContextElement function| dianomiReloadContext function| dianomiContextReady object| hjSiteSettings function| hjBootstrap object| hjBootstrapCalled string| segment_user_id string| NativeAIObject function| nativeAI function| ___tp object| localCookieStorage object| sessionCookieStorage object| TRUE_ANTHEM object| jQuery1124015316732733028537 string| __tpVersion object| nativeAIWebpackJsonp function| ns360 object| News360 object| lazyLoadOptions object| _cbm object| NativeAI function| e number| abp object| _comscore function| getValuesGWIQ function| _extends function| LazyLoad function| udm_ object| ns_p object| COMSCORE object| $jscomp function| MIIScriptCtrl object| fortyone object| gwiq string| article_platform string| article_edition number| _sf_endpt object| adobeDil object| adobe function| Visitor function| DIL object| s_c_il number| s_c_in string| topic_channel string| channel string| content_type string| adblock string| edition string| platform string| keyword_slug string| content_title string| inline_type string| dcontent_channel string| channel_list object| admp_vars function| getCookie object| pSUPERFLY_mab object| _cbq object| pSUPERFLY object| pSUPERFLY_video object| _cbv_strategies object| _cbv string| state object| __onetag object| __connect boolean| vahfo32aDetect object| vahfof41Mobile object| vahfod05b1 object| vahfod05bo1 object| vahfod05bo2 object| vahfod05bo3 object| vahfod05b2 number| vahfod05bd3 object| vahfod05b4 object| vahfod05b5 boolean| vahfo54cij object| advBidxc function| _mR function| _mD object| _mnHM object| __iasPET function| iasDataHandler object| diagPixSentCodes string| T645KQG string| TB4M82W object| ggeac object| closure_memoize_cache_ object| googleToken object| googleIMState object| google_js_reporting_queue function| processGoogleToken undefined| google_measure_js_timing number| google_srt boolean| google_noFetch number| __google_ad_urls_id function| Goog_AdSense_getAdAdapterInstance function| Goog_AdSense_OsdAdapter function| googleCompanionsServicePresent function| googleGetCompanionAdSlots function| googleSetCompanionAdContents function| google_show_companion_ad function| google_show_companion_ad_in_slot function| google_get_companion_slot_params function| google_companion_error function| google_companion_loaded function| google_increment_num_ad_mouseovers string| google_ad_output string| google_flash_version boolean| google_webgl_support string| google_ad_section string| google_country number| google_unique_id object| google_reactive_ads_global_state boolean| vahfo993Track object| google_image_requests object| __google_ad_urls object| ampInaboxIframes object| ampInaboxPendingMessages boolean| google_osd_loaded boolean| google_onload_fired function| Goog_Osd_UnloadAdBlock function| Goog_Osd_UpdateElementToMeasure function| google_osd_amcb object| Moat#G26 boolean| Moat#EVA object| MoatSuperV26 object| DOMlessLLDcallback_46948823 object| MoatDataJsonpRequest_46948823 object| __IntegralASExec object| Cbola number| cbola_abTestId string| cbola_pageViewId object| _33Across

15 Cookies

Domain/Path Name / Value
.dianomi.com/ Name: __cfduid
Value: dee4859796249e2130a5a8fcddb70662a1571758232
.reuters.com/ Name: _gat
Value: 1
.reuters.com/ Name: _fbp
Value: fb.1.1571758233089.2068739142
www.reuters.com/ Name: __pat
Value: -14400000
.reuters.com/ Name: __pvi
Value: %7B%22id%22%3A%22v-2019-10-22-17-30-32-788-nRKVpkoHbIy9nmpn-cce5f57fc77b2e7a24fd6d04f6f26144%22%2C%22domain%22%3A%22.reuters.com%22%2C%22time%22%3A1571758232938%7D
www.reuters.com/ Name: nativeAiInstallationId
Value: dd88448c-5e07-42a6-b553-9dd14b273dd1
.reuters.com/ Name: _hjid
Value: 8db969d6-f0c6-4af2-9591-4cd881afb104
.reuters.com/ Name: __tbc
Value: %7Bjzx%7Dyo9xUxAKwg32SeQvuAZGbeXBvAh2W2mk6EeEkjDkwzK4A0NacH-_oLbEbm3nmoYS-bZJtwq-qN3QzJMnJEuAM2QEdlFYfDxa9AZ8qQIL_6V_Iso8eHPVWNbr8XVSqGC6HzyVzbU0qDL8Htc3rl51Vg
.reuters.com/ Name: ajs_anonymous_id
Value: %221e3b7c2e-d0f1-478f-9bc5-ab436b478792%22
.reuters.com/ Name: _ga
Value: GA1.2.2132169831.1571758232
www.reuters.com/ Name: _cb_ls
Value: 1
.reuters.com/ Name: _gid
Value: GA1.2.1362649515.1571758232
.reuters.com/ Name: xbc
Value: %7Bjzx%7DBtS3PHr8KcpV6uj81Rx7DABVMccyC_xq_1VPUP4eVVMcR0nrm5-pcBSNAzdX2mk36d8mimHtHZe5l6HkT7ijdI42vfARtPY5wVcV-ORPJVwogNekqF_EMGuFVqmMRYPK
.reuters.com/ Name: ajs_group_id
Value: null
.reuters.com/ Name: ajs_user_id
Value: null

18 Console Messages

Source Level URL
Text
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
BODY ITEMS [object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance?count=7
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance/markets?count=7
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/us/top-nav/news/world?count=7
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/us/top-nav/politics?count=7
console-api log (Line 1)
Message:
Blocking Ads: No
console-api log (Line 1)
Message:
comscore new global fired
console-api log (Line 2)
Message:
segment identify user with traits: [object Object]
console-api warning URL: https://connect.facebook.net/en_US/fbevents.js(Line 24)
Message:
[Facebook Pixel] - Unable to parse JSON-LD tag. Malformed JSON found: ' { "@context": "http://schema.org", "@type": "NewsArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://www.reuters.com/article/us-vertex-pharms-fda-idUSKBN1X024U" }, "headline": "Vertex prices cystic fibrosis combo treatment at $311,000-per-year", "url": "https://www.reuters.com/article/us-vertex-pharms-fda-idUSKBN1X024U", "image": { "@type": "ImageObject", "url": "https://s2.reutersmedia.net/resources/r/?m=02&d=20191021&t=2&i=1443461056&w=1200&r=LYNXMPEF9K1MF", "width": "800", "height": "800" }, "thumbnailUrl": "https://s2.reutersmedia.net/resources/r/?m=02&d=20191021&t=2&i=1443461056&w=1200&r=LYNXMPEF9K1MF", "dateCreated": "2019-10-21T22:31:59+0000", "dateModified": "2019-10-21T22:31:59+0000", "datePublished": "2019-10-21T22:31:59+0000", "author": { "@type": "Person", "name": "Manojna Maddipatla" }, "publisher": { "@type": "Organization", "name": "Reuters", "logo": { "@type": "ImageObject", "url": "https://s3.reutersmedia.net/resources_v2/images/reuters_social_logo.png", "width": "200", "height": "200" } }, "description": 'Vertex Pharmaceuticals Inc has priced its three-drug combination for cystic fibrosis (CF) at $311,503 per year, after winning early U.S. approval on Monday.', "articleSection": "Homepage", "creator": ["Manojna Maddipatla"], "keywords": ["US","VERTEX","PHARMS","FDA","Company News","Health / Medicine","Pharmaceuticals and Medical Research (TRBC)","Content produced in Bangalore","Medical Regulatory Issues","Healthcare (TRBC)","Biotechnology and Medical Research (TRBC)","United States", "Article", "Health"], "about":"Article" } '.
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
Require Evidon Consent: true consent: false undefined
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
Setup media.net with GDPR applied, user not consent
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT SET NON PERSONAL
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT ENABLE SERVICES
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api debug URL: https://static.adsafeprotected.com/sca.17.4.95.js(Line 32)
Message:
a: 0.001953125ms

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

33across-d.openx.net
ad.doubleclick.net
ade.googlesyndication.com
ads.pubmatic.com
adservice.google.com
adservice.google.de
aktrack.pubmatic.com
analytics.carambo.la
ap.lijit.com
api.segment.io
async01.admantx.com
beacon.s-onetag.com
beacon.tru.am
c.evidon.com
cdata.carambo.la
cdn-sic.33across.com
cdn.adsafeprotected.com
cdn.native.ai
cdn.segment.com
cdn.tinypass.com
cdn.tynt.com
cdneast2-xch.media.net
cdnjs.cloudflare.com
connect.facebook.net
contextual.media.net
de.tynt.com
dfp-gateway.s-onetag.com
dpm.demdex.net
dt.adsafeprotected.com
eu-u.openx.net
evidon.mgr.consensu.org
experience.tinypass.com
fonts.googleapis.com
fonts.gstatic.com
gcdn.2mdn.net
geo.moatads.com
get.s-onetag.com
googleads4.g.doubleclick.net
gwiqcdn.globalwebindex.net
iabmap.evidon.com
ib.adnxs.com
ic.tynt.com
image6.pubmatic.com
inimage.carambo.la
l.betrad.com
logging.carambo.la
mab.chartbeat.com
mailview.bulletinhealthcare.com
media.carambo.la
onetag-geo.s-onetag.com
p.brid.tv
pagead2.googlesyndication.com
ping.chartbeat.net
pixel.adsafeprotected.com
pixel.watch
queso-cdn.prod.reuters.tv
r4---sn-4g5ednee.c.2mdn.net
reuters.demdex.net
reutersdfpcw319687550988.s.moatpixel.com
route.carambo.la
s.mnet-ad.net
s.ytimg.com
s2.reutersmedia.net
s3.amazonaws.com
sb.scorecardresearch.com
sc.tynt.com
script.hotjar.com
securepubads.g.doubleclick.net
services.brid.tv
sic.33across.com
sope.prod.reuters.tv
ssc.33across.com
sshowads.pubmatic.com
static.adsafeprotected.com
static.chartbeat.com
static.hotjar.com
static.reuters.com
static.reutersmedia.net
stats-dev.brid.tv
stats.g.doubleclick.net
tagan.adlightning.com
tpc.googlesyndication.com
tru.am
utoumine.net
vars.hotjar.com
vendorlist.consensu.org
wireapi.reuters.com
www.dianomi.com
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.googletagservices.com
www.reuters.com
www.youtube.com
xtr.carambo.la
z.moatads.com
33across-d.openx.net
ic.tynt.com
ssc.33across.com
104.16.39.14
104.16.87.26
104.18.135.13
104.244.36.20
13.224.196.105
13.224.196.35
13.225.78.103
13.225.78.70
136.243.25.83
143.204.101.12
143.204.101.90
143.204.101.92
143.204.99.83
147.75.33.59
147.75.85.103
147.75.85.25
152.195.39.46
172.217.18.102
172.217.23.162
172.217.23.98
185.33.223.202
185.64.189.111
185.64.190.78
199.166.0.26
199.166.0.32
2.18.233.180
2.18.235.40
2.18.235.93
2.19.43.224
208.100.17.177
208.100.17.180
208.100.17.183
208.100.17.185
216.58.208.34
23.45.108.200
23.62.140.165
2600:1f18:624f:b000:4319:b1c8:f4e4:70ed
2600:9000:200c:a600:1e:ef1b:aa40:93a1
2600:9000:200d:b200:1:af78:4c0:93a1
2600:9000:20eb:5a00:10:27b4:f500:93a1
2600:9000:20eb:ec00:5:ae3a:ba00:93a1
2600:9000:2156:3800:18:1fcd:349:ca21
2600:9000:21f3:2800:1f:287:d20a:ce1
2600:9000:21f3:dc00:a:52eb:a100:93a1
2600:9000:21f3:e400:5:9a4c:9b00:93a1
2606:4700:20::6819:a322
2606:4700::6810:4c33
2606:4700::6813:c597
2a00:1450:4001:45::a
2a00:1450:4001:800::2002
2a00:1450:4001:806::2001
2a00:1450:4001:808::200e
2a00:1450:4001:809::200e
2a00:1450:4001:814::2003
2a00:1450:4001:814::200e
2a00:1450:4001:815::2008
2a00:1450:4001:818::2002
2a00:1450:4001:81d::2003
2a00:1450:4001:821::2004
2a00:1450:4001:821::200a
2a00:1450:400c:c04::9d
2a03:2880:f01c:8012:face:b00c:0:3
2a03:2880:f11c:8183:face:b00c:0:25de
2a04:4e42:3::714
3.224.94.188
3.9.140.177
34.199.180.208
34.239.9.60
34.253.43.81
34.95.120.147
35.173.24.113
35.177.169.46
35.201.93.216
52.20.123.7
52.216.113.117
52.26.147.254
52.72.30.216
52.85.183.199
54.228.221.127
54.230.95.132
54.230.95.152
54.235.136.175
66.81.204.228
69.174.55.131
72.251.249.13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